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Abstract
Following a request from the European Commission, the EFSA Panel on Food Additives and Nutrient
sources added to Food (ANS) was asked to deliver a scientiﬁc opinion on the re-evaluation of
microcrystalline cellulose (E 460(i)), powdered cellulose (E 460(ii)), methyl cellulose (E 461), ethyl
cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), ethyl methyl
cellulose (E 465), sodium carboxy methyl cellulose (E 466) and enzymatically hydrolysed carboxy methyl
cellulose (E 469) as food additives. The Joint FAO/WHO Expert Committee on Food Additives (JECFA)
and the Scientiﬁc Committee on Food (SCF) established an acceptable daily intake (ADI) ‘not speciﬁed’
for unmodiﬁed and modiﬁed celluloses. Celluloses are not absorbed and are excreted intact in the faeces;
in addition, microcrystalline cellulose, powdered and modiﬁed celluloses could be fermented by the
intestinal ﬂora in animals and humans. Speciﬁc toxicity data were not always available for all the
celluloses evaluated in the present opinion and for all endpoints. Given their structural, physicochemical
and biological similarities, the Panel considered it possible to read-across between all the celluloses. The
acute toxicity of celluloses was low and there was no genotoxic concern. Short-term and subchronic
dietary toxicity studies performed with E 460(i), E 461, E 462, E 463, E 464, E 466 and E 469 at levels
up to 10% did not indicate speciﬁc treatment related adverse effects. In chronic toxicity studies
performed with E 460(i), E 461, E 463, E 464, E 465 and E 466, the no observed adverse effect level
(NOAEL) values reported ranged up to 9,000 mg/kg body weight (bw) per day. No carcinogenic
properties were detected for microcrystalline cellulose and modiﬁed celluloses. Adverse effects on
reproductive performance or developmental effects were not observed with celluloses at doses greater
than 1,000 mg/kg bw by gavage (often the highest dose tested). The combined exposure to celluloses
(E 460–466, E 468 and E 469) at 95th percentile of the reﬁned (brand-loyal) exposure assessment for the
general population was up to 506 mg/kg bw per day. The Panel concluded that there was no need for a
numerical ADI and that there would be no safety concern at the reported uses and use levels for
the unmodiﬁed and modiﬁed celluloses (E 460(i); E 460(ii); E 461–466; E 468 and E 469). The
Panel considered an indicative total exposure of around 660–900 mg/kg bw per day for microcrystalline,
powdered and modiﬁed celluloses.
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Summary
Following a request from the European Commission, the EFSA Panel on Food Additives and Nutrient
Sources added to Food (ANS) was asked to deliver a scientiﬁc opinion re-evaluating the safety of
microcrystalline cellulose (E 460(i)), powdered cellulose (E 460(ii)), methyl cellulose (E 461), ethyl
cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), ethyl
methyl cellulose (E 465), sodium carboxy methyl cellulose (E 466), enzymatically hydrolysed carboxy
methyl cellulose (E 469) and cross-linked carboxy methyl cellulose (E 468) as food additives. These
celluloses are authorised as food additives in accordance with Annex II and Annex III of Regulation
(EC) No 1333/2008.
Cellulose is a linear glucose homopolymer consisting of glucopyranose units linked by b-1,4-
glycosidic bonds; its molecular formula is (C6H10O5)m, with the degree of polymerisation (DP)
dependent on the origin of the cellulolytic material. Cellulose molecular weight has been calculated to
be approximately in the range 50,000–2,500,000. In modiﬁed celluloses, the chemical and physical
characteristics of the native substances are modiﬁed in order to confer different technological
properties for particular food applications.
Microcrystalline cellulose is puriﬁed, partially depolymerised cellulose prepared by treating a-
cellulose, obtained as a pulp from strains of ﬁbrous plant material, while powdered cellulose is puriﬁed,
mechanically disintegrated cellulose prepared by processing a-cellulose.
Methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl
methyl cellulose (E 464) and ethyl methyl cellulose (E 465) are celluloses obtained synthetically from
ﬁbrous plant material. Each of the celluloses is partially etheriﬁed with methyl groups, ethyl groups,
hydroxypropyl groups and contains a small degree of hydroxypropyl substitution, and methyl and ethyl
groups, respectively.
Microcrystalline cellulose (E 460(i)) and powdered cellulose (E 460(ii)) have been previously
evaluated by the Scientiﬁc Committee on Food (SCF), the most recent evaluation dating in 1999. In
1999, the SCF assessed additional toxicological data and conﬁrmed the ‘ADI not speciﬁed’, established in
1978. As a matter of precaution, the Committee repeated the advice given in 1995, according to which,
the particle size should not be lower than 5 lm with a tolerance of 10% by the number of particles.
The latest evaluation of methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose
(E 463), hydroxypropyl methyl cellulose (E 464), methyl ethyl cellulose (E 465), carboxy methyl
cellulose (E 466) by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) was done in
1989 (JECFA, 1990), where an acceptable daily intake (ADI) ‘not speciﬁed’ was established for each
modiﬁed cellulose. Latest evaluation of enzymatically hydrolysed carboxy methyl cellulose (E 469) was
done in 1998 (JECFA, 1999a,b) and an ADI ‘not speciﬁed’ was established. The ADI for cross-linked
sodium carboxy methyl cellulose previously established by JECFA (2003) is ‘not speciﬁed’ based on the
substance being poorly absorbed and of low toxicity, with which is in agreement with the known low
toxicity of other modiﬁed celluloses.
Animal and human data clearly demonstrated that microcrystalline cellulose (E 460(i)) and powdered
cellulose (E 460(ii)) are not absorbed intact in the gastrointestinal tract and could be fermented during
their passage through the large intestine by strains of bacteria found in the human colon. Data for
methyl cellulose (E 461), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), ethyl
methyl cellulose (E 465), sodium carboxy methyl cellulose (E 466), cross-linked sodium carboxy methyl
cellulose (E 468) and enzymatically hydrolysed carboxy methyl cellulose (E 469) demonstrated that
these modiﬁed celluloses are not absorbed intact, not fermented and are excreted intact via the faeces.
The Panel noted that microcrystalline, powdered and modiﬁed celluloses would not be absorbed intact
and would be less fermented than other polysaccharides such as gums, starches or pectins.
Speciﬁc toxicity data were not always available for all the celluloses evaluated in the present
opinion and for all endpoints. In general, the most complete data sets were available for
microcrystalline cellulose (E 460(i)) and sodium carboxy methyl cellulose (E 466). However, given their
structural, physicochemical and biological similarities, the Panel considered it possible to read-across
between all the celluloses.
Data on acute oral toxicity are available for microcrystalline cellulose, ethyl cellulose, hydroxypropyl
cellulose, hydroxypropyl methyl cellulose and sodium carboxy methyl cellulose. These indicate a low
oral acute toxicity.
Short-term and subchronic toxicity studies have been performed with microcrystalline cellulose
(E 460(i)), methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463),
hydroxypropyl methyl cellulose (E 464), sodium carboxy methyl cellulose (E 466) and enzymatically
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hydrolysed carboxy methyl cellulose (E 469). In the majority of studies, animals were dosed via diet at
levels up to 10%. Effects on body weight at the highest dose tested (10%) were reported in some, but
not all studies, which may reﬂect nutritional constraints rather than toxicity. No adverse effects were
reported with most of the tested celluloses, except for local effects on caecal size due to the presence of
undigested ﬁbre. Groups of 20 Albino Wistar outbred rats per sex were dosed with carboxy methyl
cellulose (E 466) or enzymatically hydrolysed carboxy methyl cellulose (E 469) via diet with 0%, 2.5%,
5% and 10% (up to 6,800 mg/kg body weight (bw) per day) for up to 102 days. Effects on caecal
weight, urothelial hyperplasia, pelvic nephrocalcinosis, corticomedullary nephrocalcinosis and increased
incidence of diffuse epithelial hyperplasia in the urinary bladder were observed. However, the ﬁndings in
kidneys and urinary bladder were attributed to the concentration of sodium, which was up to fourfold
higher in the test diet compared with the basal diet. The Panel noted that this was a plausible
explanation for the reported ﬁndings.
Avicel® RCN-15 (a mixture of 85% microcrystalline cellulose with 15% guar gum) did not induce
mutagenic effects in the presence or absence of a metabolic activation system in bacterial reverse
mutation assays (Batt, 1992), in a gene mutation assay in mouse lymphoma cells (at thymidine kinase
locus) (Cifone, 1992), in an in vitro test for unscheduled DNA synthesis (McKeon, 1992) and in the
mouse bone marrow micronucleus assays (Murli, 1992). Negative results were also reported with other
microcrystalline cellulose preparations in other unpublished studies (Documentation provided to EFSA
no. 34, 35, 36, 37). Overall, the Panel concluded that microcrystalline cellulose (E 460(i)) and
powdered cellulose (E 460(ii)), which only differs for polymerisation degree, do not raise concern for
genotoxicity.
Concerning methyl cellulose and sodium carboxy methyl cellulose, both substances were negative
in Ames tests with different Salmonella Typhimurium strains, both with and without metabolic
activation (Litton Bionetics Inc., 1975, 1980, Blevins and Taylor, 1982; Ishidate et al., 1984). Negative
results were also obtained in a chromosomal aberration assay in Chinese hamster ﬁbroblasts (CHL)
(Ishidate et al., 1984), only performed without metabolic activation, and in host-mediated assays with
yeast and bacteria (Litton Bionetics Inc., 1974, 1975).
Methyl cellulose was also tested with negative results in an in vitro chromosomal aberration assay
in human embryonic lung cells (WI-38), and in vivo in a chromosome aberration assay in rat bone
marrow and in the dominant lethal assay in male rats (Litton Bionetics Inc., 1974).
Therefore, the Panel concluded that methyl cellulose and sodium carboxy methyl cellulose do not
raise concern for genotoxicity.
The Panel also considered that read-across from methyl cellulose (E 461) to the other modiﬁed
celluloses bearing similar simple substituents (E 462, E 463, E 464, E 466) was scientiﬁcally justiﬁed,
and supported by the in silico analysis, which did not highlight additional structural alerts for
genotoxicity, and concluded that either these modiﬁed celluloses did not raise genotoxic concern.
Similarly, the Panel considered scientiﬁcally justiﬁed the read-across from sodium carboxy methyl
cellulose (E 466) to its products of enzymatic hydrolysis (E 469) or cross-linking (E 468), which do not
bear additional structural determinants of genotoxicity. Overall, the Panel concluded that
microcrystalline and powdered cellulose (E 460(i) and E 460(ii)) and modiﬁed celluloses (E 461E 469)
do not raise concern for genotoxicity.
Chronic toxicity studies have been performed with microcrystalline cellulose (E 460(i)), methyl
cellulose (E 461), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), ethyl
methyl cellulose (E 465) and sodium carboxy methyl cellulose (E 466). Although there were some
inconsistencies in the data, the main effects seen were decreases in body weight gain at the highest
dose, which are likely to be due to the amount/bulk of celluloses in the diet leading to nutritional
imbalance. Furthermore, in a chronic feeding study with microcrystalline cellulose (E 460(i)), some
dystrophic calciﬁcation of renal tubules was observed in the high dose group (15,000 mg/kg bw per
day). The no observed adverse effect level (NOAEL) values reported ranged up to 9,000 mg/kg bw per
day. The Panel concluded that microcrystalline cellulose and modiﬁed celluloses have no carcinogenic
properties and that there was no reason to expect carcinogenic properties with powdered cellulose
(E 460(ii)).
Concerning reproductive and developmental toxicity, data are available for microcrystalline cellulose
(E 460(i)), methyl cellulose (E 461), hydroxypropyl cellulose (E 463) and sodium carboxy methyl
cellulose (E 466). The substances were tested in mice, rats, hamsters and/or rabbits with oral dosing
via gavage (FDLI, 1973, 1975; Ferch, 1973a,b; Cannon Labs, 1975, 1977; Kitagawa et al., 1978a,b;
Fritz and Becker, 1981; Freeman, 1992b). Adverse effects on reproductive performance or
Re-evaluation of celluloses (E 460(i), E 460(ii), E 461466, E 468 and E 469) as food additives
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2018;16(1):5047
developmental effects were not observed with modiﬁed and unmodiﬁed celluloses at doses greater
than 1,000 mg/kg bw by gavage (often the highest dose tested).
Speciﬁc toxicity data were not always available for all the celluloses for all endpoints. In general,
the most complete data sets were available for microcrystalline cellulose (E 460(i)) and sodium
carboxy methyl cellulose (E 466). Given the similarities in their structure, relevant physicochemical,
metabolic and toxicological properties, the Panel considered it possible to read-across between all the
celluloses.
In addition, the Panel noted that methyl cellulose (E 461) and sodium carboxy methyl cellulose
(E 466) were frequently used in the formulations for administration of xenobiotics by gavage in
chronic, reproductive and developmental toxicity and carcinogenicity studies. In these studies, there
should be a negative control group receiving the formulation alone. Although modiﬁed cellulose levels
were usually only up to 2%, given the number of studies and group sizes in these studies, the overall
number of animals tested would be very large. The Panel considered that the absence of reported
adverse effects from such vehicle control groups provided additional evidence of the lack of safety
concern for modiﬁed celluloses at levels up to 2% in the vehicle.
There was evidence that repeated doses up to 35 g/person of microcrystalline cellulose or
powdered cellulose did not adversely affect clinical chemistry and haematological parameters and had
no effect on the absorption and/or the metabolism of dietary constituents.
Some modiﬁed celluloses have been used in patients suffering from diarrhoea or constipation. In
general, it can be concluded that an oral ingestion of up to 6,000 mg/person per day for 8 months
was well tolerated.
The Panel noted that carboxy methyl cellulose was one of the food additives reported to alter the
gut microbiota, promote gut inﬂammation, promote obesity and to impair glycaemic control in mice
(Chassaing et al., 2015). In several studies, other emulsiﬁers have been reported to alter the gut
microbiota, promote gut inﬂammation, promote obesity and to impair glycaemic control in
experimental studies with animals (Swidsinski et al., 2009a,b; Renz et al., 2012; Merga et al., 2014;
Cani and Everard, 2015; Chassaing et al., 2015; Romano-Keeler and Weitkamp, 2015; Lecomte et al.,
2016; Shah et al., 2017).
Some of the effects associated with emulsiﬁers are not systematically studied as speciﬁc endpoints
in toxicity studies performed according to current toxicity testing guidelines; therefore, they would
have be investigated on a case-by-case basis if indicated by the results of the general toxicity testing,
as recommended in the Guidance for submission of food additives (EFSA ANS Panel, 2012).
The Panel considered that based on the animal data, the toxicity of microcrystalline, powdered and
modiﬁed celluloses was low and that NOAELs were generally the highest dose tested (up to at least
9,000 mg/kg bw per day). In addition, the large cumulative group of exposed animals from use in
control populations to 2% would indicate that there. There were no reasons why humans would be
expected to be more sensitive than animals in toxicodynamics or. The available data in humans
indicate that daily doses of up to 6,000 mg for around 8 months were not associated with adverse
effects; however in line with many other dietary ﬁbres, large bolus intakes of celluloses were
occasionally associated with laxation, but there was a lack of dose–response data available.
The Panel considered that in line with the conceptual framework, it would be useful if risk
managers had an indicative total exposure (daily consumption value) for microcrystalline, powdered
and modiﬁed celluloses used as food additives, which would not pose a health risk and uses up to this
value would not require a further risk assessment. The Panel considered this could be based on all the
reported NOAELs from subchronic and chronic toxicity studies (ranging from 2100 to more than
9000 mg/kg bw/day), human data and allowing for interindividual uncertainty. The Panel considered
an indicative total exposure (daily consumption value) of around 660 to 900 mg/kg bw per day for
microcrystalline, powdered and modiﬁed celluloses.
To assess the dietary exposure to celluloses (E 460–466, E 468 and E 469) from their use as food
additives, the combined exposure was calculated based on (1) maximum levels of data provided to EFSA
(deﬁned as the maximum level exposure assessment scenario) and (2) reported use levels (deﬁned as
the reﬁned exposure assessment scenario brand-loyal and non-brand-loyal consumer scenario).
Celluloses (E 460–466, E 468 and E 469) are authorised in a wide range of foods. The Panel did
identify brand loyalty to speciﬁc food categories in infants and toddlers (e.g. ﬂavoured drinks). Further,
the Panel considered that the non-brand-loyal scenario covering other population groups was
appropriate and a realistic scenario for risk characterisation because it was assumed that the
population would probably be exposed long-term to the food additive present at the mean reported
use in processed food.
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A reﬁned estimated exposure assessment scenario taking into account the food for special medical
purpose (FSMP) for infants and young children (Food category (FC) 13.1.5.1 dietary foods for infants
for special medical purposes and special formulae for infants and 13.1.5.2 dietary foods for babies and
young children for special medical purposes as deﬁned by Commission Directive 1999/22/EC in which
E 466 is authorised) was also performed to estimate exposure for infants and toddlers who may be on
a speciﬁc diet. However, no reported use levels were made available by industry for these food
categories. Thus, MPLs of E 466 for FSMP were used. The Panel noted that according to Mintel, very
few baby foods were on the European market containing E 466. This was in line with the fact that no
data were submitted for the food categories 13.1.5.1 and 13.1.5.2.
A reﬁned estimated exposure assessment scenario taking into account the consumption of food
supplements for consumers only, were also performed to estimate exposure for children, adolescents,
adults and the elderly, as exposure via food supplements may deviate largely from that via food, and
the number of food supplements consumers may be low depending on populations and surveys.
The reﬁned estimates were based on 26 out of 84 food categories in which celluloses (E 460–466,
E 468 and E 469) are authorised. The Panel considered that the uncertainties identiﬁed would, in
general, result in an overestimation of the exposure to celluloses (E 460–466, E 468 and E 469) as
food additives in European countries for the reﬁned scenario if it is considered that the food additives
may not be used in food categories for which no usage data have been provided.
The Panel noted that given the information from the Mintel’s Global New Products Database
(GNPD), it may be assumed that celluloses (E 460–466, E 468 and E 469) are used in food categories
for which no data have been provided by food industry. The main food categories, in terms of amount
consumed, not taken into account were processed fermented milk products, cheeses (unripened,
processed), ﬁsh and ﬁshery products and breakfast cereals. However, according to the Mintel GNPD, in
the European Union (EU) market, a small percentage (< 1%) of food products belonging to these food
categories are labelled with celluloses (E 460–466, E 468 and E 469). Therefore, the Panel considered
that if these uncertainties were conﬁrmed, it would result in a slight underestimation of the exposure.
The Panel further noted that the exposure to celluloses (E 460–466, E 468 and E 469) from their
use according the Annex III to Regulation (EC) No 1333/2008 was not considered in the exposure
assessment.
The Panel also noted that the reﬁned exposure estimates were based on information provided on
the reported levels of use of celluloses (E 460–466, E 468 and E 469). If actual practice changes, this
reﬁned estimates may no longer be representative and should be updated.
Following the conceptual framework for the risk assessment of certain food additives re-evaluated
under Commission Regulation (EU) No 257/2010 (EFSA ANS Panel, 2014) and given that:
• their structural, physicochemical and biological similarities, allows for read-across between all
the celluloses
• animal and human data demonstrate that microcrystalline cellulose (E 460(i)) and powdered
cellulose (E 460(ii)) are not absorbed intact in the gastrointestinal tract but could be fermented
by intestinal microbiota. Chemically modiﬁed celluloses are not absorbed intact, nor fermented,
but are excreted intact via the faeces
• using the read-across approach, adequate data on short- and long-term toxicity and
carcinogenicity and reproductive toxicity are available,
• despite the limitations of some of the studies, the available data do not indicate a genotoxic
concern for microcrystalline cellulose, methyl cellulose and carboxy methyl cellulose, and by
read-across, of the other modiﬁed and unmodiﬁed celluloses
• no adverse effects were reported after repeated doses up to 35 g/person of microcrystalline
cellulose or powdered cellulose; oral ingestion of some modiﬁed celluloses up to 6,000 mg/
person per day for 8 months in patients suffering from diarrhoea or constipation was well
tolerated;
• adequate combined exposure data were available; in the general population, the highest 95th
percentile reﬁned exposure assessment estimates calculated based on the reported data from
food industry was 506 mg/kg bw per day in toddlers (brand-loyal scenario)
• an indicative high reﬁned exposure assessment of up to 448 mg/kg bw per day for the elderly
has been calculated at the 95th percentile among the population classes consuming food
supplements
The Panel concluded that there was no need for a numerical ADI and that there would be no safety
concern at the reported uses and use levels for the unmodiﬁed and modiﬁed celluloses (E 460(i);
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E 460(ii); E 461–466; E 468 and E 469). The Panel further suggested an indicative total exposure
(daily consumption value) of 660900 mg/kg bw per day where these conclusions would remain valid.
Concerning the use of sodium carboxy methyl cellulose (E 466) in ‘dietary foods for special medical
purposes and special formulae for infants’ (FC 13.1.5.1) and in ‘dietary foods for babies and young
children for special medical purposes as deﬁned in Directive 1999/21/EC’ (FC 13.1.5.2), and given that:
• for infants and toddlers consumers only of FSMP, the highest 95th percentile reﬁned exposure
estimate was 1,557 mg/kg bw per day in infants;
• no adequate speciﬁc studies addressing the safety of use of sodium carboxy methyl cellulose
(E 466) in this population under certain medical conditions were available;
the Panel concluded, that the available data did not allow for an adequate assessment of the safety
of use of sodium carboxy methyl cellulose (E 466) in infants and young children consuming foods
belonging to the categories 13.1.5.1 and 13.1.5.2. The Panel noted that E 466 seemed not to be used
in these food categories as no use or use levels were submitted by industry and only very few food
belonging to these categories appeared to be labelled with E 466.
The Panel recommended that the European Commission considers lowering the maximum limits for
the toxic elements arsenic, lead, mercury and cadmium present as impurities in the EU speciﬁcations
for unmodiﬁed and modiﬁed celluloses re-evaluated in the present opinion (E 460(i), E 460(ii), E 461,
E 462, E 463, E 464, E 465, E 466, E 468 and E 469) should be revised to ensure that these food
additives will not be a signiﬁcant source of exposure to these toxic elements in food, in particular for
infants and children.
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1. Introduction
The present opinion deals with the re-evaluation of microcrystalline cellulose (E 460(i)), powdered
cellulose (E 460(ii)), methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463),
hydroxypropyl methyl cellulose (E 464), ethyl methyl cellulose (E 465), sodium carboxy methyl
cellulose (E 466), cross-linked carboxy methyl cellulose (E 468) and enzymatically hydrolysed carboxy
methyl cellulose (E 469) when used as food additives. These celluloses are authorised food additives in
the EU according to Annex II and Annex III of Regulation (EC) No 1333/2008.
For the purpose of this opinion, the term modiﬁed cellulose is used for all the celluloses mentioned
above.
1.1. Background and Terms of Reference as provided by the European
Commission
1.1.1. Background
Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives
requires that food additives are subject to a safety evaluation by the European Food Safety Authority
(EFSA) before they are permitted for use in the European Union. In addition, it is foreseen that food
additives must be kept under continuous observation and must be re-evaluated by EFSA.
For this purpose, a programme for the re-evaluation of food additives that were already permitted in
the European Union before 20 January 2009 has been set up under the Regulation (EU) No 257/20101.
This Regulation also foresees that food additives are re-evaluated whenever necessary in light of
changing conditions of use and new scientiﬁc information. For efﬁciency and practical purposes, the
re-evaluation should, as far as possible, be conducted by group of food additives according to the main
functional class to which they belong.
The order of priorities for the re-evaluation of the currently approved food additives should be set
on the basis of the following criteria: the time since the last evaluation of a food additive by the
Scientiﬁc Committee on Food (SCF) or by EFSA, the availability of new scientiﬁc evidence, the extent
of use of a food additive in food and the human exposure to the food additive taking also into account
the outcome of the Report from the Commission on Dietary Food Additive Intake in the EU of 2001.
The report ‘Food additives in Europe 2000’ submitted by the Nordic Council of Ministers to the
Commission, provides additional information for the prioritisation of additives for re-evaluation.
In 2003, the Commission already requested EFSA to start a systematic re-evaluation of authorised
food additives. However, as a result of adoption of Regulation (EU) 257/2010 the 2003 Terms of
References are replaced by those below.
1.1.2. Terms of Reference
The Commission asks EFSA to re-evaluate the safety of food additives already permitted in the
Union before 2009 and to issue scientiﬁc opinions on these additives, taking especially into account the
priorities, procedures and deadlines that are enshrined in the Regulation (EU) No 257/2010 of 25
March 2010 setting up a programme for the re-evaluation of approved food additives in accordance
with the Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food
additives.
1.1.3. Interpretation of Terms of Reference
Speciﬁc toxicity data were not always available for all the celluloses for all endpoints. However,
given their structural, physicochemical and biological similarities, the Panel considered it possible to
read-across between all the celluloses.
The ANS Panel described its risk assessment paradigm in its Guidance for submission for food
additive evaluations in 2012 (EFSA ANS Panel, 2012). This Guidance states, that in carrying out its risk
assessments, the Panel sought to deﬁne a health-based guidance value e.g. an Acceptable Daily
Intake (ADI) (IPCS, 2004) applicable to the general population. According to the deﬁnition above, the
ADI as established for the general population does not apply to infants below 12 weeks of age (JECFA,
1 Commission Regulation (EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved food
additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives.
OJ L 80, 26.3.2010, p. 19–27.
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1978; SCF, 1998). In this context, the re-evaluation of the use of sodium carboxy methyl cellulose
(E 466) in food for infants below 12 weeks represents a special case for which speciﬁc
recommendations were given by the Joint FAO/WHO Expert Committee on Food Additives (JECFA)
(JECFA, 1972, 1978), by the SCF (SCF, 1996, 1998) and by EFSA (EFSA Scientiﬁc Committee, 2017).
The Panel endorsed these recommendations.
In the current EU legislation (Annex II of Regulation (EC) No 1333/20081), use levels of additives in
food for infants under the age of 12 weeks are included in categories 13.1.1 and 13.1.5.1.2 The
Panel considers that these uses would require a speciﬁc risk assessment in line with the
recommendations given by JECFA and SCF and endorsed by the Panel in its current Guidance for
submission for food additives evaluations (EFSA ANS Panel, 2012). Therefore, a risk assessment for the
general population is not considered applicable for infants under the age of 12 weeks, and will be
performed separately.
This re-evaluation refers exclusively to the uses of celluloses as food additives in food, including
food supplements and does not include a safety assessment of other uses of celluloses.
1.2. Information on existing authorisations and evaluations
In 1978, the SCF endorsed the ‘ADI not speciﬁed’ established by JECFA for microcrystalline cellulose
and powdered cellulose. The Committee did not give any details of the data considered (SCF, 1978). In
1995, the SCF evaluated the presumed persorption and advised: (1) that microcrystalline cellulose of
any particle size should not be used in foods specially prepared for infants and young children and, (2)
a particle size > 5 lm should be introduced in the speciﬁcation (SCF, 1995). In 1999, the SCF assessed
the additional toxicological data and conﬁrmed the ‘ADI not speciﬁed’. As a matter of precaution, the
Committee repeated the advice that particle size should not be lower than 5 lm with a tolerance of
10% by the number of particles (SCF, 1999).
In 1976, an ‘ADI not speciﬁed’ was allocated by JECFA for powdered cellulose (JECFA, 1976). The
Committee stated that the toxicological evaluation performed for microcrystalline cellulose (JECFA,
1975) should also apply to powdered cellulose (JECFA, 1976). In the latest evaluation (JECFA, 1998a,b,
1999a,b), the Committee concluded that the toxicological data from humans and animals provided no
evidence for toxic effects after the ingestion of microcrystalline cellulose in food, and endorsed the
previous evaluation ‘ADI not speciﬁed’. However, the Committee stated that small particles of other
materials may be persorbed and that the extent of persorption is greater with sub-micrometer
particles. Despite the absence of any demonstrated persorption of microcrystalline cellulose in the
recent animal studies, the Committee revised the speciﬁcations for microcrystalline cellulose to limit the
content of particles less than 5 lm in diameter (see Section 2.2).
Microcrystalline cellulose (E 460(i)) and powdered cellulose (E 460(ii)) were also evaluated by the
Nordic Council of Ministers (TemaNord, 2002). The Committee concluded that microcrystalline cellulose
and powdered cellulose as deﬁned by the speciﬁcations is covered by the toxicological evaluation,
including restriction on particle size.
Microcrystalline cellulose (E 460(i)) and powdered cellulose (E 460(ii)) (PM Ref. 43280) are included in
the Union list of authorised substances that may be intentionally used in the manufacture of plastic layers
in plastic materials and articles (Annex I to Commission Regulation (EU) No 10/20113). Furthermore,
microcrystalline cellulose (E 460(i)) is permitted as an antioxidant in cosmetic products (European
Commission database-CosIng). Microcrystalline cellulose (E 460(i)) and powdered cellulose (E 460(ii))
are included in the European Union Register of feed additives (Regulation (EC) No 1831/20034).
Methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl
methyl cellulose (E 464), ethyl methyl cellulose (E 465), sodium carboxy methyl cellulose (E 466),
cross-linked carboxy methyl cellulose (E 468) and enzymatically hydrolysed carboxy methyl cellulose
(E 469) are listed in Commission Regulation (EU) No 231/20125 as authorised food additives in the EU
2 Food of category 13.1.1: Infant formulae as deﬁned by Directive 2006/141/EC; Food of category 13.1.5.1: Dietary foods for
infants for special medical purposes and special formulae for infants. This interpretation also applies to those food additives in
food category 13.1.5.2 (Dietary foods for babies and young children for special medical purposes as deﬁned in Directive 1999/
21/EC) for which exceptional uses in food for infants under the age of 12 weeks are indicated.
3 Commission Regulation (EU) No 10/2011 of 14 January 2011 on plastic materials and articles intended to come into contact
with food. OJ L 12, 15.1.2011, p. 1–89.
4 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
5 Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down speciﬁcations for food additives listed in Annexes II
and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council. OJ L 83, 22.3.2012, p. 1.
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and are used as stabilisers, emulsiﬁers, thickeners, humectants, anticaking agents, foaming agents,
bulking agents, gelling agents and glazing agents.
These substances have been previously evaluated by JECFA in 1989 (JECFA, 1990) and 1998
(JECFA, 1999a,b). An ‘ADI not speciﬁed’ was established for each modiﬁed cellulose E 461–E 466 and
E 469 (JECFA, 1990, 1999a,b).
Toxicological data for methyl cellulose (E 461), hydroxypropyl cellulose (E 463), hydroxypropyl
methyl cellulose (E 464), methyl ethyl cellulose (E 465) and sodium carboxy methyl cellulose (E 466)
were re-evaluated by the SCF in 1992 (SCF, 1994). The Committee allocated an ADI ‘not speciﬁed’ to
the ﬁve modiﬁed celluloses. The other modiﬁed celluloses, ethyl cellulose (E 462) and enzymatically
hydrolysed sodium carboxy methyl cellulose (E 469) were not evaluated by the SCF.
In 1998, the SCF accepted the use of sodium carboxy methyl cellulose (E 466) in foods for special
medical purposes (FSMP) for infants and young children at levels up to 10 g/L in liquid foods and up at
10 g/kg in solid foods. The Committee earlier reserved its opinion on a request to use E 466 in
weaning foods pending completion of its work on persorption of macromolecular additives, but noted
that otherwise the toxicological data did not indicate any effects likely to be of concern for infants and
young children over weaning age. However, the Committee has since been informed that sodium
carboxy methyl cellulose in water is in colloidal form and hence is not likely to be persorbed.
Cross-linked sodium carboxy methyl cellulose (E 468) is listed in Commission Regulation (EU)
No 231/2012 as an authorised food additive in the EU and has been previously evaluated by JECFA in
2003 (JECFA, 2003). At its 59th meeting, JECFA concluded that the ADI could not be speciﬁed (JECFA,
2003).
Cross-linked sodium carboxy methyl cellulose (E 468) is the sodium salt of thermally cross-linked
partly O-carboxymethylated cellulose, the use of which is solely as a carrier for sweeteners.
The SCF had accepted the use of cross-linked sodium carboxy methyl cellulose (E 468) on the
grounds of lack of toxicity in a limited data set and a history of safe use of the parent compound
sodium carboxy methyl cellulose (SCF, 1996, 1998). In 1996, no ADI was established due to
insufﬁcient toxicological data, but the use of cross-linked sodium carboxy methyl cellulose was deemed
acceptable as a disintegrant for sweetener tablets due to its limited use through this application. The
most recent SCF opinion dating from 1998, refers to new data submitted to the Committee, and
recommends the use of cross-linked sodium carboxy methyl cellulose (E 468) as a disintegrant at a
level not exceeding 30 g/kg in dietary supplements. The Committee’s recommendation was based on
the newly available technical and toxicological data and the long history of safe use of the parent
compound, sodium carboxy methyl cellulose. The parent compound is stated to be poorly absorbed in
humans and animals, with a likely further reduction in absorption as a consequence of cross-linking.
Cross-linked sodium carboxy methyl cellulose was thereafter reviewed by JECFA in 2003. The
evaluation set a new ADI of ‘ADI not speciﬁed’, describing the substance as ‘poorly absorbed’ and of
‘low toxicity’, and with consideration to the available toxicological data which were consistent with that
of other modiﬁed celluloses.
In 2002, the Nordic Council reviewed cross-linked sodium carboxy methyl cellulose and concluded
that there was no need for a re-evaluation (TemaNord, 2002).
Modiﬁed celluloses are included in the Union list of authorised substances that may be intentionally
used in the manufacture of plastic layers in plastic materials and articles (Annex I to Commission
Regulation (EU) No 10/2011) (methyl cellulose (E 461), PM Ref. 66240; ethyl cellulose (E 462), PM
Ref. 53280; hydroxypropyl cellulose (E 463), PM Ref. 61680; hydroxypropyl methyl cellulose (E 464),
PM Ref. 66700; ethyl methyl cellulose (E 465), PM Ref. 66640; sodium carboxy methyl cellulose
(E 466); (hydrolysed) carboxy methyl cellulose (E 469), PM Ref. 42640).
Furthermore, in 2010, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA Panel)
issued an opinion addressing the scientiﬁc substantiation of health claims in relation to hydroxypropyl
methylcellulose (EFSA NDA Panel, 2010a,b). It was concluded that a cause and effect relationship has
been established between the consumption of hydroxypropyl methylcellulose and a reduction of post-
prandial glycaemic responses, as well as the maintenance of normal blood cholesterol concentrations.
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2. Data and methodologies
2.1. Data
The Panel was not provided with a newly submitted dossier. EFSA launched public calls for data,6,7,8,9
to collect relevant information from interested parties.
The Panel based its assessment on information submitted to EFSA following the public calls for
data, information from previous evaluations and additional available literature up to the last Working
Group (WG) meeting before the adoption of the opinion. Attempts were made at retrieving relevant
original study reports on which previous evaluations or reviews were based, however not always these
were available to the Panel.
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database10) was
used to estimate the dietary exposure.
The Mintel’s Global New Products Database (GNPD) is an online database which was used for
checking the labelling of products containing E 460(i), E 460(ii), E 461466, E 468469 within the
EU’s food products, as GNPD shows the compulsory ingredient information presented in the labelling of
products.
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA Guidance on
transparency in the scientiﬁc aspects of risk assessment (EFSA Scientiﬁc Committee, 2009) and
following the relevant existing Guidances from the EFSA Scientiﬁc Committee.
The ANS Panel assessed the safety of microcrystalline cellulose (E 460(i)), powdered cellulose
(E 460(ii)), methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463),
hydroxypropyl methyl cellulose (E 464), ethyl methyl cellulose (E 465), sodium carboxy methyl
cellulose (E 466), cross-linked carboxy methyl cellulose (E 468) and enzymatically hydrolysed carboxy
methyl cellulose (E 469) as food additives in line with the principles laid down in Regulation (EU) 257/
2010 and in the relevant guidance documents: Guidance on submission for food additive evaluations
by the Scientiﬁc Committee on Food (SCF, 2000) and taking into consideration the Guidance for
submission for food additive evaluations in 2012 (EFSA ANS Panel, 2012).
When the test substance was administered in the feed or in the drinking water, but doses were not
explicitly reported by the authors as mg/kg bw per day based on actual feed or water consumption,
the daily intake was calculated by the Panel using the relevant default values as indicated in the EFSA
Scientiﬁc Committee (2012) for studies in rodents or, in the case of other animal species, by JECFA
(2000a,b,c). When in human studies in adults (aged above 18 years) the dose of the test substance
administered was reported in mg/person per day, the dose in mg/kg bw per day was calculated by the
Panel using a body weight of 70 kg as default for the adult population as described in the EFSA
Scientiﬁc Committee Guidance document (EFSA Scientiﬁc Committee, 2012).
Dietary exposure of microcrystalline cellulose (E 460(i)), powdered cellulose (E 460(ii)), methyl
cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl methyl
cellulose (E 464), ethyl methyl cellulose (E 465), sodium carboxy methyl cellulose (E 466), cross-linked
carboxy methyl cellulose (E 468) and enzymatically hydrolysed carboxy methyl cellulose (E 469) from
their use as food additives was estimated combining the food consumption data available within the
EFSA Comprehensive European Food Consumption Database with the maximum permitted levels
(MPLs) and reported use levels submitted to EFSA following a call for data. Different exposure
scenarios were calculated. Uncertainties on the exposure assessment were identiﬁed and discussed
with regard to their impact on the ﬁnal exposure calculation.
6 Call for scientiﬁc data on food additives permitted in the EU and belonging to the functional classes of emulsiﬁers, stabilisers
and gelling agents. Published: 22 November 2009. Available online: http://www.efsa.europa.eu/en/dataclosed/call/ans091123.
7 Call for technical data on certain thickening agents permitted as food additives in the EU. Published: 19 December 2014.
Available online: http://www.efsa.europa.eu/it/data/call/141219
8 Call for food additives usage level and/or concentration data in food and beverages intended for human consumption.
Published: 12 October 2015. Available online: http://www.efsa.europa.eu/en/data/call/151012
9 Call for technical data on certain starches and celluloses authorised as food additives in the EU. Published 11 February 2016.
http://www.efsa.europa.eu/sites/default/files/consultation/160211.pdf
10 Available online: http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb.htm
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3. Assessment
3.1. Technical data
3.1.1. Identity of the substances
Cellulose is a linear homopolymer consisting of repeating b-D-glucopyranosyl units linked via (1,4)
glycosidic bonds (Figure 1). It is the most abundant substance occurring in nature and an important
structural component of the primary cell wall of green plants, many forms of algae and the oomycetes
(Iijima and Takeo, 2000; Coffey et al., 2006).
Cellulose has the CAS Registry No 9004-34-6 and the EC (EINECS) Number 232-674-9. The molecular
formula is (C6H10O5)m; ‘m’ (degree of polymerisation (DP)) is dependent on the origin of the cellulolytic
material. The molecular weight has been calculated to be approximately from 50,000 to 2,500,000,
corresponding to (DP) 300–15,000 glucose units. As an example, for native cellulose the DP varies from
3,500 to 10,000 with molecular weights of 600,000–1,500,000 (Hamilton and Mitchell, 1964), although for
cotton, the DP could be as high as 15,000 (Holtzapple, 2003). According to Stepan et al., 2016, the
cellulose of cotton linter had an average molecular weight of 253,770, which corresponds to a DP of 1,450.
Cellulose is described as a rigid material in which the molecules are associated, over extended
regions, forming polycrystalline, ﬁbrous bundles. The crystalline regions are hold together by a large
number of hydrogen bonds and are separated and connected by amorphous regions (BeMiller and
Whistler, 1996).
Cellulose is insoluble in water because of strong hydrogen bonding in its crystal lattice. However, it
is soluble in a number of solvents, including concentrated acids (e.g. 85% phosphoric, 72% sulfuric
and 40% hydrochloric acid) and inorganic salt solutions (e.g. cuprammonium hydroxide, cadmium
ethylenediamine solvent also known as cadoxen) (Holtzapple, 2003).
Celluloses are subdivided into three classes: a-, b- and c-cellulose; all have the same chemical
structure but differ in their DP: a-cellulose DP > 200; b-cellulose DP 30200; c-cellulose DP 1030
(Chen, 2014).
Celluloses differ in their solubility in 17.5% NaOH: a-cellulose is the fraction that is not removed by
treatment with 17.5% NaOH at 20°C; the fraction soluble in 17.5% NaOH contains b-cellulose and
c-cellulose; the subfraction precipitating after acidiﬁcation of the alkaline liquor is b-cellulose; the
acid-base soluble fraction that remains dispersed is c-cellulose (Walter, 1998).
3.1.1.1. Microcrystalline cellulose (E 460(i))
According to Commission Regulation (EU) No 231/2012, microcrystalline cellulose is puriﬁed,
partially depolymerised cellulose prepared by treating a-cellulose, obtained as a pulp from strains of
ﬁbrous plant material, with mineral acids. The DP is typically < 400; the molecular weight is about
36,000 g/mol.
Microcrystalline cellulose is puriﬁed, partially depolymerised cellulose with shorter crystalline
polymer chains.
Synonyms: microcrystalline cellulose is known as cellulose gel (JECFA, 2009).
Microcrystalline cellulose is a ﬁne, white, odourless, crystalline powder. The particles are insoluble
but able to swell in water, in dilute alkali and acids, and in most organic solvents. The substance is
soluble in NaOH solution (Klose and Glicksman, 1990; Coffey et al., 2006). At concentrations below
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Figure 1: Example of a general formula of a native cellulosic structure (‘n’ being variable, depending
on the origin of the cellulolytic material)
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1%, microcrystalline cellulose forms colloidal solutions, and above 1%, thixotropic gels (Klose and
Glicksman, 1990).
3.1.1.2. Powdered cellulose (E 460(ii))
According to the deﬁnition of Commission Regulation (EU) No 231/2012, powdered cellulose is
puriﬁed, mechanically disintegrated cellulose prepared by processing a-cellulose obtained as a pulp
from strains of ﬁbrous plant materials. The DP is predominantly ≥ 1,000 and greater, corresponding to
a molecular weight of > 160,000 (JECFA, 2006a).
In Commission Regulation (EU) No 231/2012, the substance is described as a white, odourless
powder, which is insoluble in water, ethanol, ether and dilute mineral acids, but slightly soluble in
sodium hydroxide solution.
Powdered cellulose is able to swell in water, dilute acid and most solvents, while alkali solutions
lead to swelling and dissolution of the present hemicelluloses (Coffey et al., 2006).
3.1.1.3. Chemically modiﬁed celluloses (E 461–466, E 468 and E 469)
Methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl
methyl cellulose (E 464) and ethyl methyl cellulose (E 465) are celluloses obtained synthetically from
ﬁbrous plant material. Each of the celluloses is partially etheriﬁed with methyl groups, ethyl groups,
hydroxypropyl groups and contains a small degree of hydroxypropyl substitution, and methyl and ethyl
groups, respectively (Figure 2).
Sodium carboxy methyl cellulose (E 466) is the partial sodium salt of a carboxymethyl ether of
cellulose.
Cross-linked sodium carboxy methyl cellulose (E 468) is obtained from carboxy methyl cellulose by
acidifying and heating the aqueous suspension.
Enzymatically hydrolysed carboxy methyl cellulose sodium salt (E 469) is obtained from carboxy
methyl cellulose by enzymatic digestion with a cellulase produced by Trichoderma longibrachiatum
(formerly Trichoderma reesei).
All modiﬁed celluloses are derived from cellulose. They carry the cellulose backbone which consists of
a polymer of b-(1?4) linked D-glucopyranose units (also called anhydroglucose unit (AGU)) (Freudenberg
and Braun, 1928; Gardner and Blackwell, 1974). The hydroxyl groups at the carbon atoms C-2, C-3 and
C-6 of the glucopyranose are more or less completely etheriﬁed depending on the used substitution
reagent and conditions during manufacturing (Klemm et al., 1998; Murray, 2009; Qi et al., 2009).
The average number of hydroxyl groups substituted per glucopyranose unit is known as degree of
substitution (DS). A complete substitution would provide a DS of 3. In the case of hydroxypropyl
cellulose (E 463) and hydroxypropyl methyl cellulose (E 464), the DS can be higher than 3 because
the hydroxypropyl group added also contains a hydroxyl group which can be etheriﬁed (Klemm et al.,
1998; Desai et al., 2006).
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The CAS Registry Numbers and EINECS numbers of the chemically modiﬁed celluloses (E 461–466,
E 468 and E 469) are given in Table 1.
Figure 2: General chemical structure of modiﬁed celluloses E 461–466 and E 468 and E 469, where R
represents hydrogen or speciﬁc groups, as indicated. In this structure, ‘n’ represents the
number of anhydrocellobiose repeating units
Table 1: CAS Registry Numbers and EINECS Numbers of chemically modiﬁed celluloses
(W€ustenberg, 2015; ChemIdplus)
Substance
CAS registry
number
EC
(EINECS)(a)
number
Molecular formula
Methyl cellulose (E 461) 9004-67-5 618-391-7 C6H7O2(OH)x(OCH3)y
x = 1.00–1.55; y = 2.00–1.45; x + y = 3.00 (y = degree
of substitution)
Ethyl cellulose (E 462) 9004-57-3 618-384-9 C2H6O.x-unspeciﬁed
Hydroxypropyl cellulose
(E 463)
9004-64-2 618-388-0 [C6H7O2(OH)x(OCH2CHOHCH3)y(OCH2CH[Rw]CH3)z]n
x + y + z = 3; y + z(1 + w) ≤ 4.6
R: substituent with ‘w’ hydroxypropyl groups
Hydroxypropyl methyl
cellulose (E 464)
9004-65-3 618-389-6 [C6H7O2(OH)x(OCH3)y(OCH2CHOHCH3)z]n
z = 0.07–0.34; y = 1.12–2.03; x = 3 – (z + y),
(z + y) = degrees of substitution
Ethyl methyl cellulose
(E 465)
9004-59-5(b) – [C6H7O2(OH)x(OCH3)y(OC2H5)z]n,
z = 0.57–0.8; y = 0.2–0.4; x = 3 – (x + y)
(x + y) = degrees of substitution
Sodium carboxy methyl
cellulose (E 466)
9004-32-4 618-378-6 [C6H7O2 (OH)x (OCH2COONa)y]n
n ≥ 4
x = 1.50–2.80; y = 0.20–1.50; x + y = 3.0
(x + y) = degree of substitution
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The CAS Registry numbers and EC (or EINECS) numbers reported in Table 1 were subject to
conﬁrmatory steps to minimise the uncertainty of a possible equivocal identiﬁcation. The
Panel considered that modiﬁed celluloses are complex structures for which — likewise modiﬁed
starches (EFSA ANS Panel, 2017a,b) — the CAS registration scheme may unintentionally allow that
multiple, possibly erratic, or redundant entries exist for identiﬁcation of a given substance. However,
regardless of the potential uncertainty underlying CAS identiﬁers, the Panel noted that attributing CAS
numbers, which are as reliable as possible to such structures, is probably the ‘best’ available way for a
reasonably accurate identiﬁcation of the chemicals.
Chemically modiﬁed celluloses are white or slightly yellowish, odourless and tasteless powders.
However, the physical appearance of the modiﬁed celluloses depends on the type of substitution, the
DP and the DS (Brandt, 2001; Murray, 2009).
All modiﬁed celluloses, except ethyl cellulose (E 462) and cross-linked sodium carboxy methyl
cellulose (E 468), are water-soluble polymers. Ethyl cellulose (E 462) is the only modiﬁed cellulose not
soluble in water but soluble in ethanol. Hydroxypropyl cellulose (E 463) and ethyl methyl cellulose
(E 465) are both soluble in water and ethanol (Archer, 1991; Brandt, 2001; Cash and Caputo, 2010).
However, the solubility of the modiﬁed celluloses is inﬂuenced by the DS, e.g. sodium carboxy methyl
cellulose (CMC, E 466) with a DS < 0.3 is only soluble in alkali. As the DS approaches 0.7, CMC can is
easily be dissolved in water, above a DS of 1, CMC (E 466) is less water soluble (Coffey et al., 2006).
The Panel noted that the data provided by industry indicated that the majority of particles of individual
modiﬁed celluloses were in the range of 10–100 lm. In addition, based on the known ability of cellulose
particles to swell in water, the presence of nanoscale material after ingestion is highly unlikely.
Aqueous solutions of modiﬁed celluloses are highly viscous, depending on concentration,
temperature, average chain length of the macromolecule (DP), and the presence of salts or other
additives (Brandt, 2001; Cash and Caputo, 2010).
The rheological behaviour of a solution at a given concentration and temperature may be Newtonian,
pseudoplastic, thixotropic or even gel-forming, depending on the chain length, the substituent distribution,
and the nature of the ether group (Coffey et al., 2006). The viscosities of 2% neutral, aqueous solutions
of modiﬁed celluloses at ambient temperature range from 5 to over 105 mPa.s (Brandt, 2001).
Aqueous solutions of methyl cellulose (E 461) and hydroxypropyl methyl cellulose (E 464) are
characterised by thermal insolubility. Increases in temperature ﬁrst lead to a minor decrease in
viscosity. When the gelling temperature is reached, there is a sharp increase in viscosity. The viscosity
or gel strength remains at a constant value. This gelation is a reversible process. Gel temperature and
texture are dependent on the DS and substitution type (Haque and Morris, 1993; Haque et al., 1993;
Klemm et al., 1998; Brandt, 2001; Coffey et al., 2006; Murray, 2009; Cash and Caputo, 2010).
The pH of aqueous extracts of E 461, E 463, E 464 and E 465 was found to be between 5 and 8,
whereas E 462 was neutral. Due to their sodium content, E 466 and E 469 have slightly elevated pH
values (between 5 and 8.5 and 6 and 8.5, respectively).
Substance
CAS registry
number
EC
(EINECS)(a)
number
Molecular formula
Cross-linked sodium
carboxy methyl cellulose
(E 468)
74811-65-7 – Substituted anhydroglucose units with as general
formula: C6H7O2(OR1)(OR2)(OR3) where R1, R2 and R3
may be any of the following groups in varying
proportions:
–H
–CH2–COONa
–CH2–COOH
Degree of substitution: 0.600.85
Enzymatically
hydrolysed carboxy
methyl cellulose (E 469)
– – [C6H7O2(OH)x(OCH2COONa)y]
n ≥ 4
x = 1.50–2.80y = 0.2–1.50x + y = 3.0(x+y) = degree of
substitution
CAS: Chemical Abstract Service; EINECS: European Inventory of Existing Commercial Chemical Substances.
(a): According to the ECHA database (ECHA, 2016), EC numbers with format 6xx-xxx-x have no ofﬁcial status and have no legal
signiﬁcance.
(b): The CAS Registry No 9004-69-7 has also been assigned to ethyl methyl cellulose (E 465).
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Infrared (IR) and nuclear magnetic resonance (NMR) spectra are available for all modiﬁed celluloses
except for E 469 (Desai et al., 2006; Qi et al., 2009). Purity data are given by Nurkeeva et al. (2005).
Cross-linked sodium carboxy methyl cellulose (E 468)
Cross-linked sodium carboxy methyl cellulose (E 468) is an internally linked polymer of carboxy
methyl cellulose sodium (E 466). It is deﬁned in Commission Regulation (EU) No 231/2012 as the
sodium salt of thermally cross-linked partly O-carboxymethylated cellulose.
Cross-linked sodium carboxy methyl cellulose (E 468) has the CAS Registry Number 748-11-65-7.
No EC (EINECS) Number has been attributed to E 468. The molecular formula is C6H7O2(OR1)(OR2)
(OR3), with R1, R2 and R3 groups in varying proportion (–H, –CH2COONa, –CH2COOH).
A representative structural formula of cross-linked sodium carboxy methyl cellulose (E 468) is
shown in Figure 3.
Cross-linked sodium carboxy methyl cellulose is described as a white to off-white, slightly
hygroscopic, odourless powder, containing not more than 10% water-soluble matter. The substance is
insoluble in ether, alcohol and organic solvents. It is indicated that cross-linking makes the substance
ﬁbrous, hydrophilic, highly water-absorbing, which results in pronounced swelling and wicking
properties (Mane and Vaidya, 2014).
Common synonyms for chemically modiﬁed celluloses are given in Table 2.
Figure 3: A representative structural formula of cross-linked sodium carboxy methyl cellulose (E 468)
Table 2: Synonyms for chemically modiﬁed celluloses
Substance Synonyms
Methyl cellulose (E 461) Methyl ether of cellulose; Cellulose methyl ether; INS No. 461
Ethyl cellulose (E 462) Ethyl ether of cellulose; INS No. 462
Hydroxypropyl cellulose (E 463) Cellulose hydroxypropyl ether; hydroxypropyl ether of cellulose;
modiﬁed cellulose; INS No. 463
Hydroxypropyl methyl cellulose (E 464) 2-Hydroxypropyl ether of methyl cellulose; INS No. 464; hypromellose
(Ph. Eur.)
Ethyl methyl cellulose (E 465) Ethyl methyl ether of cellulose; methyl ethyl cellulose; MEC; INS No. 465
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3.1.2. Speciﬁcations
Speciﬁcations for microcrystalline cellulose (E 460(i)), powdered cellulose (E 460(ii)), and modiﬁed
celluloses E 461, E 462, E 463, E 464, E 465, E 466, E 468 and E 469 as deﬁned in Commission
Regulation (EU) No 231/2012 and by JECFA are listed in Tables 3–12.
3.1.2.1. Microcrystalline cellulose (E 460(i))
Substance Synonyms
Sodium carboxy methyl cellulose
(E 466)
Sodium salt of the carboxymethyl ether of cellulose; sodium cellulose
glycolate; Na CMC; CMC; cellulose gum; sodium CMC; INS No. 466,
carmellose sodium (Ph. Eur.)
Cross-linked sodium carboxy methyl
cellulose (E 468)
Cross-linked CMC, cross-linked sodium CMC, cross-linked carboxy
methyl cellulose, croscarmellose sodium (Ph. Eur.)
Enzymatically hydrolysed carboxy
methyl cellulose sodium (E 469)
Sodium carboxy methyl cellulose; enzymatically hydrolysed; Enzymatically
hydrolysed carboxy methyl cellulose; CMC-ENZ; INS No. 469
Table 3: Speciﬁcations for microcrystalline cellulose (E 460(i)) according to Commission Regulation
(EU) No 231/2012 and JECFA (2009)
Commission Regulation (EU)
No 231/2012
JECFA (2009)
Deﬁnition Microcrystalline cellulose is puriﬁed, partially
depolymerised cellulose prepared by treating
a-cellulose, obtained as a pulp from natural
strains of ﬁbrous plant material, with mineral
acids. The degree of polymerisation is
typically less than 400
Puriﬁed, partially depolymerised cellulose
prepared by treating a-cellulose, obtained as
a pulp from ﬁbrous plant material, with
mineral acids. The degree of polymerisation
is typically less than 400
Assay Not less than 97% calculated as cellulose on
the anhydrous basis
Not less than 97% of carbohydrate calculated
as cellulose on the dry basis
Particle size Not less than 5 lm (not more than 10% of
particles of less than 5 lm)
Not more than 10% of the particles have a
diameter below 5 lm
Description A ﬁne white or almost white odourless
powder
Fine, white or almost white, odourless, free
ﬂowing crystalline powder
Identiﬁcation
Solubility Insoluble in water, ethanol, ether and dilute
mineral acids
Slightly soluble in sodium hydroxide solution
Insoluble in water, ethanol, ether and dilute
mineral acids
Slightly soluble in sodium hydroxide solution
Colour reaction To 1 mg of the sample, add 1 mL of
phosphoric acid and heat on a water bath for
30 min. Add 4 mL of a 1 in 4 solution of
pyrocatechol in phosphoric acid and heat for
30 min. A red colour is produced
–
Infrared absorption
spectroscopy
To be identiﬁed The infrared absorption spectrum of a
potassium bromide dispersion of the sample
corresponds to the infrared spectrum below
Suspension test Mix 30 g of the sample with 270 mL of water
in a high-speed (12,000 rpm) power blender
for 5 min. The resultant mixture will be either
a free-following suspension or a heavy,
lumpy suspension which ﬂows poorly, if at all,
settles only slightly and contains many
trapped air bubbles. If a free-ﬂowing
suspension is obtained, transfer 100 mL into
a 100-mL graduated cylinder and allow to
stand for 1 h. The solids settles and a
supernatant liquid appears
Mix 30 g of the sample with 270 mL of water
in a high-speed (18,000 rpm) blender for 5
min. Transfer 100 mL of the mixture to a
100-mL graduated cylinder, and allow to
stand for 3 h. A white, opaque, bubble-free
dispersion that forms a supernatant is
obtained
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In 2017, following a request from the European Commission, the ANS Panel provided a scientiﬁc
opinion regarding the safety of an amendment of the speciﬁcations for microcrystalline cellulose (E 460
(i)) (EFSA ANS Panel, 2017a,b). The applicant proposed an amendment as regards the solubility of the
food additive to ‘practically insoluble or insoluble in sodium hydroxide solution’. The Panel concluded
that the amendment proposed would not give rise to a safety concern. However, the
Panel recommended that the concentration of sodium hydroxide solution to be used in the solubility
test should be indicated in the EU speciﬁcations.
Commission Regulation (EU)
No 231/2012
JECFA (2009)
pH The pH of the supernatant liquid is between
5.0 and 7.5 (10% suspension in water)
5.0–7.5
Shake 5 g of the sample with 40 mL of water
for 20 min and centrifuge. Determine the pH
of the supernatant
Purity
Loss on drying Not more than 7% (105°C, 3 h) Not more than 7.0% (105°, 3 h)
Water-soluble
matter
Not more than 0.24% Not more than 0.24%
Shake 5 g of the sample with approximately
80 mL of water for 10 min, ﬁlter through
Whatman No. 42 or equivalent ﬁlter paper
into a tared beaker, wash residue with 20 mL
of water and evaporate to dryness on a
steam bath. Dry at 105° for 1 h, cool, weigh
and calculate as percentage
Sulfated ash Not more than 0.5% determined at
800  25°C
Not more than 0.05%
Test 10 g of the sample (Method I)
Starch Not detectable
To 20 mL of the dispersion obtained in
Identiﬁcation, suspension test, add a few
drops of iodine solution and mix. No purplish
to blue or blue colour should be produced
Not detectable
To 20 mL of the dispersion obtained in the
identiﬁcation test for starch, add a few drops
of iodine TS and mix. No purplish to blue or
blue colour should be obtained
Carboxyl groups Not more than 1% –
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Determine using an AAS/ICP-AES technique
appropriate to the speciﬁed level. The
selection of sample size and method of
sample preparation may be based on
principles of methods described in Volume 4
(under ‘General Methods, Metallic
Impurities’)
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
JECFA: Joint FAO/WHO Expert Committee on Food Additives; AAS: atomic absorption spectroscopy; ICP-AES: inductively coupled
plasma atomic emission spectroscopy.
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3.1.2.2. Powdered cellulose (E 460(ii))
Table 4: Speciﬁcations for powdered cellulose (E 460(ii)) according to Commission Regulation (EU)
No 231/2012 and JECFA (2006a)
Commission Regulation (EU)
No 231/2012
JECFA (2006a)
Deﬁnition Puriﬁed, mechanically disintegrated cellulose
prepared by processing a-cellulose obtained
as a pulp from natural strains of ﬁbrous plant
materials
Puriﬁed, mechanically disintegrated cellulose
prepared by processing a- cellulose obtained
as a pulp from ﬁbrous plant materials; occurs
as a white, odourless substance consisting of
ﬁbrous particles which may be compressed
into self-binding tablets which disintegrate
rapidly in water; exists in various grades
exhibiting degrees of ﬁneness ranging from a
dense free ﬂowing powder to a coarse, ﬂuffy
non-ﬂowing material
Assay Content not less than 92% Not less than 92% (C12H20O10)n
Particle size Not less than 5 lm (not more than 10% of
particles of less than 5 lm)
Description A white, odourless powder –
Identiﬁcation
Solubility Insoluble in water, ethanol, ether and dilute
mineral acids. Slightly soluble in sodium
hydroxide solution
Insoluble in water, ethanol, ether and dilute
mineral acids. Slightly soluble in sodium
hydroxide solution
Suspension test Mix 30 g of the sample with 270 mL of water
in a high-speed (12,000 rpm) power blender
for 5 min. The resultant mixture will be either
a free-ﬂowing suspension or a heavy, lumpy
suspension which ﬂows poorly, if at all,
settles only slightly and contains many
trapped air bubbles. If a free-ﬂowing
suspension is obtained, transfer 100 mL into
a 100-mL graduated cylinder and allow to
stand for 1 h. The solids settle and a
supernatant liquid appears
Mix 30 g of the sample with 270 mL of water
in a high-speed (12,000 rpm) power blender
for 5 min. The resultant mixture will be either
a free-ﬂowing suspension or a heavy, lumpy
suspension which ﬂows poorly, if at all,
settles only slightly and contains many
trapped air bubbles. If a free ﬂowing
suspension is obtained, transfer 100 mL into
a 100-mL graduated cylinder and allow to
stand for 1 h. The solids settle and a
supernatant liquid appears
pH The pH of the supernatant liquid is between
5.0 and 7.5 (10% suspension in water)
5.0–7.5
Mix 10 g of the dried sample, accurately
weighed, with 90 mL water and allow to
stand with occasional stirring for 1 h
Purity
Loss on drying Not more than 7% (105°C, 3 h) Not more than 7% after drying (105°C, 3 h)
Water-soluble
matter
Not more than 1.0% Not more than 1.5%
Mix about 6 g of the sample, previously dried,
with 90 mL of recently boiled and cooled water
and allow to stand with occasional stirring for
10 min. Filter, discard the ﬁrst 10 mL of ﬁltrate
and pass the ﬁltrate through the same ﬁlter a
second time if necessary to obtain a clear
ﬁltrate. Evaporate a 15 mL portion of the
ﬁltrate to dryness in a tared evaporation dish
on a steam bath, dry at 105o for 1 h. Not more
than 15 mg of residue is obtained
Sulfated ash Not more than 0.3% (800  25°C) Not more than 0.3% (at approximately 800°C
to constant weight)
Starch Not detectable
To 20 mL of the dispersion obtained in
Identiﬁcation, suspension test, add a few
drops of iodine solution and mix. No purplish
to blue or blue colour should be produced
Not detectable
To 20 mL of the mixture obtained in the
Identiﬁcation Test B add a few drops of
iodine TS and mix. No purplish-to-blue or
blue colour is produced
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The Panel noted that, according to the EU speciﬁcations for microcrystalline cellulose (E 460(i)) and
powdered cellulose (E 460(ii)), impurities of the toxic elements arsenic, cadmium, lead and mercury
are accepted up concentrations of 3, 1, 2 and 1 mg/kg, respectively. Contamination at those levels
could have a signiﬁcant impact on the exposure to these metals, for which the intake is already close
to the health-based guidance values established by EFSA (EFSA, 2009a,b; EFSA CONTAM Panel, 2009,
2010, 2012).
The Panel noted that there are monographs in the European Pharmacopoeia (Ph. Eur. 8th edition,
2014) on ‘microcrystalline cellulose’ and ‘powdered cellulose’. In these monographs, limits for total
anaerobic microbial count (TAMC) and total combined yeast and mould count (TYMC) are deﬁned and
absence of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Salmonella is
required.
3.1.2.3. Methyl cellulose (E 461)
Table 5: Speciﬁcations for methyl cellulose (E 461) according to Commission Regulation (EU)
No 231/2012 and JECFA (2006a)
Commission Regulation (EU)
No 231/2012
JECFA (2006a)
Deﬁnition Methyl cellulose is cellulose obtained directly
from strains of ﬁbrous plant material and
partially etheriﬁed with methyl groups
The methyl ether of cellulose, prepared from
wood pulp or cotton by treatment with alkali
and methylation of the alkali cellulose with
methyl chloride. The article of commerce can
be speciﬁed further by viscosity
Assay Content not less than 25% and not more
than 33% of methoxyl groups (–OCH3) and
not more than 5% of hydroxyethoxyl groups
(–OCH2CH2OH)
Not less than 25% and not more than 33%
of methoxyl groups. (Some products of
commerce designated ‘methyl cellulose’ also
contain components substituted with small
amounts (max. 5%) of hydroxyethyl and/or
hydroxypropyl groups. Development of
separate speciﬁcations for these products
should be considered)
Description Slightly hygroscopic white or slightly
yellowish or greyish odourless and tasteless,
granular or ﬁbrous powder
Hygroscopic white or off-white, odourless ﬁne
granules, ﬁlaments or powder
Identiﬁcation
Solubility Swelling in water, producing a clear to
opalescent, viscous, colloidal solution
Insoluble in ethanol, ether and chloroform
Soluble in glacial acetic acid
Swelling in water, producing a clear to
opalescent, viscous, colloidal solution;
insoluble in ethanol, ether and chloroform.
Soluble in glacial acetic acid
Foam test – A 0.1% solution of the sample is shaken
vigorously. A layer of foam appears. (This
test permits the distinction of sodium carboxy
methyl cellulose from other cellulose ethers)
Commission Regulation (EU)
No 231/2012
JECFA (2006a)
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Determine using an atomic absorption
technique appropriate to the speciﬁed level.
The selection of sample size and method of
sample preparation may be based on the
principles of the method described in Volume
4, ‘Instrumental Methods’
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
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The Panel noted that in JECFA (2006a), descriptions are included for tests on determination of lead
and determination of methoxyl groups. The Panel also noted that methyl cellulose speciﬁcations
include methyl hydroxyethyl cellulose (MHEC) (up to 5% hydroxyethyl substitution is permitted).
3.1.2.4. Ethyl cellulose (E 462)
Table 6: Speciﬁcations for ethyl cellulose (E 462) according to Commission Regulation (EU)
No 231/2012 and JECFA (2012)
Commission Regulation (EU)
No 231/2012
JECFA (2012)
Deﬁnition Ethyl cellulose is cellulose obtained directly
ﬁbrous plant material and partially etheriﬁed
with ethyl groups
Ethyl ether of cellulose, prepared from wood
pulp or cotton by treatment with alkali and
ethylation of the alkali cellulose with ethyl
chloride. The article of commerce can be
speciﬁed further by viscosity. Antioxidants
permitted for use in food may be added for
stabilisation purposes
Assay Content not less than 44% and not more
than 50% of ethoxyl groups (–OC2H5) on the
dried basis (equivalent to not more than 2.6
ethoxyl groups per anhydroglucose unit)
Not less than 44% and not more than 50%
of ethoxyl groups (–OC2H5) on the dried basis
(equivalent to not more than 2.6 ethoxyl
groups per anhydroglucose unit)
Description Slightly hygroscopic white to off-white,
odourless and tasteless powder
Free ﬂowing, white to light tan powder
Identiﬁcation
Solubility Practically insoluble in water, in glycerol and
in propane-1,2-diol but soluble in varying
proportions in certain organic solvents
depending upon the ethoxyl content. Ethyl
cellulose containing less than 46–48% of
ethoxyl groups is freely soluble in
tetrahydrofuran, in methyl acetate, in
chloroform and in aromatic hydrocarbon
ethanol mixtures. Ethyl cellulose containing
46–48% or more of ethoxyl groups is freely
soluble in ethanol, in methanol, in toluene, in
chloroform and in ethyl acetate
Practically insoluble in water, in glycerol, and
in propane-1,2-diol, but soluble in varying
proportions in certain organic solvents,
depending upon the ethoxyl content. Ethyl
cellulose containing less than 46–48% of
ethoxyl groups is freely soluble in
tetrahydrofuran, methyl acetate and aromatic
hydrocarbon ethanol mixtures. Ethyl cellulose
containing 46–48% or more of ethoxyl
groups is freely soluble in ethanol, methanol,
toluene and ethyl acetate
Commission Regulation (EU)
No 231/2012
JECFA (2006a)
Precipitate
formation
– To 5 mL of a 0.5% solution of the sample,
add 5 mL of a 5% solution of copper sulfate
or of aluminium sulfate. No precipitate
appears. (This test permits the distinction of
sodium carboxy methyl cellulose from other
cellulose ethers)
Purity
Loss on drying Not more than 10% (105°C, 3 h) Not more than 10% (105°C, 3 h)
Sulfated ash Not more than 1.5% (800  25°C) Not more than 1.5%
pH Not less than 5.0 and not more than 8.0
(1% colloidal solution)
5.0–8.0 (1 in 100 solution)
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
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The Panel noted that in JECFA (2012) descriptions are included for tests on determination of lead
and determination of the ethoxyl content. Furthermore, the Panel noted that in the European
Pharmacopeia the concentration of acetaldehyde is limited to 100 ppm (Ph. Eur. 8th edition, 2014).
3.1.2.5. Hydroxypropyl cellulose (E 463)
Table 7: Speciﬁcations for hydroxypropyl cellulose (E 463) according to Commission Regulation
(EU) No 231/2012 and JECFA (2006b)
Commission Regulation (EU)
No 231/2012
JECFA (2006b)
Deﬁnition Hydroxypropyl cellulose is cellulose obtained
directly from strains of ﬁbrous plant material
and partially etheriﬁed with hydroxypropyl
groups
An ether of cellulose containing
hydroxypropyl substitution prepared from
cellulose by treatment with alkali and
propylene oxide. The article of commerce can
be speciﬁed further by viscosity
Assay Content not more than 80.5% of
hydroxypropoxyl groups (–OCH2CHOHCH3)
equivalent to not more than 4,6
hydroxypropyl groups per anhydroglucose
unit on the anhydrous basis
Not more than 80.5% of hydroxypropoxy
groups equivalent to not more than 4.6
hydroxypropyl groups per anhydroglucose
unit on the dried basis
Description Slightly hygroscopic white or slightly
yellowish or greyish odourless and tasteless,
granular or ﬁbrous powder
Slightly hygroscopic, white or off-white,
almost odourless, granular or ﬁbrous powder
Identiﬁcation
Solubility Swelling in water, producing a clear to
opalescent, viscous, colloidal solution. Soluble
in ethanol. Insoluble in ether
Swells in water, producing a clear to
opalescent, viscous colloidal solution;
insoluble in ethanol; insoluble in ether
Gas
chromatography
Determine the substituents by gas
chromatography
Foam formation – A 0.1% solution of the sample is shaken
vigorously. A layer of foam appears. This test
permits the distinction of sodium carboxy
methyl cellulose from other cellulose ethers
Commission Regulation (EU)
No 231/2012
JECFA (2012)
Film forming test Dissolve 5 g of the sample in 95 g of an
80:20 (w/w) mixture of toluene ethanol. A
clear, stable, slightly yellow solution is
formed. Pour a few mL of the solution onto a
glass plate and allow the solvent to
evaporate. A thick, tough, continuous, clear
ﬁlm remains. The ﬁlm is ﬂammable
Dissolve 5 g of the sample in 95 g of an
80:20 (w/w) mixture of toluene-ethanol. A
clear, stable, slightly yellow solution is
formed. Pour a few mL of the solution onto a
glass plate, and allow the solvent to
evaporate. A thick, tough continuous, clear
ﬁlm remains. The ﬁlm is ﬂammable.
Purity
Loss on drying Not more than 3% (105°C, 2 h) Not more than 3% (105°C, 2 h)
Sulfated ash Not more than 0.4% Not more than 0.4%
pH Neutral to litmus (1% colloidal solution) Neutral to litmus (1 in 20 suspension)
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
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The Panel noted that JECFA and EU speciﬁcations state different solubility properties for
hydroxypropyl cellulose (E 463) in ethanol (soluble according to Commission Regulation, insoluble
according to JECFA.
3.1.2.6. Hydroxypropyl methyl cellulose (E 464)
Table 8: Speciﬁcations for hydroxypropyl methyl cellulose (E 464) according to Commission
Regulation (EU) No 231/2012 and JECFA (2011a)
Commission Regulation (EU)
No 231/2012
JECFA (2011a)
Deﬁnition Hydroxypropyl methyl cellulose is cellulose
obtained directly from strains of ﬁbrous plant
material and partially etheriﬁed with methyl
groups and containing a small degree of
hydroxypropyl substitution
Hydroxypropylmethyl cellulose is a methyl
cellulose modiﬁed by treatment with alkali and
propylene oxide by which a small number of
2-hydroxypropyl groups are attached through
ether links to the anhydroglucose units of the
cellulose. The article in commerce may be
further speciﬁed by viscosity
Assay Content not less than 19% and not more
than 30% methoxyl groups (–OCH3) and not
less than 3% and not more than 12%
hydroxypropoxyl groups (–OCH2CHOHCH3),
on the anhydrous basis
Not less than 19% and not more than 30%
of methoxy groups (–OCH3) and not less than
3% and not more than 12% hydroxypropoxy
groups (–OCH2CHOHCH3), on the dried basis
Description Slightly hygroscopic white or slightly
yellowish or greyish odourless and tasteless,
granular or ﬁbrous powder
Hygroscopic white or off-white powder, or
granules or ﬁne ﬁbres
Identiﬁcation
Solubility Swelling in water, producing a clear to
opalescent, viscous, colloidal solution.
Insoluble in ethanol
Swells in water, producing a clear to
opalescent, viscous colloidal solution;
insoluble in ethanol
Gas
chromatography
Determine the substituents by gas
chromatography
–
Foam formation – A 0.1% solution of the sample is shaken
vigorously. A layer of foam appears. This test
permits the distinction of sodium carboxy
methyl cellulose from other cellulose ethers
Commission Regulation (EU)
No 231/2012
JECFA (2006b)
Precipitate
formation
– To 5 mL of a 0.5% solution of the sample,
add 5 mL of a 5% solution of copper sulfate
or of aluminium sulfate. No precipitate
appears. This test permits the distinction of
sodium carboxy methyl cellulose from other
cellulose ethers
Purity
Loss on drying Not more than 10% (105°C, 3 h) Not more than 10% (105°C to constant
weight)
Sulfated ash Not more than 0.5% (800  25°C) Not more than 0.5%. Test 1 g of the sample
pH Not less than 5.0 and not more than 8.0 (1%
colloidal solution)
Not less than 5.0 and not more than 8.0 (1 in
100 solution)
Propylene
chlorohydrins
Not more than 0.1 mg/kg Not more than 0.1 mg/kg
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
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3.1.2.7. Ethyl methyl cellulose (E 465)
Commission Regulation (EU)
No 231/2012
JECFA (2011a)
Precipitate
formation
– To 5 mL of a 0.5% solution of the sample,
add 5 mL of a 5% solution of copper sulfate
or of aluminium sulfate. No precipitate
appears. This test permits the distinction of
sodium carboxy methyl cellulose from other
cellulose ethers
Purity
Loss on drying Not more than 10% (105°C, 3 h) Not more than 10% (105°C to constant
weight)
Sulfated ash Not more than 1.5% for products with
viscosities of 50 mPa.s or above
Not more than 3% for products with
viscosities below 50 mPa.s
Not more than 1.5% for products with
viscosities of 50 centipoise or above, and not
more than 3% for products with viscosities
below 50 centipoise
pH – Not less than 5.0 and not more than 8.0 (1 in
100 solution)
Propylene
chlorohydrins
Not more than 0.1 mg/kg Not more than 1 mg/kg
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
Table 9: Speciﬁcations for ethyl methyl cellulose (E 465) according to Commission Regulation (EU)
No 231/2012 and JECFA (2006c)
Commission Regulation (EU)
No 231/2012
JECFA (2006c)
Deﬁnition Ethyl methyl cellulose is cellulose obtained
directly from strains of ﬁbrous plant
material and partially etheriﬁed with methyl
and ethyl groups
A mixed ether of cellulose, prepared from
cellulose by treatment with alkali, dimethyl sulfate
and ethyl chloride; both the methyl and ethyl
groups are attached to the anhydroglucose units
by ether linkages. The article of commerce can be
speciﬁed further by viscosity
Assay Content on the anhydrous basis not less
than 3.5% and not more than 6.5% of
methoxyl groups (–OCH3) and not less than
14.5% and not more than 19% of ethoxyl
groups (–OCH2CH3), and not less than
13.2% and not more than 19.6% of total
alkoxyl groups, calculated as methoxyl
Methyl ethyl cellulose contains, on the dried basis,
not less than 3.5% and not more than 6.5% of
methoxyl groups (–OCH3), not less than 14.5%
and not more than 19.0% of ethoxyl groups
(–OCH2CH3), and not less than 13.2% and not
more than 19.6% of total alkoxyl groups,
calculated as methoxyl (on the dry basis)
Description Slightly hygroscopic white or slightly
yellowish or greyish odourless and tasteless,
granular or ﬁbrous powder
Hygroscopic and slightly yellowish odourless ﬁbre
or powder
Identiﬁcation
Solubility Swelling in water, producing a clear to
opalescent, viscous, colloidal solution.
Soluble in ethanol. Insoluble in ether
Swelling in water, producing a clear to opalescent,
viscous, colloidal solution; insoluble in ethanol
Foam test – A 0.1% solution of the sample is shaken
vigorously. A layer of foam appears. (This test
permits the distinction of sodium carboxy methyl
cellulose from other cellulose ether and alginates
and natural gums)
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The Panel noted that JECFA and EU speciﬁcations state different solubility properties for E 465 in
ethanol (soluble according to Commission Regulation, insoluble according to JECFA).
3.1.2.8. Sodium carboxy methyl cellulose (E 466)
Commission Regulation (EU)
No 231/2012
JECFA (2006c)
Precipitate
formation
– To 5 mL of a 0.5% solution of the sample add 5
mL of a 5% solution of copper sulfate or of
aluminium sulfate. No precipitate appears. (This
test permits the distinction of cellulose ethers
from sodium carboxy methyl cellulose, gelatine,
carob bean gum and tragacanth gum)
Substituents – Determine the substituents by gas
chromatography
Purity
Loss on drying Not more than 15% for the ﬁbrous form,
and not more than 10% for the powdered
form (105°C to constant weight)
Not more than 15% for the ﬁbrous form, and not
more than 10% for the powdered form, after
drying to constant weight
Sulfated ash Not more than 0.6% Not more than 0.6%
pH Not less than 5.0 and not more than 8.0
(1% colloidal solution)
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
Table 10: Speciﬁcations for sodium carboxy methyl cellulose (E 466) according to Commission
Regulation (EU) No 231/2012 and JECFA (2011b)
Commission Regulation (EU)
No 231/2012
JECFA (2011b)
Deﬁnition carboxy methyl cellulose is the partial
sodium salt of a carboxymethyl ether of
cellulose, the cellulose being obtained
directly from strains of ﬁbrous plant material
Prepared from cellulose by treatment with alkali
and monochloro-acetic acid or its sodium salt. The
article of commerce can be speciﬁed further by
viscosity
Assay Content on the anhydrous basis not less
than 99.5%
Not less than 99.5% of sodium carboxy methyl
cellulose, calculated on the dried basis
Description Slightly hygroscopic white or slightly
yellowish or greyish odourless and tasteless,
granular or ﬁbrous powder
White or slightly yellowish, almost odourless
hygroscopic granules, powder or ﬁne ﬁbres
Identiﬁcation
Solubility Yields a viscous colloidal solution with
water. Insoluble in ethanol
Yield viscous colloidal solution with water; insoluble
in ethanol
Foam test A 0.1% solution of the sample is shaken
vigorously. No layer of foam appears. (This
test permits the distinction of sodium
carboxy methyl cellulose from other
cellulose ethers)
Vigorously shake a 0.1% solution of the sample. No
layer of foam appears. This test distinguishes
sodium carboxy methyl cellulose from other
cellulose ethers and from alginates and natural
gums
Precipitate
formation
To 5 mL of a 0.5% solution of the sample,
add 5 mL of 5% solution of copper sulfate
or of aluminium sulfate. A precipitate
appears. (This test permits the distinction of
sodium carboxy methyl cellulose from other
cellulose ethers and from gelatine, locust
bean gum and tragacanth)
To 5 mL of a 0.5% solution of the sample add 5 mL
of a 5% solution of copper sulfate or of aluminium
sulfate. A precipitate appears. (This test permits
the distinction of sodium carboxy methyl cellulose
from other cellulose ethers, and from gelatine,
carob bean gum and tragacanth gum)
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The European Pharmacopoeia distinguishes two monographs of sodium carboxy methyl cellulose:
Carmellose sodium (Ph. Eur. 8th edition, 3rd supplement 2015), with a sodium content of not less than
6.5% and not more than 10.8% on the anhydrous basis; carmellose sodium, low-substituted (Ph. Eur.
8th edition, 2014), with a sodium content of not less than 2% and not more than 4.5% on the
anhydrous basis. Both monographs differ in their criteria for sulfated ash, which are not included in
Commission Regulation (EU) No 231/2012 and in the JECFA speciﬁcations.
3.1.2.9. Cross-linked sodium carboxy methyl cellulose (E 468)
Commission Regulation (EU)
No 231/2012
JECFA (2011b)
Colour
reaction
Add 0.5 g powdered carboxy methyl
cellulose sodium to 50 mL of water, while
stirring to produce a uniform dispersion.
Continue the stirring until a clear solution is
produced, and use the solution for the
following test: To 1 mg of the sample,
diluted with an equal volume of water, in a
small test tube, add 5 drops of 1-naphthol
solution. Incline the test tube, and carefully
introduce down the side of the tube 2 mL
of sulfuric acid so that it forms a lower
layer. A red-purple colour develops at the
interface
Add 0.5 g of powdered carboxy methyl cellulose
sodium to 50 mL of water, while stirring to produce
a uniform dispersion. Continue the stirring until a
clear solution is produced. To 1 mL of the solution,
diluted with an equal volume of water, in a small
test tube, add 5 drops of 1-naphthol TS. Incline the
test tube, and carefully introduce down the side of
the tube 2 mL of sulfuric acid so that it forms a
lower layer. A red-purple colour develops at the
interface
Purity
Degree of
substitution
Not less than 0.2 and not more than 1.5
carboxymethyl groups (–CH2COOH) per
anhydroglucose unit
Not less than 0.20 and not more than 1.50
Loss on drying Not more than 12% (105°C to constant
weight)
Not more than 12% after drying (105°, to constant
weight)
pH Not less than 5.0 and not more than 8.5
(1% colloidal solution)
6.0–8.5 (1 in 100 solution)
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Mercury Not more than 1 mg/kg –
Cadmium Not more than 1 mg/kg –
Total glycolate Not more than 0.4%, calculated as sodium
glycolate on the anhydrous basis
Not more than 0.4% calculated as sodium glycolate
on the dried basis
Sodium Not more than 12.4% on the anhydrous
basis
Not more than 12.4% on the dried basis
Sodium
chloride
– Not more than 0.5% on the dried basis
Table 11: Speciﬁcations for cross-linked sodium carboxy methyl cellulose (E 468) according to
Commission Regulation (EU) No 231/2012 and JECFA (2006a–g)
Commission Regulation (EU)
No 231/2012
JECFA (2006a–g)
Assay
Description Slightly hygroscopic, white to off white,
odourless powder
A slightly hygroscopic, white to greyish-white,
odourless powder
Identiﬁcation
Precipitate
formation
Shake 1 g with 100 mL of a solution
containing 4 mg/kg methylene blue and
allow to settle. The substance to be
examined absorbs the methylene blue and
settles as a blue, ﬁbrous mass
Mix 1 g of the powdered sample with 100 mL of
solution containing 4 mg/kg of methylene blue in
water and allow to settle. The substance absorbs
methylene blue and settles as a blue, ﬁbrous mass
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JECFA and the European Pharmacopoeia (Ph. Eur. 8th edition, 2014) include criteria for solubility,
sulfated ash and the combined content of sodium chloride and sodium glycolate, which are not
included in Commission Regulation (EU) No 231/2012. In addition, the European Pharmacopoeia
deﬁnes limits for TAMC and TYMC, and requires the absence of E. coli.
3.1.2.10. Enzymatically hydrolysed carboxy methyl cellulose (E 469)
Commission Regulation (EU)
No 231/2012
JECFA (2006a–g)
Colour
reaction
Shake 1 g with 50 mL of water. Transfer
1 mL of the mixture to a test tube, add
1 mL water and 0.05 mL of freshly
prepared 40 g/l solution of a-naphthol in
methanol. Incline the test tube and add
carefully 2 mL of sulfuric acid down the side
so that it forms a lower layer. A reddish-
violet colour develops at the interface
Add 1 g of the powdered sample to 50 mL water,
while stirring to produce a uniform dispersion.
Dilute 1 mL of this mixture with 1 mL of water in a
small test tube and add 5 drops of 1-naphthol TS.
Incline the test tube, and carefully introduce down
the side of the tube 2 mL of sulfuric acid so that it
forms a lower layer. A red-purple colour develops at
the interface
Test for
sodium
Passes test –
pH Not less than 5.0 and more than 7.0 (1%
solution)
Not less than 5.0 and not more than 7.0 (1 in 100
suspension in water)
Solubility – Practically insoluble in acetone, in ethanol and in
toluene
Purity
Loss on drying Not more than 6% (105°C, 3 h) Not more than 6% (105°C, 3 h)
Water soluble
matter
Not more than 10% Not more than 10%
Degree of
substitution
Not less than 0.2 and not more than 1.5
carboxymethyl groups per anhydroglucose
unit
Not less than 0.2 and not more than 1.5
carboxymethyl groups (–CH2COOH) per
anhydroglucose unit on the dried basis.
Sodium
content
Not more than 12.4% on anhydrous basis –
Arsenic Not more than 3 mg/kg –
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Cadmium Not more than 1 mg/kg –
Mercury Not more than 1 mg/kg –
Sulfated ash – Not less than 14.0% and not more than 28.0% on
the dried basis (2 g of sample)
Sodium
chloride and
sodium
glycolate
– Not more than 0.5% (sum of sodium chloride and
sodium glycolate) on the dried basis
Table 12: Speciﬁcations for enzymatically hydrolysed carboxy methyl cellulose (E 469) according to
Commission Regulation (EU) No 231/2012 and JECFA (2006d)
Commission Regulation (EU)
No 231/2012
JECFA (2006d)
Deﬁnition Enzymatically hydrolysed carboxy methyl
cellulose is obtained from carboxy methyl
cellulose by enzymatic digestion with a cellulase
produced by Trichoderma longibrachiatum
(formerly T. reesei)
The product is the sodium salt of a
carboxymethyl ether of cellulose, which has
been partially hydrolysed by enzymatic
treatment with food-grade Trichoderma reesei
cellulase. The total content of mono- and
disaccharides does not exceed about 7.5%
Assay Not less than 99.5%, including mono- and
disaccharides, on the dried basis
Not less than 99.5%, including mono- and
disaccharides, on the dried basis
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The Panel noted that the content of the tables is not consistent in that heavy metals are not
consistently listed at the end of the tables.
Commission Regulation (EU)
No 231/2012
JECFA (2006d)
Description White or slightly yellowish or greyish, odourless,
slightly hygroscopic granular or ﬁbrous powder
White or slightly yellowish or greyish, odourless,
slightly hygroscopic granular or ﬁbrous powder
Identiﬁcation
Solubility Soluble in water, insoluble in ethanol Soluble in water; insoluble in ethanol
Foam test Vigorously shake a 0.1% solution of the sample.
No layer of foam appears. This test distinguishes
sodium carboxy methyl cellulose, whether
hydrolysed or not, from other cellulose ethers
and from alginates and natural gums
Vigorously shake a 0.1% solution of the sample.
No layer of foam appears. This test distinguishes
sodium carboxy methyl cellulose, whether
hydrolysed or not, from other cellulose ethers
and from alginates and natural gums.
Precipitate
formation
To 5 mL of a 0.5% solution of the sample add 5
mL of a 5% solution of copper or aluminium
sulfate. A precipitate appears. This test
distinguishes sodium carboxy methyl cellulose,
whether hydrolysed or not, from other cellulose
ethers and from gelatine, carob bean gum and
tragacanth gum
To 5 mL of a 0.5% solution of the sample add 5
mL of a 5% solution of copper or aluminium
sulfate. A precipitate appears. This test
distinguishes sodium carboxy methyl cellulose,
whether hydrolysed or not, from other cellulose
ethers, and from gelatine, carob bean gum and
tragacanth gum
Colour
reaction
Add 0.5 g of the powdered sample to 50 mL of
water, while stirring to produce a uniform
dispersion. Continue the stirring until a clear
solution is produced. Dilute 1 mL of the solution
with 1 mL of water in a small test tube. Add 5
drops of 1–naphthol TS. Incline the tube, and
carefully introduce down the side of the tube 2
mL of sulfuric acid so that it forms a lower layer.
A red-purple colour develops at the interface
Add 0.5 g of the powdered sample to 50 mL of
water, while stirring to produce a uniform
dispersion. Continue the stirring until a clear
solution is produced. Dilute 1 mL of the solution
with 1 mL of water in a small test tube. Add 5
drops of 1–naphthol TS. Incline the tube, and
carefully introduce down the side of the tube 2
mL of sulfuric acid so that it forms a lower layer.
A red-purple colour develops at the interface
Viscosity
(60% solids)
Not less than 2,500 kg m1s1 at 25 °C
corresponding to an average molecule weight of
5,000 Da
Not less than 2,500 mPa.s corresponding to an
average molecular weight of 5,000 Da. This test
also distinguishes enzymatically hydrolysed CMC
from non-hydrolysed CMC since it is not possible
to make a 60% solution of ordinary CMC
Purity
Degree of
substitution
Not less than 0.2 and not more than 1.5
carboxymethyl groups per anhydroglucose unit
on the dried basis
Not less than 0.2 and not more than 1.50
carboxymethyl groups (CH2COOH) per
anhydroglucose unit on the dried basis
Loss on
drying
Not more than 12% (105°C to constant weight) Not more than 12% (105°C to constant weight)
pH Not less than 6.0 and not more than 8.5 (1%
colloidal solution)
Not less than 6.0 and not more than 8.5 (1 in
100 solution)
Lead Not more than 2 mg/kg Not more than 2 mg/kg
Sodium
chloride and
sodium
glycolate
Not more than 0.5% singly or in combination Not more than 0.5%, singly or in combination
Residual
enzyme
activity
Passes test. No change in viscosity of test
solution occurs, which indicates hydrolysis of the
sodium carboxy methyl cellulose
Passes test
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3.1.3. Manufacturing process
The raw materials for the production of the different types of celluloses are mainly wood chips.
Chemical wood pulping involves the extraction of cellulose from wood by dissolving the lignin that
binds the cellulose ﬁbres together. Several processes used in chemical pulping have been described,
among these, ‘kraft pulping’ and ‘sulﬁte pulping’ being the most important. The choice of a pulping
process is determined by the desired product, the wood species available, and by economic
considerations.
In ‘kraft pulping’ wood chips are digested at elevated temperature and pressure in ‘white liquor’,
being an aqueous solution of sodium sulﬁde (Na2S) and sodium hydroxide (NaOH). During digestion
the lignin fraction is dissolved. When cooking is complete, the content of the digester is transferred to
an atmospheric tank where the spent cooking liquor is separated from the pulp. The pulp then
proceeds through various stages of washing, and possibly bleaching, after which it is pressed and
dried into the ﬁnished product (wood pulp).
In ‘sulﬁte pulping’ wood chips are digested under high pressure in the presence of sulfurous acid.
To buffer the cooking solution, either sodium bisulﬁte (NaHSO3), magnesium bisulﬁte (Mg(HSO3)2),
calcium bisulﬁte (Ca(HSO3)2) or ammonium bisulﬁte ((NH4)HSO3) is used. Afterwards, the pulp is
treated in a similar way as in ‘kraft pulping’ (Someshwar and Pinkerton, 1992, available at: http://
citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.592.5534&rep=rep1&type=pdf).
In the patent literature, processes have been described to produce a-cellulose. In these processes,
wood chips are digested, at high temperature (> 100°C), by treatment with a mixture of sodium
hydroxide (NaOH), sodium sulﬁde (Na2S) and sodium sulﬁte (Na2SO3) in various concentrations.
During this treatment, the lignin fraction is removed. The product so obtained is extracted washed,
concentrated and bleached by treatment with chlorine dioxide (ClO2). After bleaching, the extract is
subjected to a second digestion with sodium hydroxide at lower temperature (< 50°C). The resulting
product is centrifuged and washed with oxalic acid to neutralise the residual alkali and to facilitate the
extraction of other residuals and colouring impurities. Finally, the extract consists of a-cellulose at a
concentration of > 97% (Durchman, 1930; Wayman et al., 1959).
3.1.3.1. Microcrystalline cellulose (E 460(i))
Microcrystalline cellulose (E 460(i)) is prepared by the controlled hydrolysis of highly puriﬁed
a-cellulose. Hydrolysis is performed with a dilute mineral acid, e.g. hydrochloric acid. Cellulose is thereby
converted into an acid-soluble fraction and an acid-insoluble crystalline material. The amorphous regions
of the cellulose are completely hydrolysed. Resultant water-soluble cello-oligosaccharides and glucose
are removed by subsequent rinsing and ﬁltration. The remaining wet cake contains only pure crystalline
regions of natural cellulose. Mechanical shearing in a water slurry is used to free the microcrystals
from their ﬁbrous, packed structure, in the form of short, rod-like particles. These are dried and ground
to a ﬁne, white, free-ﬂowing crystalline powder (Klose and Glicksman, 1990; Iijima and Takeo, 2000).
Haaﬁz et al. (2010) described a method for the isolation of microcrystalline cellulose from oil palm
empty fruit pulp (OPEFB-pulp). The pulp was hydrolysed with 2.5 N HCl (ratio pulp-liquor 1:20) at
105°C for 30 min under constant agitation. The reaction mixture was ﬁltered and washed repeatedly
ﬁrst with distilled water and subsequently with 5% diluted NH4OH solution. Finally, distilled water was
used to rinse the mixture until it was free from acid. The microcrystalline cellulose so obtained was
dried at 105°C under vacuum until constant weight, and further ground into a ﬁne powder, snowy-
white in appearance.
3.1.3.2. Powdered cellulose (E 460(ii))
According to Commission Regulation (EU) No 231/2012, powdered cellulose is obtained by
puriﬁcation and mechanical disintegration of a-cellulose.
JECFA (2006a) stated that puriﬁed, mechanically disintegrated cellulose is prepared by processing
a-cellulose obtained as a pulp from ﬁbrous plant materials; it occurs as a white, odourless substance
consisting of ﬁbrous particles which may be compressed into self-binding tablets which disintegrate
rapidly in water; it exists in various grades exhibiting degrees of ﬁneness ranging from a dense free-
ﬂowing powder to a coarse, ﬂuffy non-ﬂowing material.
In the patent literature, powdered cellulose is described as a product obtained from cellulose,
primarily by mechanical procedures such as grinding. It is stated to be a puriﬁed, partially
depolymerised cellulose, white (white to grey colour scale), odourless, tasteless powder. It is indicated
that various methods for obtaining powdered cellulose of different grades have been described. In all
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these methods, the cellulose chains are partially degraded, enzymatically or thermally, or by means of
using chemical reagents. The amorphous portions of the cellulose are hydrolysed with these
treatments and removed. Methods for preparing powdered cellulose are described in patents by Durian
et al. (2011) and Yamasaki et al. (2006).
3.1.3.3. Chemically modiﬁed celluloses
Chemically modiﬁed celluloses (E 461–466), except enzymatically hydrolysed carboxy methyl
cellulose (E 469) and cross-linked sodium carboxy methyl cellulose (E 468), are obtained from cellulose
as raw material. The base material for E 468 and E 469 is carboxy methyl cellulose (E 466).
The manufacturing processes of modiﬁed celluloses are detailed in literature. In general terms,
cellulose pulp is dispersed in alkali solution (generally sodium hydroxide, 5–50%) to form alkali
cellulose. Alkali celluloses are compounds with given stoichiometric relations between alkali and
cellulose (Sj€ostr€om, 1993). Subsequently, alkali cellulose is treated with appropriate reagents, under
strictly controlled conditions, to substitute the anhydroglucose monomers of the cellulose chain. In this
reaction step, the hydroxy groups of the anhydroglucose monomers of the cellulose chain are
etheriﬁed according to a nucleophilic substitution reaction (SN2 reaction; Williamson synthesis), a
bimolecular reaction with simultaneous a bond-making and a bond-breaking step.
The appropriate etherifying reagents are: (i) in case of methyl cellulose (E 461), methyl chloride;
(ii) in case of ethyl cellulose (E 462), ethyl chloride; (iii) in case of ethyl methyl cellulose (E 465) a
mixture of ethyl and methyl chloride; (iv) in case of hydroxypropyl cellulose (E 463), propylene oxide;
(v) in case of hydroxypropyl methyl cellulose (E 464), a mixture of propylene oxide and methyl
chloride.
In the patent literature (Engleman et al., 2014), it is indicated that in the course of the
manufacturing of hydroxypropyl methyl cellulose (E 464), propylene chlorohydrin (PCH) can be formed
during the process that is aimed to reduce the viscosity of hydroxypropyl methyl cellulose (by adding
HCl), via the reaction of HCl with propylene oxide. It is further indicated that PCH can also be formed
in the substitution reactor, when propylene oxide and salt react with each other as a secondary
reaction, next to the intended reaction of propylene oxide and methyl chloride with alkali cellulose to
achieve the methoxy and hydroxypropyl substitutions on the cellulose.
Engleman et al. (2014) described a method for the manufacturing of low molecular weight
hydroxyalkyl alkyl cellulose with a reduced concentration of such propylene chlorohydrin or other
alkylene halogenohydrins. It is described that alkylene halogenohydrin could be efﬁciently removed
from cellulose ether if extra water was added to the cellulose ether prior to drying, or if steam or a
steam mixture was used instead of air, nitrogen or vacuum as the drying medium.
For the manufacturing of additives E 463 and E 464, the hydroxyalkylation of alkali cellulose is not
limited to the hydroxyl groups originally present in the system; hydroxyalkylation can proceed at the
newly formed hydroxyl groups resulting in hydroxyalkyl chains of varying length and complexity
(Klemm et al., 1998; Murray, 2009).
Sodium carboxy methyl cellulose (E 466) is obtained by etheriﬁcation of alkali cellulose with sodium
monochloroacetate (up to 30%) in an alcohol–water medium. During the substitution process, the
mixture of alkali cellulose and reagent is heated (50–75°C) and stirred. The DS of the resulting
modiﬁed cellulose can be controlled by the reaction conditions and use of additives such as organic
solvents (isopropanol). Side reactions (e.g. formation of sodium glycolate) can occur, and consume a
certain amount of the aqueous alkali. The substitution reaction is followed by puriﬁcation and washing
stages to remove by-products and to achieve the purity levels speciﬁed for food additives (Feddersen
and Thorp, 1993; D€onges, 1997; Klemm et al., 1998; Mann et al., 1998; Murray, 2009; Heydarzadeh
et al., 2009).
According to JECFA (2002), cross-linked sodium carboxy methyl cellulose (E 468) is manufactured
by acidifying an aqueous suspension of sodium carboxy methyl cellulose and heating the suspension to
achieve cross-linking. The product is then washed and dried. It can also be produced during the
manufacture of sodium carboxy methyl cellulose by lowering the pH and heating to produce cross-
linking.
According to Swarbrick and Boylan (1990), cross-linked sodium carboxy methyl cellulose (E 468) is
made by soaking crude cellulose in sodium hydroxide, and reacting the cellulose with sodium
monochloroacetate to form sodium carboxy methyl cellulose. Excess sodium monochloroacetate slowly
hydrolyses to glycolic acid and the glycolic acid catalyses the cross-linkage to form cross-linked sodium
carboxy methyl cellulose.
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Enzymatically hydrolysed carboxy methyl cellulose (E 469) is manufactured by hydrolysis (at 50°C)
of carboxy methyl cellulose by an extracellular cellulase enzyme produced by T. reesei (now
T. longibrachiatum). The enzymatic hydrolysis results in the breakdown of cellulose to D-glucose. The
enzymatic hydrolysis depends on DS; hydrolysis decreases with increasing DS. However, treatment of
carboxy methyl cellulose with a DS of 0.7 results in complete hydrolysis (Melo and Kennedy, 1993).
3.1.4. Methods of analysis in food
Methods speciﬁcally used for analysing celluloses in food are available only for methyl cellulose
(E 461) and hydroxypropyl methyl cellulose (E 464) (Harfmann et al., 2007; Turowski et al., 2007).
The dried foods were subjected to sequential enzymatic digestion with the use of heat-stable
a-amylase, protease, and amyloglycosidase in order to remove starch and proteins. After enzymatic
digestion, the solutions were refrigerated for full hydrolysis of the methyl cellulose. The chilled
solutions were then ﬁltered and analysed by size-exclusion liquid chromatography (AOAC, 2011).
For the other celluloses (E 460(i), E 460(ii), E 462, E 463, E 465, E 466, E 468, E 469), no food
speciﬁc analytical methods are available.
In literature, methods are described for the determination of total dietary ﬁbre.
In 1985, the Association of Ofﬁcial Analytical Chemists (AOAC) introduced a standard method for
the determination of total dietary ﬁbre (AOAC Ofﬁcial Method 985.29); this method was based on a
method described by Prosky et al. (1985). In 1991, AOAC described an extended and optimised
gravimetric method for the measurement of total dietary ﬁbre in food (AOAC Ofﬁcial Method 991.43).
Both methods were based on the enzymatic removal of starch and protein of the samples by amylase
and protease treatment at 90°C and 60°C, respectively. Insoluble dietary ﬁbres are then separated by
ﬁltration and high-molecular weight soluble dietary ﬁbres (HMWSDF) precipitated by 78% ethanol and
collected by ﬁltration. Both ﬁbre fractions are dried and weighted and collectively give the total dietary
ﬁbre content of the sample.
McCleary (2007, 2010); McCleary et al., 2010) elaborated an ‘integrated’ method (AOAC Method
2009.01) in which the sample was incubated ﬁrst with a-amylase at 37°C, and then protein was
digested at 60°C by protease; subsequently, insoluble and high molecular weight soluble dietary ﬁbres
were precipitated at 78% ethanol and ﬁnally determined gravimetrically. Non-digestible oligosaccharides
(NDO) were measured in the ethanol ﬁltrate by high-performance liquid chromatography (HPLC).
In McCleary et al. (2012) described a new, AOAC-validated, enzymatic-gravimetric method for the
analysis of insoluble, soluble and total dietary ﬁbre, inclusive resistant starch and water:alcohol-soluble
NDO and polysaccharides with a DP ≥ 3. This method was a combination of the Ofﬁcial Methods of
Analysis AOAC 985.29 (and its extensions 991.42 and 993.19), 991.43, 2001.03 and 2002.02. In this
method, the test substance is treated with pancreatic a-amylase and amyloglucosidase for 16 h at
37°C in a sealed container under agitation. The reaction is terminated by pH adjustment and
temporary heating. Protein is then digested with proteinase.
3.1.5. Reaction and fate in food
Proteins and hydrocolloids are known to interact in a variety of ways. Hydrocolloids in general may
carry positive or negative charges or be uncharged. Few hydrocolloids carry positive charges and most
are negatively charged or uncharged. Environmental conditions such as pH, temperature and ionic
strength also inﬂuence the interaction (Tolstoguzov, 1991). Cellulose, for example, is a non-ionic
polymer, and since it does not carry a charge, the changes in pH do not affect the polymer. carboxy
methyl cellulose, however, contains a percentage of anionically charged with a pKa value of 4.0;
therefore above pH 4, it is negatively charged. The charge of meat proteins depends strongly upon the
pH and they carry an overall positive charge below their isoelectric point (5.0–5.1) and negative
charge above. Thus, one can expect no electrostatic interaction between cellulose and meat proteins
regardless of the pH, and electrostatic interaction between CMC and meat proteins below a pH of 5.0.
CMC and microcrystalline cellulose (MCC) can be used as ﬁbres in meat batters. Therefore, they
can have an impact on the structural characteristics of emulsiﬁed sausages that contain large
concentrations of proteins that may exceed 15%. Schuh et al. (2013) studied the molecular
interactions of meat protein with celluloses using a formulation of Lyoner-style sausages with 0.3–2%
CMC/MCC. The addition of CMC (> 0.7%) led to destabilisation of the batter, interfering in the protein
network; however, MCC was compatible with the protein matrix and improved ﬁrmness without
affecting the water binding capacity.
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For modiﬁed celluloses, different substitutions on the cellulose backbone, as anionic groups in CMC
or certain hydrophobicity in hydroxypropyl methyl cellulose (HPMC), lead to macromolecules with
different properties compared to native cellulose.
Modiﬁed celluloses affect gluten network conformation, depending on the interactions on the type
of hydrocolloid and NaCl addition.
Correa and Cristina Ferrero (2014) studied the interaction of modiﬁed celluloses (MCC, CMC, HPMC)
and pectins with gluten proteins. The modiﬁed celluloses were employed at 1.5% (ﬂour basis) of
wheat bread dough making. They have reported that they can induce changes on gluten network
during their formation, affecting strongly the secondary conformation of the proteins, the CMC dough
showing the smallest percentage of a-helix conformation and the highest unfolded structures. CMC is
an anionic molecule that could interact with gluten proteins through electrostatic forces, leading to a
less cross-linked structure. While MCC samples showed similar structural characteristics to the control,
samples with CMC and HPMC led to a more ﬁlamentous and oriented gluten network. CMC, as a
negatively charged molecule, could establish electrostatic interactions in the absence of NaCl, while for
HPMC, the addition of NaCl favoured the hydrophobic interactions.
CMC is widely used as a stabiliser and thickener in the food industry. Bayarri and Costell, 2010,
reported the behaviour of CMC in dairy desserts, which are complex systems where CMC interactions
with carbohydrates and milk proteins can be studied. The inﬂuence of CMC concentration (0.75%,
1.00%, 1.25% and 1.50% w/w) and type of dispersing media (aqueous solution, skimmed milk and
whole milk) on the viscoelastic properties of aqueous and milk systems were studied. Both parameters
affected the viscoelastic behaviour, which ranged from ﬂuid-like to weak gel. Concentrations of CMC
below 0.75% w/w did not have any effect. The highest CMC concentration (1.5% w/w) the most
affected systems were the whole milk samples with higher values for the viscoelastic parameters and
the aqueous solutions the less affected, suggesting some substantial interaction between the protein
adsorbed in oil droplet of the milk and CMC.
Xue and Ngadi (2009) studied the functionality of methyl cellulose (MC) and CMC in batter systems
during thermal processing, and the synergistic effects of the hydrocolloids and different ﬂour blend
combinations on the thermal properties of the different batter systems. For this study, three ﬂour
blends were prepared with rice, wheat and corn ﬂours, with 2.5% salt and 3.1% leavening agent
(1.78% sodium acid pyrophosphate/1.32% sodium bicarbonate). The MC and CMC powders were ﬁrst
dispersed and mixed in with the total amount of cold distilled water required for the batter. Afterwards,
the hydrocolloid was totally dissolved, and the dry ingredients (ﬂour, salt and leavening) were added to
the hydrocolloid solution and manually mixed thoroughly until the batter was uniform and free of
lumps. Addition of these hydrocolloids increased the gelatinisation temperatures but depressed the
glass transition temperatures of the resulting batters. Batters with MC showed increased DHm (melting
enthalpy) for all the thermal processes, whereas batters with CMC only showed signiﬁcant effect on
total melting enthalpies DHm for cooked samples. To simulate processing of battered products that are
ﬁrst frozen before they are cooked (namely freezing–cooking (FC) process), the samples were ﬁrst
rapidly cooled to 50°C at the rate of 20°C/min, then heated to 120°C at 10°C/min.
The effect of these hydrocolloids on glass transition temperature was more pronounced in raw
samples (FC process) than in cooked samples and increased with increasing levels of CMC and MC
used in the formulations.
Floury et al. (2003) observed, when studying the effect of high-pressure homogenisation (at 350
mPa) on methyl cellulose as a food emulsiﬁer, that microphase separation occurred at homogenisation
temperatures > 63°C. At these temperatures, methyl cellulose lost a great part of its stabilising
properties and precipitated. The phenomenon was explained by the fact that methyl cellulose was
subject to thermoreversible gelation upon increasing the temperature due to the fact that the polymer
its phase-transition temperature (Chevillard and Axelos, 1997).
3.2. Authorised uses and use levels
Maximum levels of microcrystalline cellulose (E 460(i)), powdered cellulose (E 460(ii)), methyl
cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl methyl
cellulose (E 464), ethyl methyl cellulose (E 465), sodium carboxy methyl cellulose (E 466), cross-linked
sodium carboxy methyl cellulose (E 468) and enzymatically hydrolysed carboxy methyl cellulose
(E 469) have been deﬁned in Annex II to Regulation (EC) No 1333/2008 on food additives, as
amended. In this document, these levels are named maximum permitted levels (MPLs).
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Currently, microcrystalline cellulose (E 460(i)), powdered cellulose (E 460(ii)), methyl cellulose
(E 461), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose
(E 464), ethyl methyl cellulose (E 465), sodium carboxy methyl cellulose (E 466) and enzymatically
hydrolysed carboxy methyl cellulose (E 469) are authorised food additives in the EU at quantum satis
(QS), in almost all authorised food categories listed in Table 13. They are also included in Group I of
food additives authorised at QS. Cross-linked sodium carboxy methyl cellulose (E 468) is an authorised
food additive in the EU at levels of 30,000–50,000 mg/kg in three food categories.
Table 13 summarises foods that are permitted to contain E 460466 and E 468 and E 469 and the
corresponding MPLs as set by Annex II to Regulation (EC) No 1333/2008.
Table 13: MPLs of E 460–466 and E 468 and E 469 in foods according to the Annex II to
Regulation (EC) No 1333/2008
Food
category
number
Food category name E-number Restrictions/exceptions
MPL (mg/L
or mg/kg as
appropriate)
01.3 Unﬂavoured fermented milk
products, heat-treated after
fermentation
Group I Quantum satis
01.4 Flavoured fermented milk products
including heat-treated products
Group I Quantum satis
01.6.1 Unﬂavoured pasteurised cream
(excluding reduced fat creams)
E 466 Quantum satis
01.6.2 Unﬂavoured live fermented cream
products and substitute products
with a fat content of less than 20%
E 460,
E 466
Quantum satis
01.6.3 Other creams Group I Quantum satis
01.7.1 Unripened cheese excluding
products falling in category 16
E 460(ii) Only grated and sliced
mozzarella
Quantum satis
01.7.1 Unripened cheese excluding
products falling in category 16
Group I Except mozzarella Quantum satis
01.7.2 Ripened cheese E 460 Only sliced and grated ripened
cheese
Quantum satis
01.7.4 Whey cheese E 460(ii) Only grated and sliced cheese Quantum satis
01.7.5 Processed cheese Group I Quantum satis
01.7.6 Cheese products (excluding
products falling in category 16)
Group I Quantum satis
01.7.6 Cheese products (excluding
products falling in category 16)
E 460 Only grated and sliced ripened
products and unripened
products
Quantum satis
01.8 Dairy analogues, including beverage
whiteners
Group I Quantum satis
02.2.2 Other fat and oil emulsions including
spreads as deﬁned by Council
Regulation (EC) No 1234/2007 and
liquid emulsions
Group I Quantum satis
02.3 Vegetable oil pan spray Group I Quantum satis
03 Edible ices Group I Quantum satis
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Food
category
number
Food category name E-number Restrictions/exceptions
MPL (mg/L
or mg/kg as
appropriate)
04.1.1 Entire fresh fruit and vegetables E 464 Only for citrus fruit, melons and
pomegranates in order to:
• repeat all or some of
the mandatory
information particulars
required by the Union
legislation and/or
national law and/or
• provide on a voluntary
basis brand name,
production method,
PLU-code, QR-code
and/or barcode
10
04.2.1 Dried fruit and vegetables Group I Quantum satis
04.2.2 Fruit and vegetables in vinegar, oil,
or brine
Group I Quantum satis
04.2.4.1 Fruit and vegetable preparations
excluding compote
Group I Quantum satis
04.2.5.4 Nut butters and nut spreads Group I Quantum satis
04.2.6 Processed potato products Group I Quantum satis
05.1 Cocoa and Chocolate products as
covered by Directive 2000/36/EC
Group I Only energy-reduced or with no
added sugar
Quantum satis
05.2 Other confectionery including breath
freshening microsweets
Group I Quantum satis
05.3 Chewing gum Group I Quantum satis
05.4 Decorations, coatings and ﬁllings,
except fruit-based ﬁllings covered by
category 4.2.4
Group I Quantum satis
06.2.2 Starches Group I Quantum satis
06.3 Breakfast cereals Group I Quantum satis
06.4.2 Dry pasta Group I Only gluten free and/or pasta
intended for hypoproteic diets
in accordance with Directive
2009/39/EC
Quantum satis
06.4.4 Potato gnocchi Group I Except fresh refrigerated potato
gnocchi
Quantum satis
06.4.5 Fillings of stuffed pasta (ravioli and
similar)
Group I Quantum satis
06.5 Noodles Group I Quantum satis
06.6 Batters Group I Quantum satis
06.7 Pre-cooked or processed cereals Group I Quantum satis
07.1 Bread and rolls Group I Except products in 7.1.1 and
7.1.2
Quantum satis
07.2 Fine bakery wares Group I Quantum satis
08.3.1 Non-heat-treated meat products Group I Quantum satis
08.3.2 Heat-treated meat products Group I Except foie gras, foie gras
entier, blocs de foie gras,
Libamaj, libamaj egeszben,
libamaj t€ombben
Quantum satis
08.3.3 Casings and coatings and
decorations for meat
Group I Quantum satis
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Food
category
number
Food category name E-number Restrictions/exceptions
MPL (mg/L
or mg/kg as
appropriate)
09.2 Processed ﬁsh and ﬁshery products
including molluscs and crustaceans
Group I Quantum satis
09.3 Fish roe Group I Only processed ﬁsh roe Quantum satis
10.2 Processed eggs and egg products Group I Quantum satis
11.2 Other sugars and syrups Group I Quantum satis
11.4.1 Table-top sweeteners in liquid form E 460(i),
E 463,
E 464,
E 465,
E 466
Quantum satis
11.4.2 Table-top sweeteners in powder
form
E 460,
E 461,
E 463,
E 464,
E 465,
E 466
Quantum satis
11.4.2 Table-top sweeteners in powder
form
E 468 50,000
11.4.3 Table-top sweeteners in tablets E 460,
E 461,
E 463,
E 464,
E 465,
E 466
Quantum satis
11.4.3 Table-top sweeteners in tablets E 468 50,000
12.1.2 Salt substitutes Group I Quantum satis
12.2.1 Herbs and spices E 460 Only when dried
12.2.2 Seasonings and condiments Group I Quantum satis
12.3 Vinegars Group I Quantum satis
12.4 Mustard Group I Quantum satis
12.5 Soups and broths Group I Quantum satis
12.6 Sauces Group I Quantum satis
12.7 Salads and savoury-based sandwich
spreads
Group I Quantum satis
12.8 Yeast and yeast products Group I Quantum satis
12.9 Protein products, excluding products
covered in category 1.8
Group I Quantum satis
13.1.5.1 Dietary foods for infants for special
medical purposes and special
formulae for infants
E 466 From birth onwards in products
for the dietary management of
metabolic disorders
10,000
13.1.5.2 Dietary foods for babies and young
children for special medical purposes
as deﬁned in Directive 1999/21/EC
E 466 From birth onwards in products
for the dietary management of
metabolic disorders
10,000
13.2 Dietary foods for special medical
purposes deﬁned in Directive 1999/
21/EC (excluding products from
food category 13.1.5)
Group I Quantum satis
13.3 Dietary foods for weight control
diets intended to replace total daily
food intake or an individual meal
(the whole or part of the total daily
diet)
Group I Quantum satis
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According to Annex III, Part 1 of Regulation (EC) No 1333/2008, E 460–466 are also authorised as
carriers in all food additives at QS; E 468 is authorised as a carrier in sweeteners at QS and E 469 is
authorised as a carrier in all food additives at QS.
Food
category
number
Food category name E-number Restrictions/exceptions
MPL (mg/L
or mg/kg as
appropriate)
13.4 Foods suitable for people intolerant
to gluten as deﬁned by Regulation
(EC) No 41/2009
Group I Including dry pasta Quantum satis
14.1.2 Fruit juices as deﬁned by Directive
2001/112/EC and vegetable juices
Group I Only vegetable juices Quantum satis
14.1.3 Fruit nectars as deﬁned by Directive
2001/112/EC and vegetable nectars
and similar products
Group I Only vegetable nectars Quantum satis
14.1.3 Fruit nectars as deﬁned by Directive
2001/112/EC and vegetable nectars
and similar products
E 466 Only traditional Swedish and
Finnish fruit syrups from citrus
Quantum satis
14.1.4 Flavoured drinks Group I Quantum satis
14.1.5.2 Other Group I Excluding unﬂavoured leaf tea;
including ﬂavoured instant
coffee
Quantum satis
14.2.3 Cider and perry Group I Quantum satis
14.2.4 Fruit wine and made wine Group I Quantum satis
14.2.5 Mead Group I Quantum satis
14.2.6 Spirit drinks as deﬁned in Regulation
(EC) No 110/2008
Group I Except whisky or whiskey Quantum satis
14.2.7.1 Aromatised wines Group I Quantum satis
14.2.7.2 Aromatised wine-based drinks Group I Quantum satis
14.2.7.3 Aromatised wine-product cocktails Group I Quantum satis
14.2.8 Other alcoholic drinks including
mixtures of alcoholic drinks with
non-alcoholic drinks and spirits with
less than 15% of alcohol
Group I Quantum satis
15.1 Potato-, cereal-, ﬂour- or starch-
based snacks
Group I Quantum satis
15.2 Processed nuts Group I Quantum satis
16 Desserts excluding products covered
in category 1, 3 and 4
Group I Quantum satis
17.1(a) Food supplements supplied in a
solid form including capsules and
tablets and similar forms, excluding
chewable forms
Group I Quantum satis
17.1(a) Food supplements supplied in a
solid form including capsules and
tablets and similar forms, excluding
chewable forms
E 468 30,000
17.2(a) Food supplements supplied in a
liquid form
Group I Quantum satis
17.3(a) Food supplements supplied in a
syrup-type or chewable form
Group I Quantum satis
18 Processed foods not covered by
categories 1–17, excluding foods for
infants and young children
Group I Quantum satis
MPL: maximum permitted level.
(a): FCS 17 refers to food supplements as deﬁned in Directive 2002/46/EC of the European Parliament and of the Council
excluding food supplements for infants and young children.
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According to Annex III, Part 2 of Regulation (EC) No 1333/2008, E 460, E 461, E 462, E 463,
E 464, E 465, E 466 and E 469 are authorised as food additives other than carriers at QS, in all food
additive preparations.
According to Annex III, Part 3 of Regulation (EC) No 1333/2008, E 460, E 461, E 463, E 464 and
E 466 are authorised as food additives including carriers in food enzymes at QS, while E 462, E 465
and E 469 are authorised as food additives at QS levels but cannot be used as carriers.
According to Annex III, Part 4 of Regulation (EC) No 1333/2008, E 460, E 461, E 462, E 463,
E 464, E 465, E 466 and E 469 are authorised as food additives including carriers in all food
ﬂavourings at QS.
In addition, according to Annex III, Part 5, Section A of Regulation (EC) No 1333/2008, E 460–466
and E 469 are authorised to be used as food additives including carriers in all nutrients at QS except
for nutrients intended to be used in foodstuffs for infants and young children listed in point 13.1 of
Part E of Annex II.
Finally, according to Annex III, Part 5, Section B of Regulation (EC) No 1333/2008, E 466 is
authorised as a food additive for uses in nutrient preparations under the condition that the maximum
level in foods mentioned in point 13.1 of Part E of Annex II is not exceeded,11 in all nutrients in dietary
foods for infants and young children for special medical purposes as deﬁned in Directive 1999/21/EC,
nutrients intended to be used in foodstuffs for infants and young children listed in point 13.1 of Part E
of Annex II.
3.3. Exposure data
3.3.1. Reported use levels or data on analytical levels
Most food additives in the EU are authorised at a speciﬁc MPL. However, a food additive may be
used at a lower level than the MPL. Therefore, information on actual use levels is required for
performing a more realistic exposure assessment, especially for those food additives for which no MPL
is set and which are authorised according to QS.
In the framework of Regulation (EC) No 1333/2008 on food additives and of Commission
Regulation (EU) No 257/2010 regarding the re-evaluation of approved food additives, EFSA issued
public calls,12,13 for occurrence data (usage level and/or concentration data) on microcrystalline
cellulose (E 460(i)), powdered cellulose (E 460(ii)), methyl cellulose (E 461), ethyl cellulose (E 462),
methyl cellulose (E 464), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464),
ethyl methyl cellulose (E 465), sodium carboxy methyl cellulose (E 466), cross-linked sodium carboxy
methyl cellulose (E 468) and enzymatically hydrolysed carboxy methyl cellulose (E 469). In response to
this public call, updated information on the actual use levels of celluloses (E 460–466, E 468 and E
469) in foods was made available to EFSA by industry. One analytical data on the concentration of
these food additives in foods was made available by Member State (MS).
3.3.1.1. Summarised data on reported use levels in foods provided by industry
Industry provided EFSA with data on use levels (n = 1,177) of celluloses (E 460–466, E 468 and
E 469) in foods for 57 out of the 84 food categories in which celluloses (E 460–466, E 468 and E 469)
are authorised.
Updated information on the actual use levels of celluloses (E 460–466, E 468 and E 469) in foods
was made available to EFSA by the Association of the European Self-Medication Industry (AESGP),
Aviko, Dr Loges Naturheilkunde neu entdecken, the European Dairy Association (EDA), the European
Federation of Associations of Health Products Manufacturers (EHPM), FoodDrinkEurope (FDE), Food
Supplements Europe (FSE), the International Chewing Gum Association (ICGA), Kruger GmbH & Co
and the Organisation des Fabricants de produits Cellulosiques Alimentaires (OFCA) [Documentation
provided to EFSA, n. 1–10].
The Panel noted that some data providers (e.g. OFCA) are not food industry using celluloses in
their food products but food additive producers. Usage levels reported by food additive producers
should not be considered at the same level as those provided by food industry. Food additive
producers might recommend usage levels to the food industry but the ﬁnal levels might, ultimately,
differ, unless food additive producers conﬁrm that these levels are used by food industry. In all other
11 10,000 mg/kg.
12 http://www.efsa.europa.eu/sites/default/ﬁles/consultation/151012.pdf
13 http://www.efsa.europa.eu/sites/default/ﬁles/consultation/ans091123.pdf
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cases, data from food additive producers will only be used in the MPL scenario in case of QS
authorisation and no data are available from food industry or MSs in order to have the most complete
exposure estimates. In any case, all usage data provided will be acknowledged in the appendices.
Appendix A provides data on the use levels of celluloses (E 460–466, E 468 and E 469) in foods as
reported by industry.
3.3.1.2. Summarised data on concentration levels in foods submitted by Member States
In total, one analytical result was reported to EFSA by Germany, on a meat product sampled and
analysed in 2013, with a level of 3,700 mg/kg. This meat preparation was not taken into account in
the exposure estimates.
Complete information on the methods of analysis (e.g. validation) was not made available to EFSA,
but the sample was derived from accredited laboratory.
3.3.2. Summarised data extracted from the Mintel Global New Products Database
The Mintel GNPD is an online database which monitors product introductions in consumer packaged
goods markets worldwide. It contains information of over 2 million food and beverage products of
which more than 900,000 are or have been available on the European food market. Mintel started
covering EU’s food markets in 1996, currently having 20 out of its 28 member countries and Norway
presented in the Mintel GNPD.14
For the purpose of this Scientiﬁc Opinion, the Mintel GNPD15 was used for checking the labelling of
products containing E 460–466, E 468 and E 469 within the EU’s food products as the Mintel GNPD
shows the compulsory ingredient information presented in the labelling of products.
According to Mintel, celluloses (E 460–466, E 468 and E 469) are labelled on more than 18,000
products out of which around 11,500 between 2012 and 2017.
Appendix B presents the percentage of the food products labelled with celluloses (E 460–466,
E 468 and E 469) out of the total number of food products per food subcategory according to the
Mintel GNPD food classiﬁcation. The percentages ranged from less than 0.1% in many food
subcategories to 27.7% in Mintel’s GNPD subcategory ‘Vitamins and dietary supplements’. The average
percentage of foods labelled to contain celluloses (E 460–466, E 468–469) was 2.3%.
3.3.3. Food consumption data used for exposure assessment
EFSA Comprehensive European Food Consumption Database
Since 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive
Database) has been populated with national data on food consumption at a detailed level. Competent
authorities in the European countries provide EFSA with data on the level of food consumption by the
individual consumer from the most recent national dietary survey in their country (cf. Guidance of
EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a). New consumption surveys16 added in the Comprehensive database were
also taken into account in this assessment.10
The food consumption data gathered by EFSA were collected by different methodologies and thus
direct country-to-country comparisons should be interpreted with caution. Depending on the food
category and the level of detail used for exposure calculations, uncertainties could be introduced owing
to possible subjects’ underreporting and/or misreporting of the consumption amounts. Nevertheless,
the EFSA Comprehensive Database represents the best available source of food consumption data
across Europe at present.
Food consumption data from the following population groups: infants, toddlers, children,
adolescents, adults and the elderly were used for the exposure assessment. For the present
assessment, food consumption data were available from 33 different dietary surveys carried out in 19
European countries (Table 14).
14 Missing Bulgaria, Cyprus, Estonia, Latvia, Lithuania, Luxembourg, Malta and Slovenia.
15 http://www.gnpd.com/sinatra/home/ accessed on 31/08/2017.
16 Available online: http://www.efsa.europa.eu/en/press/news/150428.htm
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Consumption records were codiﬁed according to the FoodEx classiﬁcation system (EFSA, 2011b).
Nomenclature from the FoodEx classiﬁcation system has been linked to the Food Classiﬁcation System
(FCS) as presented in Annex II of Regulation (EC) No 1333/2008, part D, to perform exposure
estimates. In practice, FoodEx food codes were matched to the FCS food categories.
Food categories selected for the exposure assessment of celluloses (E 460–466, E 468 and E
469)
The food categories in which the use of celluloses is authorised were selected from the
nomenclature of the EFSA Comprehensive Database (FoodEx classiﬁcation system), at the most
detailed level possible (up to FoodEx Level 4) (EFSA, 2011b).
Some food categories are not referenced in the EFSA Comprehensive Database and could therefore
not be taken into account in the present estimate. This is the case for 12 food categories and may
result in an underestimation of the exposure. The food categories which were not taken into account
are described below (in ascending order of the FCS codes):
• 01.7.6 Cheese products;
• 02.3 Vegetable oil pan spray;
• 06.6 Batters;
• 06.7 Pre-cooked or processed cereals;
• 08.3.3 Casings and coatings and decorations for meat;
• 12.1.2 Salt substitutes;
• 14.1.3 Fruit nectars, only vegetable nectars;
• 14.1.3 Fruit nectars, only traditional Swedish and Finnish fruit syrups from citrus;
• 14.2.4 Fruit wine and made wine;
• 14.2.5 Mead;
• 14.2.7.2. Aromatised wine-based drinks;
• 14.2.7.3. Aromatised wine-product cocktails.
For the following food categories, the restrictions/exceptions which apply to the use of celluloses
(E 460–466, E 468 and E 469) could not be taken into account, and therefore the whole food category
was considered in the exposure assessment. This is the case for three food categories and may result
in an overestimation of the exposure:
• 07.1 Bread and rolls, except products in 7.1.1 and 7.1.2;
• 09.3 Fish roe, only processed ﬁsh roe;
Table 14: Population groups considered for the exposure estimates of celluloses
Population Age range
Countries with food consumption surveys covering more
than one day
Infants From 12 weeks up to and
including 11 months of age
Bulgaria, Denmark, Finland, Germany, Italy, UK
Toddlers(a) From 12 months up to and
including 35 months of age
Belgium, Bulgaria, Denmark, Finland, Germany, Italy,
the Netherlands, Spain, UK
Children(b) From 36 months up to and
including 9 years of age
Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France,
Germany, Greece, Italy, Latvia, Netherlands, Spain, Sweden, UK
Adolescents From 10 years up to and
including 17 years of age
Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France,
Germany, Italy, Latvia, Netherlands, Spain, Sweden, UK
Adults From 18 years up to and
including 64 years of age
Austria, Belgium, Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Italy, Latvia, Netherlands, Romania,
Spain, Sweden, UK
The elderly(b) From 65 years of age and
older
Austria, Belgium, Denmark, Finland, France, Germany, Hungary,
Ireland, Italy, Netherlands, Romania, Sweden, UK
(a): ‘Toddlers’ in the EFSA Comprehensive Database corresponds to ‘young children’ in Regulations (EC) No 1333/2008 and (EU)
No 609/2013.
(b): The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’
in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a).
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Celluloses (E 460–466, E 468 and E 469) are also allowed in FC 13.2, 13.3, 13.4 and 18. Food items
under food categories 13.2, 13.3 and 13.4 consumed by population groups – children, adolescents,
adults and the elderly – may be very diverse and, in addition, there is very limited information on their
consumption. Therefore, eating occasions belonging to the food categories 13.2, 13.3 and 13.4 were
reclassiﬁed under food categories in accordance to their main component. The use levels available for
food categories 13.2, 13.3 and 13.4 were not considered for the exposure assessment.
For all scenarios, additional food categories were not taken into account because no concentration
data were provided for these food categories to EFSA (Appendix C). Overall, for the maximum level
exposure scenario, 48 food categories were included, while for the reﬁned scenarios, 26 food
categories were included in the present exposure assessment to celluloses (E 460–466, E 468 and
E 469). For the remaining food categories, the reﬁnements considering the restrictions/exceptions as
set in Annex II to Regulation No 1333/2008 were applied (Appendix C).
3.4. Exposure estimate(s)
3.4.1. Exposure to celluloses from their use as food additives
The Panel estimated chronic exposure to celluloses (E 460–466, E 468 and E 469) for the following
population groups: infants, toddlers, children, adolescents, adults and the elderly. Dietary exposure to
celluloses was calculated by multiplying celluloses concentrations for each food category (Appendix C)
with their respective consumption amount per kilogram of body weight for each individual in the
Comprehensive Database. The exposure per food category was subsequently added to derive an
individual total exposure per day. These exposure estimates were averaged over the number of survey
days, resulting in an individual average exposure per day for the survey period. Dietary surveys with
only one day per subject were excluded, as they are considered as not adequate to assess repeated
exposure.
This was carried out for all individuals per survey and per population group, resulting in
distributions of individual exposure per survey and population group (Table 3). Based on these
distributions, the mean and 95th percentile of exposure were calculated per survey for the total
population and per population group. High percentile exposure was only calculated for those
population groups where the sample size was sufﬁciently large to allow calculation of the 95th
percentile of exposure (EFSA, 2011a). Therefore, in the present assessment, high levels of exposure
for infants from Italy and for toddlers from Belgium, Italy and Spain were not included.
Exposure assessment to celluloses (E 460–466, E 468 and E 469) was carried out by the ANS
Panel based on (1) maximum levels of data provided to EFSA (deﬁned as the maximum level exposure
assessment scenario), and (2) reported use levels (deﬁned as the reﬁned exposure assessment
scenario) as provided by industry. These two scenarios are discussed in detail below.
These scenarios do not consider the consumption of food supplements (FC 17.1, FC 17.2 and FC
17.3), nor the consumption of foods for special medical purposes (FSMP), which are covered in
additional reﬁned exposure scenarios detailed below (food supplements consumers only scenario and
food for special medical purposes consumer only scenario).
Considering that the food category 18 (Processed foods not covered by categories 1–17, excluding
foods for infants and young children) is extremely unspeciﬁc (e.g. composite foods), processed foods,
prepared, or composite dishes belonging to the food category 18 were reclassiﬁed under food
categories in accordance to their main component. Therefore, food category 18 is not taken into
account as contributor to the total exposure estimates.
Concerning the uses of celluloses (E 460–466, E 468 and E 469) as carriers, there might be food
categories where celluloses are used according to Annex III and not to Annex II. These food
categories can only be addressed by analytical data or limits set in the Regulation (EC) No 1333/2008.
According to Annex III, Parts 1, 2, 3, 4 and 5 of Regulation (EC) No 1333/2008, celluloses (E 460–466,
E 468 and E 469) are also authorised at QS; as no data were made available to EFSA, this added
dietary exposure could not be taken into account in the any of the exposure scenarios.
3.4.1.1. Maximum level exposure assessment scenario
The regulatory maximum level exposure assessment scenario is based on the MPLs as set in Annex
II to Regulation (EC) No 1333/2008. As celluloses (E 460–466, E 468 and E 469) are authorised
according to QS in almost all food categories, a ‘maximum level exposure assessment’ scenario was
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estimated based on the maximum reported use levels provided by industry (food industry and food
additive producers) as described in the EFSA Conceptual framework (EFSA ANS Panel, 2014).
A possible additional exposure from the use of celluloses (E 460–466, E 468 and E 469) in
accordance with Annex III to Regulation (EC) No 1333/2008 (Part 1, 3, 5) was not considered in the
maximum level exposure assessment scenario. Despite this, the Panel considers the exposure
estimates derived following this scenario as the most conservative, as it is assumed that the population
group will be exposed to celluloses (E 460–466, E 468 and E 469) present in food at maximum
reported use levels over a longer period of time.
3.4.1.2. Reﬁned exposure assessment scenario
The reﬁned exposure assessment scenario is based on use levels reported by food industry. This
exposure scenario can consider only food categories for which the above data were available to the
Panel.
Appendix C summarises the concentration levels of celluloses (E 460–466, E 468 and E 469) used
in the reﬁned exposure assessment scenario. Based on the available data set, the Panel calculated two
reﬁned exposure estimates based on different model populations:
• The brand-loyal consumer scenario: It was assumed that a consumer is exposed long-term to
celluloses (E 460–466, E 468 and E 469) present at the maximum reported use level for one
food category. This exposure estimate was calculated as follows:
 Combining food consumption with the maximum of the reported use levels, for the main
contributing food category at the individual level.
 Using the mean of the typical reported use levels, for the remaining food categories.
• The non-brand-loyal consumer scenario: It was assumed that a consumer is exposed long-
term to celluloses (E 460–466, E 468 and E 469) present at the mean reported use level in
food. This exposure estimate was calculated using the mean of the typical reported use levels
for all food categories.
3.4.1.3. Speciﬁc exposure assessment scenario
• Food supplements consumers only scenario: celluloses (E 460–466, E 468 and E 469) are
authorised in the food category 17 (i.e. FC 17.1, 17.2, 17.3) (Table 13) Food supplements as
deﬁned in Directive 2002/46/EC excluding food supplements for infants and young children. As
exposure via food supplements may deviate largely from the one via food, and the number of
food supplement consumers may be low depending on populations and surveys, an additional
scenario was calculated in order to reﬂect additional exposure to food additives from food
supplements compared to exposure to food additives excluding these sources. This scenario
was estimated as follow:
 Consumers only of food supplements were assumed to be exposed to a food additive
present at the maximum reported usage on a daily basis via consumption of food
supplements. For the remaining food categories, the mean of the typical reported use
levels was used.
As food category 17 does not consider food supplements for infants and toddlers as deﬁned in the
legislation, exposure to celluloses (E 460–466, E 468 and E 469) from food supplements is not
estimated for these two population groups.
• FSMP scenario consumers only: as E 466 is also authorised in the FC 13.1.5 (13.1.5.1 and
13.1.5.2), an additional exposure assessment scenario taking into account this food category
was performed to estimate the exposure of infants and toddlers who may eat and drink these
FSMP.
The consumption of these foods under FC 13.1.5 is not reported in the EFSA Comprehensive
database. To consider the exposure to food additives via consumption of these foods, the
Panel assumed that the amount of FSMP consumed by infants and toddlers resembles that of
comparable foods for infants and toddlers from the general population. Thus, the consumption
of FSMP categorised as food category 13.1.5 was assumed to equal that of formulae and food
products categorised as food categories 13.1.1, 13.1.2, 13.1.3 and 13.1.4.
The Panel noted that no data were submitted for the food categories 13.1.5.1 and 13.1.5.2,
thus, the FSMP exposure assessment scenario for consumers only was performed using the
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MPLs of E 466 for these two food categories; for the remaining food categories, the mean of
the typical reported use levels was used.
Certain FSMP consumed by other population groups (children, adolescents, adults and the
elderly) may be very diverse; they cannot be considered because of very limited information
on consumption. Eating occasions belonging to the food categories 13.2, 13.3, 13.4 were
therefore reclassiﬁed under food categories in accordance to their main component.
3.4.1.4. Dietary exposure to celluloses (E 460–466, E 468 and E 469)
Table 15 summarises the estimated exposure to celluloses from their use as food additives in six
population groups (Table 14) according to the different exposure scenarios (Section 3.4.1). Detailed
results per population group and survey are presented in Appendix D.
From the maximum level exposure assessment scenario, mean exposure to celluloses (E 460–466,
E 468 and E 469) from their use as food additives ranged from 22 mg/kg body weight (bw) per day in
infants to 546 mg/kg bw per day in toddlers. The 95th percentile of exposure to celluloses (E 460–466,
E 468 and E 469) ranged from 60 mg/kg bw per day in infants to 745 mg/kg bw per day in children.
From the reﬁned estimated exposure scenario, in the brand-loyal scenario, mean exposure to
celluloses (E 460–466, E 468 and E 469) from their use as food additives ranged from 5 mg/kg bw per
day in infants to 190 mg/kg bw per day in toddlers. The high exposure to celluloses (E 460–466, E 468
and E 469) ranged from 30 mg/kg bw per day in infants to 506 mg/kg bw per day in toddlers. In the
non-brand-loyal scenario, mean exposure to celluloses (E 460–466, E 468 and E 469) from their use as
food additives ranged from 2 mg/kg bw per day in infants to 64 mg/kg bw per day in toddlers. The
95th percentile of exposure to celluloses (E 460–466, E 468 and E 469) ranged from 13 mg/kg bw per
day in infants to 111 mg/kg bw per day in toddlers.
From the reﬁned estimated exposure scenario taking into account FSMP (FC 13.1.5.1 and 13.1.5.2)
in which E 466 is authorised, consumers only, mean exposure to celluloses from their uses as food
additives ranged for infants between 4 and 508 mg/kg bw per day and between 6 and 154 mg/kg bw
per day for toddlers. The 95th percentile of exposure ranged for infants between 14 and 1,557 mg/kg
bw per day, and for toddlers between 14 and 557 mg/kg bw per day.
For the food supplement consumers only, mean exposure to celluloses (E 460–466, E 468 and E
469) from their use as food additives ranged between 23 and 332 mg/kg bw per day across the
different population classes of children, adolescents, adults and the elderly. The 95th percentile of
exposure to celluloses (E 460–466, E 468 and E 469) ranged between 78 and 448 mg/kg bw per day
across the same population groups.
Table 15: Summary of anticipated exposure to celluloses (E 460–466, E 468 and E 469) from their
use as food additives in the maximum level exposure assessment scenario and in the
reﬁned exposure scenarios, in six population groups (minimum–maximum across the
dietary surveys in mg/kg bw per day)
Infants
(12 weeks–
11 months)
Toddlers
(12–35
months)
Children
(3–9
years)
Adolescents
(10–17
years)
Adults
(18–64
years)
The elderly
(≥ 65
years)
Maximum level exposure assessment scenario
Mean 22135 103546 138410 65260 58157 55116
High level (95th
percentile)
60394 259718 270745 136460 120303 109190
Reﬁned estimated exposure assessment scenario
Brand-loyal scenario
Mean 550 15190 44177 27126 2067 1837
High level (95th
percentile)
30186 42506 112387 86274 47180 3780
Non-brand-loyal scenario
Mean 218 564 1158 740 723 716
High level (95th
percentile)
1355 14111 30103 2173 1648 1429
bw: body weight.
Re-evaluation of celluloses (E 460(i), E 460(ii), E 461466, E 468 and E 469) as food additives
www.efsa.europa.eu/efsajournal 45 EFSA Journal 2018;16(1):5047
3.4.1.5 Main food categories contributing to exposure to celluloses (E 460466,
E 468469)
Main food categories contributing to exposure to celluloses (E 460466, E 468469)
using the maximum level exposure assessment scenario
From the maximum level exposure assessment scenario, the main contributing food categories to
the total mean exposure estimates were breakfast cereals and ﬁne bakery wares for infants and bread
and rolls, ﬂavoured fermented milk products and ﬂavoured drinks for toddlers. For children,
adolescents and adults, the main contributing food categories were bread and rolls, ﬁne bakery wares
and ﬂavoured drinks; while, for the elderly, the main contributing food category was bread and rolls
(see Appendix E for more details).
Main food categories contributing to exposure to celluloses (E 460466, E 468469)
using the reﬁned exposure assessment scenario
The main contributing food categories for the reﬁned estimated exposure scenario, brand-loyal
scenario were bread and rolls, sauces and processed fruits and vegetables for infants; bread and rolls,
ﬁne bakery wares and ﬂavoured drinks were the main contributing food categories for the other
population groups: toddlers; children, adolescents, adults and the elderly. In the non-brand-loyal
scenario, the main contributing food categories were bread and rolls, processed fruits and vegetables
and ﬁne bakery wares for infants and toddlers. For children, adolescents and adults, the main
contributing food categories were bread and rolls, ﬁne bakery wares and ﬂavoured drinks; while for
the elderly, the main contributing food categories were bread and rolls and processed fruits and
vegetables (see Appendix E for more details).
Appendix E can be found in the online version of this output (‘Supporting information’ section):
https://doi.org/10.2903/j.efsa.2018.5047
3.4.1.6. Uncertainty analysis
Uncertainties in the exposure assessment of celluloses have been discussed above. In accordance
with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment
(EFSA, 2006), the following sources of uncertainties have been considered and summarised in Table 16.
Table 16: Qualitative evaluation of inﬂuence of uncertainties on the dietary exposure estimate
Sources of uncertainties Direction(a)
Consumption data: different methodologies/representativeness/underreporting/
misreporting/no portion size standard
+/–
Use of data from food consumption survey of a few days to estimate long-term (chronic)
exposure for high percentiles (95th percentile)
+
Correspondence of reported use levels to the food items in the EFSA Comprehensive Food
Consumption Database: uncertainties to which types of food the levels refer to
+/–
Food categories selected for the exposure assessment: exclusion of food categories due to
missing FoodEx linkage (n = 12/84 food categories)
–
Food categories selected for the exposure assessment: inclusion of one food category
without considering the restriction/exception
+
Food categories included in the exposure assessment: n = 48 food categories for max
scenario, and 26 for reﬁned scenario, as no data available for certain food categories
which were therefore not considered in the exposure estimates
–
Concentration data:
• use levels considered applicable for all foods within the entire food category,
whereas on average, 2.3% of the foods, belonging to food categories with foods
labelled with celluloses, was labelled with the additives.
+/–
Maximum level exposure assessment scenario:
• authorisation according to Annex III to Regulation (EC) No 1333/2008 not
considered
• exposure calculations based on the maximum reported use levels from industries
–
+
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Overall, the Panel considered that the uncertainties identiﬁed would, in general, result in an
overestimation of the real exposure to celluloses (E 460–466, E 468 and E 469) as food additives in
European countries considered in the EFSA European database for the maximum level exposure
scenario and for the reﬁned scenario, if it was considered that the food additives may not be used in
food categories for which no usage data have been provided.
This assumption of non-use was supported by the observation that celluloses (E 460–466, E 468 and
E 469) are authorised as Group I food additives in the majority of food categories (Table 13). Since all
these food categories correspond to the general Group I food additives authorisation, celluloses (E 460–
466, E 468 and E 469) may not necessarily be used in some of these food categories. It may thus be
explained why reported use levels adequate for the reﬁned exposure scenario of celluloses (E 460–466, E
468 and E 469) were only available for 26 food categories. The Panel noted that the information from the
Mintel GNPD supported the observation that due to its Group I authorisation, celluloses (E 460–466, E
468 and E 469) may not be used in all food categories in which these are authorised (Section 3.3.2). For
the 26 food categories considered for the reﬁned exposure assessment, the products labelled with
celluloses (E 460–466, E 468 and E 469) were also reported in the Mintel GNPD.
Regarding food supplements consumers only scenario, the Panel considered that the uncertainties
would result in an overestimation of the exposure to celluloses (E 460–466, E 468 and E 469) as food
additives, given that the calculations were based on consumers only of food supplements and
assuming a long-term brand loyal consumption of these food products on a daily basis.
Regarding FSMP consumers only scenario, the Panel considered that the uncertainties would also
result in an overestimation of the exposure, given that the calculations were based on consumers only
of FSMP, and no data from industry were provided; therefore, only the MPLs were used.
In none of the exposure scenarios, the use of celluloses (E 460–466, E 468 and E 469) according to
Annex III to Regulation (EC) No 1333/2008 was considered. Neglecting this source of exposure may
have resulted in an underestimation of exposure to celluloses (E 460466, E 468469) in all scenarios.
3.4.2. Exposure via the regular diet
In 2010, the NDA Panel published a scientiﬁc opinion on the Dietary Reference Values for
carbohydrates and dietary ﬁbre (EFSA NDA Panel, 2010a,b). In this opinion, the intakes of carbohydrates
and dietary ﬁbre among several population groups (toddlers, children, adolescents and adults) in EU
countries are presented. For adults (19–65 years old), the mean intake for dietary ﬁbre is reported to be
in the range from 15.7 to 29.7 g/day. At high levels, the dietary ﬁbre intakes are up to 39 g/day (p95).
Sources of uncertainties Direction(a)
Reﬁned exposure assessment scenarios:
• scenario including only the food categories according to Annex II to Regulation
(EC) No 1333/2008
• exposure calculations based on the maximum or mean levels (reported use from
industries)
–
+/–
Food supplements consumers only scenario:
• exposure calculations based on consumers only
• exposure calculations based on the maximum levels for food supplements and
the mean levels for all other food categories
• foods which may contain the food additive according to Annex III to Regulation
(EC) No 1333/2008 not taken into account
+
+/–
–
FSMP consumers only scenario:
• exposure calculations based on consumers only
• exposure calculations based on the MPL levels for the FSMP and mean levels for
all other food categories
• foods which may contain the food additive according to Annex III to Regulation
(EC) No 1333/2008 not taken into account
+
+
–
Uncertainty in possible national differences in use levels of food categories +/–
(a): +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of
exposure.
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Considering that the mean body weight for this population group equals 70 kg (EFSA Scientiﬁc
Committee, 2012), the highest intake of dietary ﬁbre would be around 560 mg/kg bw per day.
3.4.3. Exposure from all sources
Based on the data from the EFSA NDA opinion on Dietary Reference Values for carbohydrates and
dietary ﬁbre (EFSA NDA Panel, 2010a,b), mean intakes of dietary ﬁbre coming from natural sources
were estimated in mg/kg bw using default body weight values (EFSA Scientiﬁc Committee, 2012).
Mean intake from all sources and estimated exposure from food additives (non-brand-loyal scenario)
were added in order to give an overall intake estimate of ﬁbre.
Table 17 summarises the estimated exposure to celluloses from their use as food additives and
from natural sources.
Celluloses intake as food additives would correspond to 6% (non-brand-loyal scenario) of the
overall dietary mean intake in the adolescent population.
3.4.4. Exposure via other sources
Exposure to celluloses due to the following uses was not considered in this opinion.
Celluloses as ingredients in foods
Cause and effect relationships have been established between the consumption of hydroxypropyl
methylcellulose and a reduction of post-prandial glycaemic responses and maintenance of normal
blood cholesterol concentrations. In order to obtain these physiological effects, 4 g of hydroxypropyl
methylcellulose per meal or 5 g/day of hydroxypropyl methylcellulose consumed in two or more
servings, respectively, are required (EFSA NDA Panel, 2010a,b).
Pharmaceutical uses
Celluloses are used as active ingredients and excipients in medicinal products. As excipients, mostly
in medicinal products that come in various types of tablet forms (hard, chewable, ﬁlm-coated,
prolonged-release tablets), in capsules, in granules/powders for oral suspensions, injections, syrups (E
466) and in gels. Their function as excipients is described as disintegrants, diluents/ﬁllers, binders,
thickeners, taste maskers, compression aids, stabilising and swelling agents (Guo et al., 1998; Kadajji
and Betageri, 2011; Shokri and Adibkia, 2013; Martindale, 2016).
From data provided by the European Medicines Agency (EMA), information about the current
medicinal usage of celluloses and their usage as active ingredients and excipients was retrieved
(Documentation provided to EFSA n. 11).
In a medicinal product on the European market, methylcellulose is used for the control of
consistency of the intestinal content after colostomy, ileostomy and diarrhoea, in the management of
diverticular disease and ulcerative colitis, in the management of constipation and as an aid to appetite
control and the treatment of obesity. The daily dose used was up to 6 g daily. It was pointed out that
Table 17: Estimated exposure to celluloses from their use as food additives and from natural
sources
Infants
(12 weeks–
11 months)
Toddlers
(12–35
months)
Children
(3–9
years)
Adolescents
(10–17
years)
Adults
(18–64
years)
The elderly
(≥ 65 years)
Food additive reﬁned exposure, non-brand-loyal scenario (mg/kg bw per day)
Mean
[range]
10
[2-18]
35
[564]
35
[1158]
24
[740]
15
[723]
11
[716]
Natural sources of dietary ﬁbre (EFSA NDA Panel, 2010)
Mean (g)
[range] (g)
NA
NA
12
[9.015.0]
15
[9.420.2]
23
[12.033.0]
23
[15.729.7]
NA
NA
Mean (mg/kg bw) NA 1008 649 431 311 NA
% of food additives exposure out of all sources
Mean – 3% 5% 6% 5% –
NA, Not available; bw: body weight (default values from EFSA, 2012).
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adequate ﬂuid intake should be maintained to avoid intestinal obstruction. Furthermore, it was stated
that bulk laxatives such as oral methylcellulose lower the transit time through the gut and could affect
the absorption of other drugs. Contraindications are hypersensitivity to methylcellulose, imminent or
threatened intestinal obstruction, faecal impaction, difﬁculties in swallowing, colonic atony, infective
bowel disease and severe dehydration. As undesirable effects, gastrointestinal (GI) troubles, including
ﬂatulence and abdominal distension, are mentioned [Celevac17].
Microcrystalline cellulose (E 460(i)) may also be used in combination with other polymers such as
sodium carboxy methyl cellulose (E 466) and guar gum. Incompatibilities of sodium carboxy methyl
cellulose (E 466) have been reported with strongly acidic solutions, soluble salts of iron and some
other metals, and with xanthan gum (Martindale, 2016).
Upon oral intake of cellulose-containing medicines, reactions noted were abdominal discomfort,
abdominal distension/pain, constipation, dysphagia, dyspepsia, weight decrease or increase and
ﬂatulence. In addition, in some cases, a chocking sensation was also reported associated to the property
of cellulose ethers to swell, forming hydro gels in contact with water (Kamel et al., 2008; FDA, 2015).
4. Biological and toxicological data
4.1. Absorption, distribution, metabolism and excretion
4.1.1. Microcrystalline cellulose (E 460(i)) and powdered cellulose (E 460(ii))
4.1.1.1. Studies on absorption and metabolism of cellulose
JECFA (1998a,b, 1999a,b) and the SCF (1999) referred to several studies on persorption of
microcrystalline cellulose particles in animal models. Persorption corresponds to the enteral
translocation of particles into the gut-associated lymph system and is one part of the mechanism of
absorption of xenobiotics. However, due to the low surface area available for persorption compared to
that available for passive diffusion, persorption is generally a minor quantitative contributor to the
absorptive capacity of the GI tract. Thus, in cases where persorption is the major, or only, absorption
mechanism, only a small amount (a few percent) of the dose can be absorbed.
Animal studies
Microcrystalline cellulose
Four rats received 14C-labelled microcrystalline cellulose at 10% or 20% of the diet (Baker, 1966;
cited in JECFA, 1998a,b, 1999a,b). The recovery of radioactivity in faeces ranged from 96% to 104%
and was complete for all labelled material. There was no evidence of degradation or digestion and no
radioactivity appeared in the urine (only limited information available).
Pahlke and Friedrich (1974) used 29 Wistar rats (14 males and 15 females), 8 mini pigs and 9 Beagle
dogs to study the absorption of microcrystalline cellulose (Avicel® PH-101 or Elcema® P 050). The
animals were fasted for 12 h prior to oral administration of the test compound in suspension. Rats,
dogs and pigs were given 0.5, 140 and 200 g, respectively, of microcrystalline cellulose using whipped
cream for preparation of the suspension. In rats, ﬁve other vehicles were also used. No details were
given about the number of animals used for each experimental trial. The microcrystalline cellulose was
stained with Schiff’s reagent before application. Venous blood was taken from the animals 1–2 h after
administration, haemolysed with saponin and the sediment was examined for particles via light
microscopy. The authors reported that small numbers of particles could be detected in venous blood
samples by light microscopy, but there were insufﬁcient details to further interpret these ﬁndings.
A gavage study in Sprague–Dawley rats used doses of 1,000, 2,000, 3,000, 4,000 and 5,000 mg/kg
bw per day microcrystalline cellulose (median particle size 6 lm, 28% of particles < 5 lm) in groups of
5 rats/sex (presumably including control). No absorbed particles were detected in the gut or in the
Peyer’s patches at 5,000 mg/kg bw per day (no further details; FMC, 1994; cited in SCF, 1999).
In a subchronic gavage study according to current standards, Kotkoskie et al. (1996) examined the
possible absorption and translocation of microcrystalline cellulose particles. Groups of 20 male and 20
female Sprague–Dawley rats received once daily via gavage microcrystalline cellulose (median particle
size 6 lm, 35% of particles < 5 lm) as a 25% suspension in tap water at dose levels of 0, 500, 2,500
or 5,000 mg/kg bw per day for 90 consecutive days (data on subchronic toxicity are presented in
17 Celevac, 2016. Product information. https://www.medicines.org.uk/emc/medicine/20700 (accessed January 2016).
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Section 4.2.2.1). Necropsy was conducted on study days 91–94 under conditions that reduced the
contamination of tissues with particulates, and tissues/organs were processed for histopathology. After
conventional histopathology, sections were also examined by polarised light microscopy for the
detection of cellulose particles. The limit of detection of birefringent particles was < 1 lm. This speciﬁc
examination revealed a lack of birefringent cellulose particles in all organs and tissues, including gut-
associated lymphoid tissue (GALT), liver, lung and spleen. These results indicated no detectable
absorption of particles.
Powdered cellulose
In a feeding study using a-cellulose with Elcema®, a mixture of four types of a-cellulose in the ratio of
1/1/1/1 (particle size 1–50 lm (powder); 1–100 lm (powder); 1–150 lm (ﬁbrillar); 90–250 lm
(granulate)) was fed to groups of male and female Wistar rats (number of rats not clearly stated but
presumably n = 5/dose per sex) for 30 days at a dietary level of 0% or 50% (equivalent to 45,000 mg/
kg bw per day) (Ferch, 1973a,b). Statistical analysis of results was not performed. All rats were
subjected to a ‘persorption test’: on the last day of the treatment period a cellulose-staining dye
(substitution of 5% of Elcema® by Remalbordo®) was added to the diet. The animals were sacriﬁced
24 h after addition of the dye, followed by histological examination of the GI tract, spleen, liver, kidney
and heart for stained particles. Even at this high dose level, no detectable absorption of cellulose
particles occurred.
Human studies
Microcrystalline cellulose
The absorption of ingested radiolabelled microcrystalline cellulose was examined in one male
volunteer (no further details reported) (Baker, 1968; referred to by JECFA, 1998a,b, 1999a,b). In a
15-day adaptation period, the subject received 150 g/day of unlabelled microcrystalline cellulose in two
portions. He then received 47.6 lCi of 14C-labelled microcrystalline cellulose in two portions on one
day. The following 10 days the supplementation of the diet with unlabelled microcrystalline cellulose
was continued. After oral exposure to the labelled test substance, samples of faeces and urine
collected over 24 h were examined for radioactivity. All administered radioactivity (98.9  3.0%) was
recovered from the faeces within 2 days and no radioactivity appeared in the urine or in the expired
CO2, suggesting no absorption of microcrystalline cellulose from the GI tract.
In another publication (Pahlke and Friedrich, 1975), the authors reported data on absorption of
microcrystalline cellulose (no further details about the test item) in humans. The study was performed
in one male volunteer. Due to the insufﬁcient reporting, the Panel considered this study as not relevant
for risk assessment.
4.1.1.2. Studies on fermentation of cellulose
There is evidence that certain high molecular weight dietary polysaccharides can be partially broken
down by fermentation in the large intestine of animals and man. However, celluloses are known to be
less fermentable than other polysaccharides such as gums, starches or pectins. In addition to
intermediate metabolites such as lactic, acrylic or fumaric acids, the main end products of this colonic
anaerobic digestive process are short-chain fatty acids (SCFA) such as acetic, propionic and butyric
acids, which are absorbed from the colon (Cummings and Englyst, 1987).
In vitro studies
Microcrystalline cellulose
The ﬁbrolytic microbiota of the human large intestine was examined to determine the numbers and
types of cellulolytic and hemicellulolytic bacteria present (Wedekind et al., 1988). Faecal samples from
each of ﬁve individuals contained bacteria capable of degrading the hydrated cellulose in spinach and
in wheat straw pretreated with alkaline hydrogen peroxide (AHP-WS), whereas degradation of the
relatively crystalline cellulose in Whatman no. 1 ﬁlter paper (PMC) was detected for only one of the
ﬁve samples. The mean concentration of cellulolytic bacteria, estimated with AHP-WS as a substrate,
was 1.2 9 108/mL of faeces. Pure cultures of bacteria isolated on AHP-WS were able to degrade PMC,
indicating that interactions with other microbes were primarily responsible for previous low success
rates in detecting faecal cellulolytic bacteria with PMC as a substrate. The cellulolytic bacteria included
Ruminococcus spp., Clostridium sp. and two unidentiﬁed strains. According to the authors, this work
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demonstrated that many humans harbour intestinal cellulolytic bacteria and that a hydrated cellulose
source such as AHP-WS is necessary for their consistent detection and isolation.
Microorganisms involved in the breakdown of cellulose were isolated, quantiﬁed and identiﬁed from
human faecal samples (n = 34) (Robert and Bernalier-Donadille, 2003). The cellulolytic isolates
corresponded to new Ruminococcus species and to Enterococcus species. These isolated species were
incubated for 10 days at 37°C with 100 mg of paper cellulose as sole energy source. The end products
of cellulose fermentation were mainly succinic acid, acetic acid and ethanol. The authors stated that
microcrystalline cellulose degraders could only be enumerated in faecal samples from methane
excretors, indicating that these species seem to be linked to methanogenic archaea in the gut.
In further investigations, the composition and activity of the cellulose-degrading bacterial
population were shown to vary depending on the presence or absence of methanogens in the human
gut (Chassard et al., 2010). The main microcrystalline cellulose-degrading bacteria belonged essentially
to Bacteroidetes in non-methane-excreting subjects, while they were predominantly represented by
Firmicutes in methane-excreting individuals. The degradation of cellulose has been shown in vitro.
In additional experiments, an anaerobic cellulolytic bacterial strain (Ruminococcus champanellensis
sp. nov., strain designated 18P13(T)) was isolated from a human faecal sample (Chassard et al.,
2012). In in vitro experiments, this strain was able to degrade microcrystalline cellulose (Avicel®
PH-101), but the utilisation of soluble sugars was restricted to cellobiose. Acetic and succinic acid were
the major end products of cellulose and cellobiose fermentation.
Powdered cellulose
Sunvold et al. (1995) evaluated the inﬂuence of GI tract microﬂora from several species on ﬁbre
fermentation characteristics in vitro. Among other ﬁbrous substrates (beet pulp, citrus pulp and citrus
pectin), powdered cellulose (Solka Floc) was incubated for 6, 12, 24, and 48 h with ruminal ﬂuid from
cattle or faeces from dogs, cats, pigs, horses or humans. In the case of human faeces, after pooling
data across all substrates and fermentation times, organic matter (OM) disappearance was 41.2% and
acetic, propionic, butyric acid and total SCFA production were, respectively, 1.70, 0.60, 0.39, and
2.70 mmol/g of OM. Lactic acid production was 0.06 mmol/g of OM. When data were pooled across
species, substrate OM disappearance and SCFA production ranked from least to greatest in the
following order: cellulose < beet pulp < citrus pulp < citrus pectin. According to the authors, the
fermentation of different ﬁbrous substrates by faecal or ruminal microﬂora from various species seems
to be dependent not only on the fermentative activity of the microbial population but on other factors
such as lag time and rate of digesta passage.
In vivo study
Microcrystalline cellulose
In rat studies, evidence of fermentation of microcrystalline cellulose by the microﬂora of the large
intestine was shown. Male Wistar rats (n = 6 per group) were exposed via the diet (adapted from the
AIN-76A puriﬁed diet; ﬁbre-free) at a level of 5% microcrystalline cellulose (Avicel® PH-101, unlabelled
test substance) for 14 days (Hsu and Penner, 1989). Food consumption was analysed, as well as
cellulose content in faeces (validated methods). The mean total ingestion of microcrystalline cellulose
was 13.1 g/rat and the mean faecal output 11.9 g/rat, resulting in a mean digestibility of 9%. The
individual digestibility ranged between 6.4% and 10.8%. The authors stated that this variation may
reﬂect differences in the population of cellulolytic bacteria in the intestine of individual rats.
The fermentation of cellulose was also studied in a comparative study conducted in conventional or
germ-free (absence of intestinal microﬂora) male Wistar rats (Juhr and Franke, 1992). In this study,
14C-labelled starch-free cellulose (synthesised by fermentation of [U-14C]glucose with Acetobacter
xylinum, was used. No data were given about the form of the test item or further impurities. Groups of
5 rats received a single oral application of 145 kBq of the labelled cellulose in 0.5 mL of physiological
saline by gavage (no further details about the dose). Excretion via faeces, urine and exhaled air was
measured for 30 h in metabolism cages. The total recovery after 30 h was 101% in both groups,
illustrating the validity of the methods. In germ-free rats, 94.6% of the applied radioactivity was
detected in the faeces and intestinal content, 4.6% in the carcass, 1.1% in exhaled air (CO2
measured) and 0.7% in urine. In conventional rats, however, 65.4% of the applied radioactivity was
found in the faeces and intestinal content, but 30.0% in exhaled air, 3.9% in the carcass and 1.6% in
urine. The authors stated that the portion of the dose remaining within the intestine at 30 h was
resistant to fermentation. In germ-free rats, in the absence of fermentation of cellulose via the
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intestinal microﬂora, nearly complete excretion via faeces was demonstrated (94.6%), suggesting no
or little absorption from the GI tract. However, the absorption rate of 6.4% (4.6% in the carcass,
1.1% in exhaled air and 0.7% in urine) was clearly above background and may represent persorption
and/or metabolism of radiolabelled impurities of the test item. Fermentation of cellulose is unlikely
because the germ-free status of the rats was veriﬁed before and after the treatment. There is
evidence from experiments with conventional rats that fermentation of cellulose occurs and the
fermentation products (not identiﬁed or speciﬁed) were absorbed and mainly used as energy source,
since 30% of the applied radioactivity was exhaled via 14CO2.
4.1.1.3. Studies on excretion of cellulose in humans
Most of the excretion studies performed in humans used celluloses prepared from botanicals which
were, generally, not speciﬁed.
Unspeciﬁed cellulose
Southgate and Durnin (1970) compared the intake and the faecal excretion of proteins, fat,
pentosan and cellulose (origin unspeciﬁed) in young (n = 26) and elderly (n = 23) volunteers of both
sexes. The authors reported that the apparent digestibility of orally administered cellulose in the human
gut ranged from 15% to 26% and from 26% to 55% in young and elderly subjects, respectively.
Kelleher et al. (1984) used 14C-labelled cellulose prepared from Cana indica leaves, which were
allowed to photosynthesise in an atmosphere of 14CO2 for 24 h. The test item contained also labelled
starch. The puriﬁcation of the commercial product resulted in a 14C-cellulose in which > 90% of the
starch had been removed. Less than 1% of the test substance was soluble in water and 98% was
retained by a 0.45 lm Millipore ﬁlter. The experiment was performed in 10 volunteers (6 elderly and 4
younger subjects without GI disease). All fasted subjects received orally 500 mg 14C-labelled cellulose
mixed with 15 g mashed potatoes, followed by a cup of tea. Thereafter, the volunteers consumed
mixed normal diets. Excretion of the applied radioactivity was determined by liquid scintillation
measurements of faeces (n = 9) and exhaled air (n = 8; 4 elderly and 4 younger volunteers). The
faecal collection was nearly complete and reached a mean of 92% in nine subjects (one subject
excluded from faecal results). A mean of 57% of the applied radioactivity was excreted in the faeces
(no data about sampling period) and 16% of applied radioactivity was expired as 14CO2 (collection
time 72 h); an average of 7.5% of the faecal radioactivity was water-soluble. About 4% of the
administered radioactivity appeared in the exhaled air 0–10 h after ingestion. In the four elderly
subjects, a mean of 18% of the applied dose occurred in expired air 10–72 h after application, but
only 7% in the four younger volunteers. The early exhalation of 14CO2 was discussed by the authors
as due to possible metabolic products of impurities (non-cellulose polysaccharides). Metabolites in
faeces were not analysed. The authors concluded that a signiﬁcant quantity of ingested cellulose was
metabolised within the human GI tract, absorbed and appeared in the expired air as 14CO2.
Walters et al. (1989) used the same puriﬁed test item in additional in vitro experiments for
specifying that the puriﬁed 14C-labelled cellulose was completely hydrolysed by cellulase. In a ﬁrst trial,
six healthy volunteers (40–50 years of age, no further details) received 500 mg of the radiolabelled
cellulose after an overnight fast. The exhaled radioactivity was measured 0–24 h after ingestion (no
data about other excretion routes); 1.6% of the applied dose was exhaled during the ﬁrst 4 h,
whereas the cumulative amount of exhaled 14CO2 reached 11% of the applied radioactivity. In a
second trial, the degradation of the puriﬁed 14C-labelled cellulose was compared in six subjects with an
ileostomy, following total colectomy and rectal resection. Using the same experimental protocol, 1.1%
of the applied radioactivity was exhaled within the ﬁrst 4 h after ingestion, but the cumulative amount
in expired air (0–24 h) was only 3% in the ileostomy subjects; negligible 14CO2 excretion was detected
from 15 h onwards. Analysis of ileostomy contents showed that 81% of the administered cellulose was
excreted by this route. According to the authors, this comparison of normal and ileostomy subjects
revealed the important role of the colonic microﬂora in the degradation of cellulose in the human GI
tract. In a third trial, increase (by 54%) in exhaled 14CO2 was observed in four healthy volunteers,
pretreated with increased dietary ﬁbre for 3 months.
Powdered cellulose
The fate of orally ingested 131I-labelled a-cellulose was quantiﬁed in eight healthy volunteers (four
men, aged 27–75 years; four women, aged 21–76 years) by monitoring samples of faeces, urine and
blood (Carryer et al., 1982). Details about the test substance were not available, except for the
statement that strands < 1 mm were eliminated by sieving before use. The volunteers ingested
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100 lCi of the radiolabelled cellulose with a meal after an overnight fast. Complete urine and stool
collections were obtained over a 5-day period after ingestion; in two subjects, faeces were also
collected at days 6 and 7 and analysed. Venous blood samples were taken once daily. Aliquot samples
of faeces and urine were ﬁltered (0.45 lm Millipore ﬁlter) to assess also the unbound radiolabel. No
radioactivity was detected in blood, but 87% of the applied dose was excreted via faeces (58% at
days 1 and 2) and 2% via urine (1.6% at days 1 and 2). Less than 2% of radioactivity in faeces, but
total radioiodine in urine, was unbound. The total recovery of the applied radioactivity was 89%; the
authors did not discuss the fate of the remaining amount, but concluded that 131I-labelled a-cellulose
was resistant to degradation by colonic microﬂora due to the large ﬁbre size and/or chemical
transformation of the test item produced by the radioactive labelling.
4.1.2. Methyl cellulose (MC; E 461)
Animal data
Groups of adult male Hooded Wistar rats were fed sucrose-based diets containing 80 g/kg of MC of
low (25 cP), medium (400 cP) and high (1,500 cP) viscosity (Topping et al., 1988). After 10 days of
adaptation to the three diets, blood and liver were sampled. The whole caeca were also removed and
the contents extruded for measurement of weight, viscosity, pH, volatile fatty acids (VFA) and bile
acids. The viscosity of stomach and caecal contents was increased in proportion to that of the dietary
ﬁbre. Plasma cholesterol and VFA concentrations were unaffected by the viscosity of the dietary ﬁbre.
The concentrations of acetic and propionic acid in caecal contents decreased with increasing viscosity
of the diet; according to the authors, this effect could be related to the availability of dietary starch
and sucrose trapped in the methyl cellulose matrix. Finally, this study gave no indication of
fermentation of MC by gut microﬂora.
Male and female Sprague–Dawley rats (3/sex per group, 185250 g) were dosed once or once
daily over 5 days via gavage with ~ 500 mg/kg bw per day of 14C-MC labelled in the methoxyl group
and with a viscosity of 3,300 cP (Braun et al., 1974). In the single-dose study, the animals were kept
in metabolism cages for separate collection of urine, faeces and CO2 in expired air. Urine and faecal
samples were collected at 6-h intervals for the ﬁrst 24 h and at 12-h intervals thereafter. The rats were
killed 4 days after dosing, the carcasses were skinned and the hearts, livers, lungs, kidneys and GI
tracts were removed. In the repeated-dose study, rats were housed in metabolism cages designed for
a separate collection of urine and faeces. Samples of excreta were collected at 24-h intervals, the rats
were killed 24 h after the ﬁnal dose, and the carcasses and tissue samples were assayed for
radioactivity contents. In the single-dose study, 96105% of the total dose of 14C activity was
eliminated via the faeces within 48 h. No radioactivity was detected in the expired air and less
than 0.1% of the dose was found in the urine, selected tissues and remaining carcass. In the
repeated-dose study, there was also no increase in the 14C activity in the heart, kidney, liver, lung,
carcass and skin, as the total amount found in these tissues was less than 0.1% of the total dose. The
Panel noted that all the administered MC was eliminated in the faeces of the rats and was neither
absorbed intact, nor fermented, in the GI tract.
Human data
In an older study (Machle et al., 1944) with two male adults and one 10-year-old girl, it was shown
that nearly the entire MC (up to > 95%) was excreted via faeces, practically unaltered, within 3 days.
In each experiment, 10 g of MC were given orally in a single dose, except in one experiment, where
5 g were given. The product was taken as a 5% solution and in one experiment as a gel. Irrespective
of the accompanying diet (e.g. milk diet, customary diet, bran daily), practically all of the methoxyl
groups of ingested MC were recovered from the faeces.
4.1.3. Ethyl cellulose (EC; E 462)
No data available.
4.1.4. Hydroxypropyl cellulose (HPC; E 463)
Animal data
Male and female Wistar-Imamichi strain rats (3/sex per group) were dosed once via gavage with
1,300 mg/kg bw of 14C-HPC (labelling in the methylenic carbon of the hydroxypropyl group),
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containing 12% of the hydroxypropyl group (2.74 lCi/mg) (Kitagawa et al., 1976a). After dosing, the
rats were placed in metabolism cages and urine and faeces were collected for 96 h. For the detection
of possible metabolites in urine, gel ﬁltration was used. Bile duct was cannulated and samples were
taken for 24 h and at different time points (6, 12, 24, 48 and 72 h after dosing). Radioactivity was
determined in tissues and GI contents (blood, liver, kidney, lung, heart, spleen, cerebrum, cerebellum,
thymus, thyroid, fat, stomach and intestinal contents from the upper part of the duodenum to the
caecum, testes, prostate, uterus, ovaries). Up to 69% and 97% of the radioactivity were excreted in
the faeces within 24 and 96 h, respectively. Only minor amounts (up to 2.6%) were excreted in urine
within 96 h. Less than 0.015% was excreted in bile within 24 h after dosing. Due to the very minor
amounts of 14C-HPC excreted via urine, no speciﬁc metabolites could be identiﬁed. Their molecular
weight was slightly higher than that of glycerol or glucose and the elution position was different from
propylene glycol, which was present at a level of < 2% in the test material. Apart from liver and
kidneys, radioactivity was not detectable in other tissues examined. Peak amounts in livers were given
with 1.02% of the dose in male rats 12 h after dosing, and with 0.026% of the dose in females, 24 h
after dosing.
When 250 or 1,000 mg/kg bw of 14C-HPC were administered to rats in a 5% aqueous solution,
radioactivity no greater than 0.01% of the administered dose was detected in organs, urine and
expired air (Industrial Bio-Test Lab, 1964; unpublished report, cited in JECFA, 1990). Recovery of
activity in the faeces varied from 98.3% to 102.7%. Hence, orally ingested material was not absorbed
from the GI tract of the rat and was excreted quantitatively in the faeces, principally in the ﬁrst 48 h.
To check on enterohepatic circulation, two additional rats with cannulated bile ducts were administered
1,000 mg/kg bw of radiolabelled material. Bile was collected for 72 h, but no signiﬁcant activity was
found.
4.1.5. Hydroxypropyl methyl cellulose (HPMC; E 464)
Experimental data
In vitro
Wyatt et al. (1988) compared the effect of a ﬁbre-free diet and of diets containing non-digestible
polysaccharides, including HPMC, on rat caecal and colonic physiology and microﬂora. All polysaccharide-
containing diets led to enlargement of the caecum and colon, associated with increased weight of
contents and tissue. In vitro, HPMC remained almost completely unfermented, with only 5% of the
substrate utilised after 7 days of incubation. According to the authors, caecal and colonic enlargement
would be due to tissue hypertrophy in response to increased bulk of contents, irrespective of the nature
of that bulk, which varies with diet. It would be unlikely that SCFA or other microbial metabolites are the
stimulus for the trophic response seen when non-digestible dietary polysaccharides are fed to rats.
In vivo
Groups of three young male and three young female Sprague–Dawley rats were dosed with
500 mg/kg bw per day of 14C-HPMC (viscosity of 2.25 cP) once or once daily over ﬁve consecutive
days via gavage (Gorzinski et al., 1986). After single dosing, about 73101% of the applied dose was
excreted within 24 h via faeces (100105% within 72 h), while within 72 h only up to 1.5% was
found in urine, 0.2% in carcass and tissues and 0.07% in expired air. In bile, a collection over 24 h in
two male rats gave 0.05% of the applied dose. In plasma, the elimination of radioactivity was
monophasic, with a half-live of about 2 h. Most of the residual radioactivity was found in the GI tract
(no details given). In urine, methyl ethers of glucose and oligomers were identiﬁed, determined by thin
layer chromatography in 6-h urine from one animal of each sex. Also, after dosing once daily over
5 days, most of the applied dose was excreted via faeces (97104%), while only 1% was recovered in
urine. There was no evidence of accumulation in the tissues examined (adrenals, brain, heart, liver,
kidneys and spleen). A determination in exhaled air was not performed.
Human data
In a study with 25 young and healthy adults (23 males and 2 females), each person was given 3
graduated doses of HPMC ranging from 0.6 to 8.9 g (Knight et al., 1952). The time interval between
the doses was at least 1 week. Following each dose, stool specimens were collected at approximately
24-h intervals for 72 or 96 h. For a determination of the quantitative amounts of HPMC in the samples
of dried faeces, an analytical procedure, consisting of a methoxyl determination made directly on the
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faeces samples, was used. Nearly all of the ingested substance (average of total recovery 97%, with a
range of 89110%) was excreted via faeces within 96 h following administration.
4.1.6. Ethyl methyl cellulose (EMC; E 465)
Animal data
After feeding a single dose of 600 mg of EMC in the diet of rats, about 90% of the dose was
recovered from the faeces by the end of the fourth day (Gage, 1962; unpublished report, as cited in
JECFA, 1990). Nearly all alkoxyl groups remained attached to the cellulose chain during passage
through the gut.
4.1.7. Sodium carboxy methyl cellulose (NaCMC; E 466)
Experimental data
Wyatt et al. (1988) compared the effect of a ﬁbre-free diet and of diets containing non-digestible
polysaccharides, including CMC, on rat caecal and colonic physiology and microﬂora. All
polysaccharide-containing diets led to enlargement of the caecum and colon, associated with increased
weight of contents and tissue. CMC had the most marked effect and treated animals had watery
faeces. In vitro, CMC was poorly fermented even after prolonged incubation. According to the authors,
caecal and colonic enlargement would be due to tissue hypertrophy in response to increased bulk of
contents, irrespective of the nature of that bulk, which varies with diet. It would be unlikely that SCFA
or other microbial metabolites are the stimulus for the trophic response seen when non-digestible
dietary polysaccharides are fed to rats.
Adiotomre et al. (1990) investigated the effects of dietary ﬁbres, including NaCMC, on caecal
fermentations by using fresh human microﬂora. Evolution of SCFA and water-holding capacity after
fermentation were also measured. Among other polysaccharides, NaCMC (E 466 grade) yielded low
amount of total SCFA (25.8 vs 15.5 mmol/L for controls). The major SCFA produced were acetic and
propionic acids, with smaller amounts of butyric, isobutyric, valeric and isovaleric acids. By contrast,
the amount of water held by 1 g of the fermented residue was the highest in the case of NaCMC (11.9
vs 0.91 g/g for controls).
The absorption and excretion of NaCMC was examined in rats (B€ar et al., 1995b). The 14C label was
in the two carbon atoms of the carboxymethyl group and the speciﬁc radioactivity was 0.27 lCi/mg.
One group of four male and four female Wistar rats were fed diets with 5% unlabelled CMC for a
2-week adaption period, followed by a single oral dose of 500 mg/kg bw of a 14C-CMC solution via
gavage. Immediately after dosing, the rats were housed for 48 h in metabolism cages and then for
72 h in open metabolism cages. Expired CO2 was collected every 2 h during the ﬁrst 24 h and then at
12-h intervals until 48 h. Urine and faeces were collected. At study termination on day 5, the animals
were killed and plasma and blood cells were collected. The content of the GI segments, testes,
prostate, uterus, ovaries, adrenals, urinary bladder, as well as samples of perirenal fat, abdominal skin
and skeletal muscle, together with the remaining carcass were collected and weighed. The
14C administered and recovered in excreta and different organ and tissue samples was determined by
liquid scintillation counting. At the end of the 5-day sampling period, the total mean recovery rate for
14C-CMC was 98.07% and the applied dose was mainly excreted via faeces (94.39%). Most of the
radioactivity was excreted within 48 h after dosing. In the contents of the GI tract, only about 0.01% of
the dose was recovered. Only small amounts were excreted via urine (less than 2% of the dose). Via
expired CO2, only < 1% of the applied radioactivity was expired within 48 h. The highest expiration rate
was seen during the ﬁrst 2 h after dosing (0.19%). Only a small incorporation of the 14C label in organs
and tissues was seen (0.58%), with highest amounts found in fat, skin, muscles and liver. An
examination of the pooled faeces showed that about 51% of the label from 14C-CMC remained with the
sediment obtained by centrifugation of the faecal suspensions. As most of the soluble 14C-labelled
excretion products were extracted in a ﬁrst extraction step (the second step provided only about 10%
of the radioactivity of the ﬁrst step), the label was apparently tightly bound to the faecal matrix or was
incorporated in the bacterial cells. Gel permeation chromatography (GPC) of the dosing solutions and
the faecal extracts revealed that CMC was depolymerised during intestinal passage.
In an unpublished study (Wiebe, 1962; cited in JECFA, 1990), 14C-labelled CMC containing up to
0.34% radioactive sodium glycolate was given orally to two groups of ﬁve male rats each, in a dose of
400 mg. No detectable activity (less than 0.02% of the dose) was found in the livers and kidneys and
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about 0.14% of the administered radioactivity was found in the 48-h urine samples. This amount,
however, could be accounted for the free radioactive glycolate present in the test compound.
Five rats (strain and sex not speciﬁed) were fed 5 g of CMC collectively and faeces were collected
at 24-h intervals. Approximately 90% of the applied dose was recovered in the faeces (Shelanski and
Clark, 1948; as cited in JECFA, 1990).
In a study with six young albino rats, CMC was given via diet at levels of 5, 10 or 14% during four
periods of 10 days each. About 96.3100% of the applied doses could be recovered in faeces
(Ziegelmayer et al., 1951).
In a study with three rabbits, CMC was given via diet at levels of 4.76% and 9.09% during two
periods of 10 days each. About 4857% of the applied doses could be recovered in faeces
(Ziegelmayer et al., 1951).
Human data
In three volunteers given daily oral doses of 20 or 30 g of CMC over 4 days, about 90% of the
applied doses could be recovered in faeces. The dosing was well tolerated (Ziegelmayer et al., 1951).
4.1.8. Cross-linked sodium carboxy methyl cellulose (E 468)
As reported above, a comparative disposition study was carried out with 14C-labelled sodium CMC
and enzymatically hydrolysed sodium CMC in adult Wistar rats (8 animals/sex; age not stated) (B€ar
et al., 1995b). The enzymatically hydrolysed sodium CMC was recovered from the GI tract with an
unchanged molecular weight, whereas the sodium CMC was reduced in molecular size. This implies
that the passage of CMC through the rat GI tract leads to the breakdown of some of the monomers of
CMC to units similar to the ones of its enzymatically hydrolysed counterpart. JECFA (2003) noted that
the cross-linked form will be more insoluble in water and therefore less likely to be absorbed and
degraded than the parent compound itself.
4.1.9. Enzymatically hydrolysed carboxy methyl cellulose (E 469)
The absorption and excretion of partially enzyme-hydrolysed 14C-labelled enzymatically hydrolysed
carboxy methyl cellulose was compared in rats to those of CMC in the above described study (B€ar
et al., 1995b). Following the same experimental protocol, most of the radioactivity (89–99% of the
dose) was excreted within 48 h after dosing. In the contents of the GI tract, at study termination, only
about 0.01% of the dose could be recovered. Only small amounts (about 2%) were excreted via urine.
Via expired CO2, only < 1% was expired within 48 h. Only a small incorporation of the
14C label in
organs and tissues was seen (0.75%), with highest amounts in fat, skin, muscles and liver. An
examination of the pooled faeces showed that about 35% of the label from 14C-enzymatically
hydrolysed carboxy methyl cellulose remained with the sediment obtained by centrifugation of the
faecal suspensions. The label was apparently tightly bound to the faecal matrix or was incorporated in
the bacterial cells. GPC of the dosing solutions and the faecal extracts revealed that enzymatically
hydrolysed carboxy methyl cellulose was excreted nearly intact.
4.1.10. Summary
Animal and human data clearly demonstrated that microcrystalline and powdered cellulose are not
absorbed intact in the GI tract and could be fermented during their passage through the large intestine
by strains of bacteria found in the human colon. Microcrystalline, powdered and modiﬁed celluloses
would be less fermented than other polysaccharides such as gums, starches or pectins. A comparative
human study in normal and ileostomy subjects conﬁrmed the role of the intestinal microbiota in the
degradation of 14C-labelled cellulose in the human GI tract. Data on methyl cellulose (E 461),
hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), ethyl methyl cellulose (E 465),
sodium carboxy methyl cellulose (E 466), cross-linked sodium carboxy methyl cellulose (E 468) and
enzymatically hydrolysed carboxy methyl cellulose (E 469) demonstrated that these modiﬁed celluloses
would not be absorbed intact and not fermented in the GI tract of animals or humans. They are
excreted intact mainly via faeces (more than 90% of the administrated doses), while only minor
amounts of radiolabelled material are excreted via urine or via expired air (as 14CO2) and there is no
indication for accumulation in the body. Overall, by comparing their respective databases, the
Panel considered that microcrystalline, powdered and modiﬁed celluloses would not be absorbed intact
and would be less fermented than other polysaccharides such as gums, starches or pectins.
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4.2. Toxicological data
Speciﬁc toxicity data were not available for all the celluloses for all endpoints. Where studies were
conducted, the speciﬁcations of the celluloses tested were not always clearly stated. However, given
their structural, physicochemical and biological similarities, the Panel considered it possible to read-
across between all the celluloses.
4.2.1. Acute oral toxicity (E 460(i), E 460(ii), E 462–464, E 466)
Data on acute oral toxicity were available for microcrystalline cellulose, powdered cellulose, ethyl
cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose and sodium carboxy methyl cellulose.
Apart from one unpublished study with hydroxypropyl methyl cellulose, where an oral LD50 value of
> 1,000 mg/kg bw was given for rats (CTFA, 1978), the oral LD50 values for the different other
celluloses were consistently ≥ 3,000 mg/kg bw (Documentation provided to EFSA n. 20, 25, Freeman,
1996a; referred to by JECFA, 1998a,b, 1999a,b, Palotta, 1959; referred to by JECFA, 1998a,b, 1999a,
b, Rowe et al., 1943; Shelanski and Clark, 1948; Industrial Bio-Test Lab, 1962; Kitagawa et al., 1970,
1976b; Moreno, 1977). Therefore, the Panel considered the oral acute toxicity of these compounds to
be low.
4.2.2. Short-term and subchronic toxicity
4.2.2.1. Microcrystalline cellulose (E 460(i))
Male Wistar rats (n = 6/group) fed a diet containing 5% microcrystalline cellulose (Avicel® PH-101;
equivalent to 6,000 mg/kg bw per day) for 14 days did not show any effects on body weight gain,
ﬁnal body weight or food consumption in comparison to the controls receiving ﬁbre-free diet (Hsu and
Penner, 1989). The treatment induced a signiﬁcant increase in wet and dry weight of faeces; the
cellulose content of faeces reached 70%.
A subacute 28-day gavage study in Sprague–Dawley rats used doses of 1,000, 2,000, 3,000, 4,000
or 5,000 mg Avicel® FD-006/kg bw per day microcrystalline cellulose (median particle size of 6 lm;
28% of particles with size < 5 lm) in groups of ﬁve rats/sex (presumably including control) (FMC
1994, referred to by SCF, 1999). No adverse toxicological effects occurred at any dose level. No
persorbed particles were detected in the gut or in the Peyers’ patches at 5,000 mg/kg bw per day. The
Panel noted that the test substance was not compliant with the speciﬁcations of the food additive.
Male Wistar rats (n = 12 per group) were fed for 4 weeks a diet (26% casein) supplemented with
0%, 5%, 10% or 20% microcrystalline cellulose (Avicel®) (equivalent to 0, 2,500, 5,000 or 10,000 mg/
kg bw per day) (Sundaravalli et al., 1971). Rats were sacriﬁced and the body composition was
analysed (moisture, fat and protein). No effects were detected. The body weight gain was not
signiﬁcantly inﬂuenced. In additional experiments, groups of 12 male Wistar rats received for 5 weeks
a cholesterol-rich diet (1.5% cholesterol) supplemented with 0% or 20% microcrystalline cellulose.
Cellulose treatment reduced signiﬁcantly the total cholesterol level in plasma and liver and increased
the excretion of bile acids in the faeces.
Groups of ﬁve male rats (no data about strain) received 0.5% or 10% microcrystalline cellulose
(equivalent to 450 or 9,000 mg/kg bw per day) in their diet for 8 weeks (Asahi Chemical Industry Co.,
1966; referred to by JECFA, 1998a,b, 1999a,b). The high-dose group showed slightly lower body
weights than control rats. Haematology, serum chemistry and vitamin B1 levels in blood and faeces
revealed no differences from control (no further details available).
In a study in Russian (Dorkina et al., 2007), groups of six male and six female Wistar rats received
0, 200, 1,000 or 2,000 mg microcrystalline cellulose/kg bw per day (dosing not clearly stated,
presumably by gavage and in mg/kg bw per day) for 2 months. The treatment reduced signiﬁcantly
the body weight gain in males and females at ≥ 1,000 mg/kg bw per day, and in females also at the
low dose level. However, the initial weight at the start of the experiment differed between groups
(difference > 10%), limiting the evaluation of this result. Haematology revealed statistically signiﬁcant
effects even at the low dose level for some parameters (e.g. thrombocytopenia, erythrocytopenia,
decreased haematocrit, reticulocytosis, reduced number of monocytes but increased number of
lymphocytes and segmented neutrophils, decreased coagulation time). However, no data were given
on the historical range of these parameters. The toxicological relevance of these effects is questionable
and not in accordance with other studies.
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Sprague–Dawley rats (20/sex per group) received a diet containing 0%, 5% or 10%
microcrystalline cellulose (Avicel® PH-101; median particle size 70 lm) (equivalent to 0, 4,500 or
9,000 mg/kg bw per day) for 13 weeks (Schmitt et al., 1991). Animals were observed daily for overt
signs of toxicity. Body weights and food consumption were determined weekly for all animals.
Haematology and clinical chemistry analyses were performed at termination (n = 10/group). Liver,
adrenals, testes with epididymides, and kidney weights were recorded for all animals. All animals were
necropsied and tissues from control and high-dose animals, as well as all gross lesions from all
animals, were examined microscopically (no further data). No treatment-related clinical signs or effects
on mean body weight or mean body weight gain were noted. The food consumption was increased in
treated groups due to the reduced caloric intake. In haematology and clinical chemistry, no treatment-
related effects were detected. There were no notable gross pathologic ﬁndings at necropsy and no
effects on organ weights. Microscopic evaluation of tissues revealed no treatment-related lesions,
including in the GI tract. The Panel considered 10% microcrystalline cellulose in the diet (9,000 mg/kg
bw per day, the highest dose tested) as the no observed adverse effect level (NOAEL). Similar results
were obtained with cellulose ﬁbre (CellulonTM; cellulose produced by a bacterial fermentation process)
using the same experimental design and dose levels (Schmitt et al., 1991).
Groups of 20 male and 20 female Crl:CD(R) BR/VAF/Plus rats received a diet containing 0 (control),
25,000 or 50,000 mg Avicel® RCN-15/kg diet (a mixture of 85% microcrystalline cellulose with 15%
guar gum) (equal to 1,794 or 3,769 mg/kg bw per day for males and 2,131 or 4,446 mg/kg bw per
day for females) for 90 days (Freeman, 1992a referred to by JECFA 1998). The study was performed
according to the current guidelines. During the study, no treatment-related clinical signs were noted.
In the high-dose group, increased food consumption was observed during several weeks, probably due
to the increased dietary ﬁbre content. This effect was also observed during the ﬁrst week in the
25,000 mg/kg group. However, body weight gain was not affected. No treatment-related effects were
detected in clinical chemistry and haematology. Necropsy revealed no evidence of treatment-related
changes. The organ weights were unaffected by the treatment. Histopathology was performed in 34
organs or tissues, including the GI tract and GALT of the ileum; there was no evidence for toxicity of
microcrystalline cellulose (data from secondary source). The author noted that the NOAEL was
50,000 mg/kg diet, the highest dose tested, (equal to 3,769 mg/kg bw per day for males and
4,446 mg/kg bw per day for females). The Panel agreed with this NOAEL.
In a 90-day study performed according to the current guidelines, Sprague–Dawley rats (20/sex per
group) received a diet containing 0 (control), 25,000 or 50,000 mg Avicel®CL-611/kg diet
(microcrystalline cellulose and carboxy methyl cellulose) (equivalent to 0, 2,250 or 4,500 mg/kg bw
per day), Documentation provided to EFSA n. 32). Clinical signs were recorded daily. Body weights and
food consumption were measured weekly. Blood samples were collected at termination for
haematology and clinical chemistry. Necropsy was conducted on study days 91–94 and organ weights
(brain, liver, kidneys, adrenals and testes) measured. Thirty-three organs/tissues of high-dose and
control rats were examined histopathologically. No treatment-related clinical signs and no mortality
occurred. In males, no effect on body weight and body weight gain was observed. Males of both
treated groups showed increased food consumption. This effect was considered to be a response to
the decreased caloric content of the test diets. Females of both treated groups showed a decreased
body weight and body weight gain, without any signiﬁcant increase in food consumption. The effect
on body weight gain was considered to be caused by the decreased caloric intake. There were no
other toxicologically relevant effects in treated animals with respect to clinical chemistry, haematology
and absolute and relative organ weights. No treatment-related lesions were detected in histopathology.
The authors considered the high-dose group (4,500 mg/kg bw per day) as the NOAEL of this study.
The Panel agreed with this NOAEL.
A subchronic gavage study was conducted according to current standards to evaluate the potential
toxicological effects associated with intestinal translocation of microcrystalline cellulose (Kotkoskie
et al., 1996). Sprague–Dawley rats (20/sex per group) received once daily, via gavage, microcrystalline
cellulose (Avicel® FD-006, median particle size 6 lm, 35% particles < 5 lm) for 90 consecutive days as
a 25% (weight/volume preparation) suspension in tap water at dose levels of 0, 500, 2,500 or
5,000 mg/kg bw per day. The suspension was prepared fresh daily. The control group received the
same dosage volume of tap water as the high-dose group. Clinical signs were recorded daily after
dosing. Body weights and food consumption were measured weekly. Blood samples were collected at
termination for haematology and clinical chemistry. Necropsy was conducted on study days 91–94 and
the organ weights (brain, liver, kidneys, adrenals and testes) measured. Thirty three organs/tissues of
high-dose and control rats were examined histopathologically. After conventional histopathology,
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sections were also examined by polarised light microscopy for the detection of cellulose particles (limit
of detection of birefringent particles < 1 lm). No treatment-related mortality occurred. The only
treatment-related clinical sign noted during the study was pale faeces at ≥ 2,500 mg/kg bw per day.
This effect was attributed to the presence of the test material in the faeces and was not considered by
the authors to be of toxicological relevance. Body weights or body weight gains were not signiﬁcantly
altered. There were no toxicologically relevant effects in treated animals with respect to food
consumption, clinical chemistry, haematology, absolute and relative organ weights. No treatment-
related lesions were detected in histopathology. Particularly, there were no macroscopic or microscopic
ﬁndings of microemboli or inﬂammation in any tissue, including the spleen, intestinal wall and GALT.
Polarised light examination revealed a lack of birefringent cellulose particles in all organs and tissues
from all high-dose rats, indicating no intestinal uptake. According to the authors, the NOAEL of this
subchronic gavage study was 5,000 mg/kg bw per day, the highest dose tested. The Panel agreed
with this conclusion. The Panel noted that the test substance was not compliant with the speciﬁcations
of microcrystalline cellulose (E 460(i)) used as food additive.
4.2.2.2. Powdered cellulose (E 460(ii))
Rats
In a subacute feeding study performed according to current standards, fermentation-derived cellulose
(60% purity, mixed with 20% sodium carboxy methyl cellulose and 20% sucrose; white powder) was
administered to groups of six male and six female F344 rats at dietary levels of 0, 1.25, 2.5 or 5.0% for
28 days (equal to 1,340, 2,644 or 5,331 mg/kg bw per day for males and 1,280, 2,611 and 5,230 mg/kg
bw per day for females) (Hagiwara et al., 2010). The treatment had no effects on clinical signs, mortality,
body weight, food and water consumption. No adverse effects were detected in urinalysis,
ophthalmology, haematology, blood biochemistry and histopathology. Slightly increased absolute and
relative caecum weights were measured at necropsy in females ingesting ≥ 2.5% dietary level. This
effect was considered by the authors to be a physiological adaptation to the poorly absorbed cellulose.
The authors concluded that the NOAEL was 5.0% of the test item in the diet, equal to 5,331 mg/kg bw
per day for males and 5,230 mg/kg bw per day for females. The Panel agreed with this conclusion.
The addition of 15% cellulose to the diet of six male rats for 5 weeks did not produce clinical signs
of toxicity or statistically signiﬁcant changes on body weight gain when compared with animals that
received a ﬁbre-free diet (Shiau and Ong, 1992). Food intake was signiﬁcantly increased in cellulose-
treated animals, probably due to the high concentration of non-nutritive material in the diet.
In a feeding study with Elcema (a mixture of four types of a-cellulose in the ratio of 1/1/1/1
(particle size 1–50 lm (powder), 1–100 lm (powder), 1–150 lm (ﬁbrillar), 90–250 lm (granulate)),
groups of male and female Wistar rats (n = 20/sex per group) were fed for 90 days at a dietary level
of 0% or 10% (equivalent to 0 or 9,000 mg/kg bw per day) (Ferch, 1973a,b, 1974). Statistical analysis
of results was not performed. Treated rats gained less weight than those in the control group (> 10%
reduction in males and maximal 8% in females). Food consumption was not affected. No treatment-
related mortality and behavioural abnormalities were observed. Urinalysis, haematology and clinical
chemistry at week 0, 6 and 13 revealed similar results for test and control groups. At necropsy, some
of the treated rats had distended stomachs, which often contained considerable amounts of the test
diet. The absolute liver and kidney weights of male rats and the ratio of the weight of these organs to
brain weight were decreased in test animals (no data about statistical signiﬁcance). No treatment-
related histopathological effects were reported (totally 31 organs examined, no further data). The
effects on liver and kidney weight were considered by the authors to be without toxicological
relevance, since no effects were detected in histopathology and clinical chemistry. Overall, no toxic
effects were induced in this subchronic feeding study in rats at a dose of 10% a-cellulose in the diet
(equivalent to 9,000 mg/kg bw per day), the highest dose tested. The Panel agreed with the NOAEL of
9,000 mg/kg bw per day proposed by the authors. The Panel noted that the test substance was not
compliant with the speciﬁcations of powdered cellulose (E 460(ii)) used as food additive.
Rats (15/sex per group) received 0% or 10% cellulose powder in the diet (equal to 8,200 mg/kg
bw per day for male rats and 9,800 mg/kg per day for female rats) for 3 months (Rowland et al.,
1982). Rats given the cellulose powder exhibited higher food consumption than control animals,
presumably due to the high concentration of non-nutritive material in their diet. No effects were
observed on the following parameters: body weight, water intake, haematology, clinical chemistry,
urinalysis, organ weights or histopathology.
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A group of 20 male and 20 female Crl:CDBR rats received for 13 weeks a basal diet containing a
mixture of 10% powdered cellulose (Solka-Floc, no further data) (equivalent to 9,000 mg/kg bw per
day) and 10% fructose; concurrent controls were fed the basal diet (Kruger et al., 1999). All rats were
checked once daily for clinical signs. Body weight and food consumption were measured once weekly.
Haematological and clinical chemistry parameters were determined in blood collected just prior to
necropsy. Macroscopic and microscopic pathology was performed. Histopathology of 34 organs and all
gross lesions was performed. No clinical signs were detected and all rats survived to study termination.
No effects were reported on body weight. Treated rats apparently consumed more food to compensate
for the reduction in caloric intake. The treatment induced no signiﬁcant haematological or clinical
chemistry effects and no changes in organ weights (determined in liver, kidney, adrenals, testes, brain,
heart, thymus, spleen, thyroid, epididymal fat pads, mesenteric lymph nodes). No treatment-related
effects were reported in the histopathology. No adverse effects were induced in rats receiving a diet
supplemented with 10% powdered cellulose (equivalent to 9,000 mg/kg bw per day) for 13 weeks.
The effects of a synthetic diet (AIN-76TM) containing 5% cellulose (equivalent to 2,500 mg/kg bw
per day; no further details) were compared with a cereal-based diet (4.5% crude ﬁbre, no further
details) in female rats (n = 6 per group) (Bieri et al., 1977). After an exposure period of 24 weeks, no
effects were noted on terminal body weight, absolute and relative organ weight of liver and kidney or
haemoglobin and haematocrit values. No further parameters were measured.
Groups of 10–15 male Sprague–Dawley rats were fed diets containing 0%, 10%, 20% or 30%
cellulose ﬁbre (equivalent to 0, 5,000, 10,000 or 15,000 mg/kg bw per day; no further details), for
23 weeks (Nigro et al., 1979). A slight increase in body weight (measured every fourth week) was
found at the low dose, but a dose-dependent decrease was observed at ≥ 20% in the diet, signiﬁcant
at the high dose level (30%). Food consumption was increased at ≥ 20% and faecal wet weight
increased in all treatment groups. No further parameters measured.
4.2.2.3. Methyl cellulose (MC; E 461)
Rats
Groups of ﬁve male and ﬁve female rats (not further speciﬁed) were dosed via diet with 0 or 10%
of MC (4,000 cP) (equivalent to 0 or 9,000 mg/kg bw per day) for 95 days. In females, the feed intake
was decreased, resulting in decreased body weight gains (107 vs 125 g in controls). At study
termination on day 95, the rats were autopsied and tissues were examined microscopically. The dosing
had no adverse effects on relative organ weights of heart, liver, spleen and kidneys. However, the
stomachs of the dosed rats were 15% heavier compared with controls. There were no signiﬁcant
microscopic changes indicative of toxic effects in the examined visceral organs (not further speciﬁed)
(Tainter, 1943).
In two 90-day studies, groups of 10 male and 10 female Sprague–Dawley rats were dosed via diet
with 0%, 1%, 3% and 10% low viscosity (10 cP) MC (equivalent to 0, 900, 2,700 or 9,000 mg/kg bw
per day) or with 0%, 3% and 10% high viscosity (4,000 cP) MC (equivalent to 0, 2,700 or 9,000 mg/kg
bw per day). In both studies, weekly body weight and food consumption records were kept.
Haematological evaluations (packed cell volume (PCV), haemoglobin (Hb) determinations and
erythrocyte and total and differential leucocyte counts) were conducted during week 12 on ﬁve male
and ﬁve female rats from controls and high-dose rats. Urine analyses were performed in ﬁve rats of
each sex fed 0% and 10% of the test material. Blood urea nitrogen (BUN), serum alkaline phosphatase
(AP) and serum glutamic-pyruvic transaminase were determined terminally. At termination, weights of
brain, heart, liver, kidneys and testes were recorded and gross examinations were carried out on all
rats. Histopathology was conducted on haematoxylin-eosin-stained sections of selected tissues from
rats fed the control and 10% diets. Most, or all, of the following tissues were examined: thyroid,
pituitary, trachea, lung, aorta, heart, liver, kidneys, adrenals, spleen, pancreas, stomach, small and large
intestine, reproductive organs, urinary bladder, brain, spinal cord, peripheral nerve, skeletal muscle,
bone marrow, mesenteric and mediastinal lymph nodes and any lesions suggesting a possible
pathological change. Male rats receiving diets containing 10% low viscosity MC (10 cP) showed a
signiﬁcant decrease in their mean starved body weight at autopsy (p < 0.05). The average weights, in
grams, of few of the organs from these rats were also signiﬁcantly lower than controls. Especially in
male rats dosed with ≥ 3% of low and high viscosity MC, a dose-dependent and signiﬁcantly increased
feed consumption was noted. For all other investigated parameters, no adverse effects were reported
(McCollister et al., 1973). In both trials, there were no signiﬁcant adverse effects at a dose level of 3%
(equivalent to 2,700 mg/kw bw per day).
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4.2.2.4. Ethyl cellulose (EC; E 462)
Rats
In an unpublished study with rats, no adverse effects were reported in 80 animals dosed via diet
with 1.2% of EC (equivalent to 1,080 mg/kg bw per day) (Hake and Rowe, 1963; cited in JECFA,
1990).
4.2.2.5. Hydroxypropyl cellulose (HPC; E 463)
Rats
Groups of 10 young adult male and 10 female Wistar rats were administered daily doses of 0,
1,500, 3,000 or 6,000 mg/kg bw of HPC via gavage for 30 days. The rats were weighed every day and
food consumption was measured twice a week during the experiment. After 30 days, blood samples
were collected for the following tests: aspartate aminotransferase (serum glutamic-oxaloacetic
transaminase (S-GOT)), alanine aminotransferase (serum glutamate-pyruvate transaminase (S-GPT)),
total cholesterol, AP, blood sugar, total protein, haematocrit, Hb, white blood cell (WBC) and red blood
cell (RBC) counts and speciﬁc gravity of whole blood and blood plasma. Furthermore, urine of the
individual rats was collected for the qualitative detection of glucose, protein and pH. Then the rats
were autopsied and the wet weight of liver, kidneys, heart, spleen, brain (including cerebellum), lungs,
adrenals and testes or ovaries were recorded. For histopathological examination, besides these organs,
stomach, small intestine and bone were also prepared. For all examined parameters, no adverse
effects were reported (Kitagawa et al., 1976b).
In an unpublished study, groups of ﬁve male and ﬁve female rats were dosed via diet with 0, 0.2, 1
or 5% of HPC (equivalent to 0, 180, 900 or 4,500 mg/kg bw per day) over 90 days. The dosing
caused no adverse effects on mortality, growth, food utilisation, urinalysis, haematological indices,
organ weight, gross pathology and histopathology. Higher dietary levels (not further speciﬁed) resulted
in increased food consumption and decreased food utilisation due to the inertness of the material
(Industrial Bio-Test Lab, 1963; cited in JECFA, 1969).
4.2.2.6. Hydroxypropyl methyl cellulose (HPMC; E 464)
Rats
Groups of ﬁve male Wistar rats were dosed via diet with 0 or 10% of HPMC over 12 days and at
termination, caecum and ascending colon were removed (Wyatt et al., 1988). The dosing caused an
up to ﬁvefold increase in the wet weights of the full and empty caecum and ascending colon and a
decrease in the density of bacteria in the caecum and colon. HPMC was poorly fermented by caecal
and colonic bacteria in vitro, with only 5% of the substrate being utilised after 7 days of incubation (no
signiﬁcant change in the level of reducing-ends in the culture ﬂuid). The authors concluded that caecal
and colonic enlargement was due to tissue hypertrophy in response to increased bulk of contents, and
that it is unlikely that SCFA or other microbial metabolites are the stimulus for the trophic response.
In a study with weanling rats (no further data), groups of 10 male and 10 female rats were dosed
via diet with 0%, 2%, 10% or 25% of HPMC (equivalent to 0, 2,400, 12,000 or 30,000 mg/kg bw per
day) over 30 days (Hodge et al., 1950). The highest dose level caused diarrhoea and a decrease in
body weights; three of 10 males and six of 10 females died. At this dose level, there was also a minor
decrease in red blood cell counts, while other haematological and also urine parameters, as well as
organ weights, were unchanged. A histopathological examination revealed no adverse effects.
In an additional study, groups of 10 male and 10 female young Wistar-derived rats were dosed via
diet with 0%, 1%, 3%, 10% or 30% (equivalent to 0, 900, 2,700, 9,000 or 27,000 mg/kg bw per day)
of HPMC over 121 days (McCollister and Oyen, 1954). All rats were weighed twice weekly during the
study and examinations included general appearance, mortality and average daily food consumption.
Whenever possible, failing animals were sacriﬁced when moribund. Terminal haematological values
were obtained from a group of ﬁve female control rats and ﬁve female rats dosed with 10% HPMC. At
termination, all surviving rats were killed and examined. The livers and kidneys from each rat were
weighed. Haematoxylin-eosin-stained sections from these organs, as well as from the pancreas, lung,
heart, spleen, testes and adrenals were prepared for histologic examination. At a dose level of 30%,
body weight gain was markedly decreased and four male and six female rats died during the study
due to undernourishment. In male rats dosed with 10%, there also was a slight body weight gain
retardation. No other adverse effects were reported and the histological examination revealed no
abnormalities in any of the different groups.
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In two follow-up studies, groups of 10 male and 10 female young Wistar-derived rats were dosed
via diet with 0%, 0.3%, 1%, 3%, 10% or 20% of HPMC containing 24–27% methoxyl groups and
3–5.5% hydroxypropoxyl groups (equivalent to 0, 270, 900, 2,700, 9,000 or 27,000 mg/kg bw per day)
for 90 days or with HPMC containing 19–24% methoxyl groups and 4–12% hydroxypropoxyl groups for
84 days (McCollister et al., 1961). During the studies, the rats were observed frequently for changes in
gross appearance and behaviour. Body weights were determined twice weekly and average food
consumption per rat was recorded. At termination, gross pathological examinations were performed,
and the lungs, heart, liver, kidneys, testes and spleen were removed and weighed. Portions of these
tissues, as well as adrenals and pancreas, were prepared for a microscopic examination. In addition,
blood haematocrit values were determined. In the ﬁrst study, three rats of each sex died after dosing
with 20% and there was a marked reduction in body weight gain in both sexes. In male rats, a
signiﬁcant retardation in body weight gain was seen at 10%. In none of the dosed animals, were
adverse histopathologic effects noted. Also, in the second study, male rats showed a signiﬁcant
retardation of body weight gain at the 20% level and a slight retardation at 10%. As a result of
undernourishment, there were also corresponding changes in liver, kidney and testes weights. The
gross and microscopic examination gave no indications for adverse effects and there were no changes
in haematocrit values. In both trials, there were no signiﬁcant adverse effects at a dose level of 3%
(equivalent to 2,700 mg/kg bw per day).
In an additional, unpublished study, groups of 10 male and 10 female young rats (unknown strain)
were dosed via diet with 0%, 1%, 3% and 10% of HPMC (higher viscosity; 31,800 cP) and with 0%,
1%, 3% and 10% of HPMC (lower viscosity; 8,480 cP) (equivalent to 0, 900, 2,700 or 9,000 mg/kg bw
per day) over 92 days (McCollister and Copeland, 1967; cited in JECFA, 1990). The treatment gave no
adverse effects concerning mortality, growth, general appearance and behaviour, body weights, food
consumption, haematological and clinical chemistry analysis, organ weights and at gross and
histological examination.
In two other 90-day studies, groups of 10 male and 10 female Dow-Wistar rats were dosed via diet
with 0%, 1%, 3% and 10% low viscosity (10 cP) HPMC or with 0%, 3% and 10% high viscosity
(4,000 cP) HPMC (equivalent to 0, 900, 2,700 or 9,000 mg/kg bw per day) (McCollister et al., 1973).
No adverse effects concerning mortality, body weight gain, food consumption, urine and
haematological analyses and serum chemistry were noted. Terminal absolute and relative organ
weights showed no treatment-related effects. The gross and histopathological examination of the
tissues revealed similar ﬁndings for control and treated rats. At all dose levels (i.e. up to 9,000 mg/kg
bw per day), no adverse effects were reported in both studies.
Groups of 15 male and 15 female young Sprague–Dawley rats were dosed via diet with 0%, 1% or
5% low viscosity (4.22 cP) HPMC (equivalent to 0, 900 or 4,500 mg/kg bw per day) for 90–91 days
(Schwetz, 1976). No adverse effects concerning mortality, body weight gain, food consumption, urine
and haematological analyses and serum chemistry were noted. Terminal absolute and relative organ
weights showed no treatment-related effect. The gross and histopathological examination of the
tissues revealed similar ﬁndings for control and treated rats. For none of the examined parameters
were adverse effects reported at a dose level up to 4,500 mg/kg bw per day.
Groups of ﬁve male and ﬁve female Crj:CD (SD) IGS rats (SPF) with an age of about 5 weeks and
body weights of 125176 g were dosed via gavage with 0, 505, 1,020 or 2,100 mg/kg bw per day of
HPMC (viscosity of 2.83 mPa.s) for 91 days (Obara et al., 1999). For both high-dose male and female
rats, lower body weights were observed from day 28 onwards; in high-dose males there was also a
decrease in food consumption and urine volume. However, these differences were not statistically
signiﬁcant. For all other examined endpoints, no treatment-related effects were noted. Based on the
decrease in body weights, the authors of this study identiﬁed a NOAEL value of 1,020 mg/kg bw.
However, the Panel considered the level of 2,100 mg/kg bw per day as the NOAEL, because the effects
observed were all not statistically signiﬁcant.
Rabbits
In groups of six rabbits (approximately 6 months old and with a body weight of 1.8 kg) dosed via
diet with 0%, 10% or 25% of HPMC (equivalent to 0, 3,000 or 7,500 mg/kg bw per day) over 30 days,
no adverse effects concerning body weights, urine analysis, haematology, organ weights and
histological examination were reported (Hodge et al., 1950).
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Dogs
Two dogs (body weights of 11 and 13 kg) were dosed with 25 or 50 g/day, respectively, of HPMC
over 30 days (Hodge et al., 1950). In the higher dose animal, effects such as diarrhoea, slight weight
loss and slight depression in RBC count were noted, while the lower dose in the other animal was well
tolerated. An urine analysis and a histological examination revealed no adverse effects at both dose
levels.
In another study, groups of two male and two female beagle dogs were dosed via diet with 0, 2
and 6% low viscosity (10 cP) HPMC for 90 days (equivalent to 0, 500 or 1,500 mg bw per day)
(McCollister et al., 1973). Body weights and food consumption were recorded weekly. Before starting
the study and at termination on day 90, standard haematological and clinical chemistry parameters
(PCV, Hb, RBC, total and differential WBC, BUN, AP, S-GOT, S-GPT and bromosulfothalein retention)
were determined and also tissues from all dogs were examined. No adverse effects concerning
mortality, body weight gain, food consumption, urine and haematological analyses and serum
chemistry were noted. Terminal absolute and relative organ weights showed no treatment-related
effect. The gross and histopathological examination of the tissues revealed similar ﬁndings for control
and treated dogs. There was no evidence of storage of the test material within the cells of the
reticuloendothelial system of the dosed animals.
Groups of four male and four female adult beagle dogs were dosed via diet with 0, 1 or 5% low
viscosity (4.22 cP) HPMC (equivalent to 0, 250 or 1,250 mg/kg bw per day) for 90–91 days (Schwetz,
1976). No adverse effects concerning mortality, body weight gain, food consumption, urine and
haematological analyses and serum chemistry were noted. Terminal absolute and relative organ
weights showed no treatment-related effects. The gross and histopathological examination of the
tissues revealed similar ﬁndings in control and treated dogs. For none of the examined parameters,
were adverse effects reported.
4.2.2.7. Ethyl methyl cellulose (EMC; E 465)
No data available.
4.2.2.8. Sodium carboxy methyl cellulose (NaCMC; E 466)
Rats
Groups of ﬁve male Wistar rats were dosed via diet with 0% or 10% of CMC (equivalent to 0 or
12,000 mg/kg bw per day) over 12 days, and at termination caecum and ascending colon were
removed (Wyatt et al., 1988). Dosed rats showed diarrhoea from the second day of dosing and a
signiﬁcantly increased output of faecal material. There was a visible enlargement of the caecum and
increased wet weights of contents and tissues (almost eightfold increase in weight of caecal contents
coupled with a doubling of tissue weight). The dosing had no signiﬁcant effect on the density of
bacteria in the caecum and colon. The aerobic microﬂora of the control group was composed primarily
of Streptococcus spp. (95100% of isolates), while both in caecal and colonic contents of CMC-dosed
rats, almost exclusively E. coli was found (93% of isolates). No enterotoxin activity was detected in the
E. coli strains isolated from CMC-fed rats with diarrhoea, and serotyping showed that the strains (O54
and O24) belonged to groups that are not commonly associated with diarrhoea in man. A substantial
amount of unfermented CMC was present in the intestinal contents of dosed rats and the proportion of
CMC increased distally. CMC appeared not to have been hydrolysed to shorter chain lengths, as no
increase in reducing ends could be demonstrated compared with animals maintained on the control
diet. CMC also was poorly fermented by caecal and colonic bacteria in vitro. By day 7 of incubation,
there was only a very slight increase in the level of reducing-ends in the culture ﬂuid and dosed rats
had signiﬁcantly lower SCFA concentrations in the caecum. The authors concluded that caecal and
colonic enlargement was due to tissue hypertrophy in response to increased bulk of contents and that
it was unlikely that SCFA or other microbial metabolites were the stimulus for the trophic response.
In an unpublished study, 12 rats/per group (not further speciﬁed) were dosed over 21 days with a
high-protein diet containing 0% or 15% sodium CMC of 10 viscosity grades (35–4,500 cP) or four
other vegetable gums (Anderson, 1986; cited in JECFA, 1990). Animals were weighed on alternate
days. Body weight gain in animals dosed with one sample of CMC exceeded that of controls and body
weight gains in animals dosed with two other CMC samples were less than that of controls. Average
faecal water content (measured as %) was increased in all CMC-fed animals from 1.9- to 3-fold, and
average ﬁlled caecal weight (g/kg bw) was increased 1.5- to 3.3-fold, compared to controls. It was
noted that there was a tendency for CMC samples of low molecular weight to produce high faecal wet
Re-evaluation of celluloses (E 460(i), E 460(ii), E 461466, E 468 and E 469) as food additives
www.efsa.europa.eu/efsajournal 63 EFSA Journal 2018;16(1):5047
weights. Measurement of the viscosities of completely hydrated samples of CMC indicated that CMC
can have large or narrow molecular weight distributions. It was suggested that different molecular
weight distributions in samples of CMC may produce different physiologic or dietary responses.
In a study with young male Sprague–Dawley rats (3-weeks old) with conventional gut microﬂora,
six animals per group were dosed via diet with 0% or 5% of CMC (equivalent to 0 or 6,000 mg/kg bw
per day) over 4 weeks (Mallett et al., 1984). At termination, the caecal contents from each animal
were collected and used for different enzyme assays. In dosed rats, the body weights were decreased
(about 9%) compared to the control group, and the weights of both the caecal wall and caecal
contents were signiﬁcantly increased. The treatment signiﬁcantly increased the total bacterial
population of the caecum and the mean caecal ammonia concentration was increased fourfold. All
measured enzyme activities (azoreductase, b-glucosidase, b-glucuronidase, nitrate reductase, nitro
reductase and urease) were also signiﬁcantly increased compared to controls. The authors assumed
that the b-1,4-glucose backbone of CMC was susceptible to attack by gut bacteria.
In groups of three young rats (no further data), the dosing with 0% or 14% of CMC (equivalent to 0 or
16,800 mg/kg bw per day) via diet over 5 weeks caused no adverse effects (Ziegelmayer et al., 1951).
In a study with limited documentation, the daily dosing of 10 rats (no further data) with 300–500
mg of CMC over 2 months caused no adverse effects (Werle, 1941).
In another study, 10 female Wistar rats with an age of 82–98 days were fed a diet containing 20%
CMC (equivalent to 18,000 mg/kg bw per day) for 63 days (Rowe et al., 1943). All animals were
weighed twice weekly and individual weight records were kept throughout the experimental period.
The treatment caused slight growth retardation and a laxative effect was observed. Organ weights and
gross examination revealed no abnormalities. Also, the results of a histopathological examination of
the liver, kidney, spleen, pancreas and adrenal gland revealed no signiﬁcant differences between the
treated and the control groups.
Groups of albino Wistar outbred rats [Crl:WI(WU)BR] (20/sex, 8 weeks of age) were dosed via diet
with 0, 2.5, 5 and 10% of CMC (equivalent to 0, 2,250, 4,500 or 9,000 mg/kg bw per day) for 91–95
days in male rats and for 98–102 days in female rats (B€ar et al., 1995a). To adapt the animals of the
mid- and high-dose groups, the dose of CMC was increased gradually from 2.5% on days 1–3 to 5%
on days 4–7 and to 10% from day 7 onwards. The mean intakes were 0, 1,360–1,570, 2,810–3,230 or
6,150–6,800 mg/kg bw per day (higher values are for female rats) and the dietary sodium content
was 0.31%, 0.57%, 0.81% and 1.27%. In general, the ingestion of CMC was well tolerated, except
that all high-dosed rats had some diarrhoea during the entire study period. In both sexes, there was a
dose-dependent increase in food intake, although in high-dosed females the body weights were
slightly below control values. Also, the water intake was dose dependently increased in both sexes
and was statistically signiﬁcant in low-dosed males and in mid- and high-dosed rats of both sexes. In
high-dosed female rats, the activity of plasma AP was signiﬁcantly increased, while in high-dosed male
rats, the alanine aminotransferase activity was signiﬁcantly increased. As a result of the higher water
intake, urine volumes in both sexes also increased dose dependently. In addition, a dose-dependent
increase of sodium, calcium and citrate in urine was seen at ≥ 5% CMC (equivalent to 4,500 mg/kg bw
per day). Terminal body weights did not differ signiﬁcantly between treated groups and controls. The
dosing caused some changes in absolute or relative organ weights of liver and kidneys, but especially
for the caecum weights, there was a clear dose-dependent increase both in male and female rats. A
gross examination at autopsy revealed the presence of caecal enlargement and an increased liquid
content in the intestinal tract, particularly in high-dosed male and female rats. On microscopic
examination, an increased incidence of dilatation of the colon was observed in high-dosed females.
The renal observations included an increased occurrence of pelvic urothelial hyperplasia (5 out of 20
rats) and pelvic nephrocalcinosis (6 out of 20 rats) in low-dosed male animals. Corticomedullary
nephrocalcinosis was seen in ﬁve of out 20 high-dosed female rats. In the bladder of male rats, an
increased incidence of diffuse epithelial hyperplasia was found in 8 out of 20 high-dosed rats. For all
the reported ﬁndings, a toxicological concern was not concluded, as the ﬁndings in the GI tract were
considered to be a consequence of the accumulation of poorly absorbed water-soluble material in the
caecum and colon, while the ﬁndings in kidneys and urinary bladder were attributed to the four times
higher concentration of sodium in the CMC diet compared with the basal diet.
Dogs
In a study with dogs, aged about 16 weeks (not further speciﬁed), three groups of 10 animals each
were dosed with 0, 500 or 1,000 mg/kg bw per day of CMC via diet for 6 months (Shelanski and Clark,
1948). None of the animals died during the course of the study. The dosing was well tolerated and
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caused no changes in body weights. At study termination, all dogs were autopsied; the histological
examination of stomach, intestines, spleen, liver, kidney, heart, lung and pancreas revealed no
changes.
4.2.2.9. Cross-linked sodium carboxy methyl cellulose (E 468)
Rats
Cross-linked sodium carboxy methyl cellulose was administered to Sprague–Dawley CD rats (20
animals/sex, 8 weeks old) at 0, 10,000 or 50,000 mg/kg diet for 90 days (equal to 757 and 893 or
3,922 and 4,721 mg/kg bw per day for males and females, respectively) (Freeman et al., 2003). The
study was conducted according to a current OECD guideline and in compliance with Good Laboratory
Practice (GLP). A control group of 20 animals were given a basal diet. No treatment-related deaths
took place and no clinical signs were reported in response to the test article administration. The body
weights were signiﬁcantly reduced in males receiving 50,000 mg/kg during the last 3 weeks of the
study (p value not stated). The food consumption of females receiving the 50,000 mg/kg dose was
signiﬁcantly increased (p value not stated) compared to controls during most of the study (data not
shown). No effects were seen in the clinical chemistry or haematology investigations, no treatment-
related ﬁndings were noted in the necropsy and there were no effects on organ weights or organ-to-
brain ratios. The study authors concluded that the daily administration of 50,000 mg/kg cross-linked
sodium carboxy methyl cellulose did not result in adverse effects in rats following 90-day exposure,
and the NOAEL was concluded to be 3,922 mg/kg bw per day for males and 4,721 mg/kg bw per day
for females.
Dogs
In a 1-year study, groups of two dogs (strain and sex not further speciﬁed) were dosed with 0,
100, 300, 1,000 or 3,000 mg cross-linked sodium carboxy methyl cellulose/kg bw per day. The
treatment had no adverse effects on body weights and none of the animals died. Urine analyses
(performed twice monthly) and haematological examinations performed prior to starting, four times
during the experiment and terminally, showed no changes. At necropsy, organ weights were recorded
and a number of tissue sections (heart, lung, spleen, stomach, large and small intestine, pancreas,
liver, gall bladder, adrenal, kidney, bladder, gonads, thyroid, bone marrow and brain) were examined
microscopically. No adverse effects were reported (Hodge et al., 1950).
4.2.2.10. Enzymatically hydrolysed carboxy methyl cellulose (E 469)
Rats
Groups of albino Wistar outbred rats [Crl:WI(WU)BR] (20 per sex, 8 weeks of age) were dosed via diet
with 0%, 2.5%, 5% and 10% of enzymatically hydrolysed carboxy methyl cellulose for 91–95 days for
male rats and for 98102 days for female rats (B€ar et al., 1995a). To adapt the animals of the mid- and
high-dose groups, the dose of enzymatically hydrolysed carboxy methyl cellulose was increased gradually
from 2.5% on days 1–3, to 5% on days 4–7, and to 10% from day 7 onwards. The mean intakes were
equal to 0, 1,340–1,560, 2,830–3,170 or 5,920–6,610 mg/kg bw per day (higher values are for female
rats) and the dietary sodium content was 0.31%, 0.51%, 0.72% and 1.16%. In general, the ingestion of
enzymatically hydrolysed carboxy methyl cellulose was well tolerated, except that all high-dosed rats had
some diarrhoea during the entire study period. In both sexes, there was a dose-dependent increase in
food intake, although in high-dosed females the body weights were slightly below control values. Also,
the water intake was dose-dependently increased and the differences were statistically signiﬁcant in mid-
and high-dosed rats of both sexes. In high-dosed females, Hb concentrations and PCVs were slightly
decreased (details were not provided). Plasma AP activity was signiﬁcantly increased in high-dosed male
rats and in mid-dosed female rats. As a result of the higher water intake, urine volumes also increased
with increasing doses of enzymatically hydrolysed carboxy methyl cellulose in male and female rats. In
addition, a dose-dependent increase in sodium, calcium and citrate was seen at ≥ 2.5% enzymatically
hydrolysed carboxy methyl cellulose. Terminal body weights did not differ signiﬁcantly between treated
groups and controls. The dosing caused some slight changes in absolute or relative organ weights of liver
and kidneys, but especially for the caecum weights, there was a clear dose-dependent increase both for
male and female rats. Gross examination at autopsy revealed the presence of caecal enlargement and an
increased liquid content in the intestinal tract, particularly in high-dosed male and female rats. On
microscopic examination, an increased incidence of dilatation of the colon was observed in high-dosed
females. The renal observations included an increased occurrence of pelvic urothelial hyperplasia in males
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dosed with 10% (6 out of 20 rats) and pelvic nephrocalcinosis at ≥ 5% in males (ﬁve or nine of 20 rats).
In the bladder of male rats, an increased incidence of diffuse epithelial hyperplasia was found in ﬁve of 20
high-dosed rats. For all the reported ﬁndings, a toxicological concern was not concluded, as the ﬁndings
in the GI tract were considered to be a consequence of the accumulation of poorly absorbed water-
soluble material in the caecum and colon, and the ﬁndings in kidneys and urinary bladder were attributed
to the four times higher concentration of sodium in the enzymatically hydrolysed carboxy methyl cellulose
diet compared with the basal diet.
4.2.2.11. Summary
Data are available for microcrystalline cellulose, powdered cellulose, methyl cellulose, ethyl
cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, sodium carboxy methyl cellulose and
enzymatically hydrolysed carboxy methyl cellulose.
• The subacute and subchronic toxicity of microcrystalline and powdered cellulose was low. The
NOAELs found in oral studies (gavage, drinking water or diet) in rats ranged from 3,769 to
9,000 mg microcrystalline cellulose/kg bw per day (5–10% in the diet) and 9,000 mg
powdered cellulose/kg bw per day (the highest dose tested in each case). No effects were
detected when an increased percentage of particles below the recommended particle size in
the EU speciﬁcations was present in the test substance.
• In two 90-day feeding studies, groups of 10 male and 10 female Sprague–Dawley rats were
dosed via diet with 0%, 1%, 3% and 10% low viscosity (10 cP) methyl cellulose or with 0%,
3% and 10% high viscosity (4,000 cP) methyl cellulose. In high-dosed male rats, a signiﬁcant
decrease in body weights was noted, while for all other investigated parameters no adverse
effects were reported (McCollister et al., 1973). Therefore, a NOAEL value of 3% (equivalent to
2,700 mg/kw bw per day) was derived from this study.
• In a 30-day gavage study, groups of 10 young adult male and female Wistar rats were dosed
with 0, 1,500, 3,000 or 6,000 mg/kg bw of hydroxypropyl cellulose. Even at the highest dose
level, no adverse effects were reported (Kitagawa et al., 1976b).
• In two 90-day feeding studies, groups of 10 male and 10 female DowWistar or Sprague–
Dawley rats were dosed via diet with 0%, 1%, 3% and 10% low viscosity (10 cP)
hydroxypropyl methyl cellulose or with 0%, 3% and 10% high viscosity (4,000 cP)
hydroxypropyl methyl cellulose. In both trials, even at the highest dose level of 10% (equivalent
to 9,000 mg/kg bw per day), no adverse effects were reported (McCollister et al., 1973).
• In another study, groups of ﬁve male and ﬁve female Crj:CD (SD) IGS rats (SPF) were dosed
via gavage with 0, 505, 1,020 or 2,100 mg/kg bw per day of hydroxypropyl methyl cellulose
(viscosity of 2.83 mPa.s) for 91 days. Apart from a decrease in body weights in high-dosed
male and female rats, which was not statistically signiﬁcant, no treatment-related effects were
noted for all the other endpoints examined. The food consumption data were limited, but
suggested decreased food consumption. The authors of this study gave a NOAEL value of
1,020 mg/kg bw (Obara et al., 1999). The Panel considered 2,100 mg/kg bw per day of
hydroxypropyl methyl cellulose as the NOAEL in this study.
• In two parallel studies, groups of 20 Albino Wistar outbred rats [Crl:WI(WU)BR] per sex were
dosed with carboxy methyl cellulose or enzymatically hydrolysed carboxy methyl cellulose via
diet with 0%, 2.5%, 5% and 10% (equal to 0, 1,500, 3,000 and 6,000 mg/kg bw per day) for
up to 102 days (Til, 1992; B€ar et al., 1995a). Although, in both studies, some effects
(increased caecum weights, urothelial hyperplasia, pelvic nephrocalcinosis, corticomedullary
nephrocalcinosis, increased incidence of diffuse epithelial hyperplasia in the urinary bladder)
were observed, for all the reported ﬁndings, a toxicological concern was not concluded for
carboxy methyl cellulose or enzymatically hydrolysed carboxy methyl cellulose itself, as the
ﬁndings in the GI tract were considered to be a consequence of the accumulation of poorly
absorbed water-soluble material in the caecum and colon, and the ﬁndings in kidneys and
urinary bladder were attributed to the up to fourfold higher concentration of sodium in the fed
diet compared with the basal diet.
Several additional studies, which do not meet current criteria for toxicological testing or which were
not available (unpublished data) for evaluation, supported the low toxicity of this group of modiﬁed
celluloses.
Although there were some inconsistencies in the data, the main effects seen were decreases in
body weight gain at the highest dose, which are likely to be due to the amount/bulk of cellulose in the
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diet decreasing the nutrient intake. The NOAEL values reported ranged from 2,000 up to 9,000 mg/kg
bw per day.
4.2.3. Genotoxicity
4.2.3.1. Microcrystalline cellulose (E 460(i))
In vitro
Avicel® RCN-15 (a mixture of 85% microcrystalline cellulose with 15% guar gum, no further data)
was not mutagenic in a bacterial reverse mutation assay in the Salmonella Typhimurium strains TA98,
TA100, TA1535, TA1537 and TA1538 when tested as suspension in dimethylsulfoxide (DMSO) at ﬁve
dose levels between 50 and 5,000 lg/plate, with and without metabolic activation by rat liver S9-mix
in an unpublished study performed in compliance with GLP (Batt, 1992).
The same test system resulted also in no mutagenic activity with the test substance Avicel® AC-815
(composed of 85% microcrystalline cellulose and 15% calcium alginate). In this study, E. coli WP2uvrA
or S. Typhimurium strains TA98, TA100, TA1535, TA1537 and TA1538 were exposed to the test
substance suspended in DMSO at doses from 10 to 5,000 lg/plate in the presence or absence of
metabolic activation with rat liver S9-mix (Documentation provided to EFSA n. 37).
In a third bacterial reverse mutation assay, using S. Typhimurium strains TA98, TA100, TA1535,
TA1537 and TA1538, microcrystalline cellulose suspended in DMSO produced no increase in revertants
at doses up to 5,000 lg/plate (no further information available) (FMC, 1991; referred to by SCF, 1999).
Avicel® RCN-15 was tested in a mammalian gene mutation assay in L5178Y mouse lymphoma cells
in an unpublished study performed in compliance with GLP (Cifone, 1992). The test material was
dissolved in DMSO at 100 mg/mL and tested in replicated experiments at six dose levels, ranging from
100 to 1,000 lg/mL (top concentration based on the 1% ﬁnal concentration of DMSO in culture
medium) both with and without metabolic activation. In both cases, a 4-h treatment was applied. No
toxicity and no increase in forward mutation at the thymidine kinase locus which was dose-related or
exceeded twice the solvent control was observed. Precipitation in culture medium was observed above
100 lg/mL. Positive control substances, methyl methansulfonate and 3-methylcholanthrene, elicited a
distinct mutagenic response. The Panel noted that an extended treatment without metabolic activation
was not performed, but this was not recommended in the relevant OECD Guideline at the time the
study was performed. In another study, also Avicel® CL-611 was tested with negative results in the
same test system (Documentation provided to EFSA no. 34).
Avicel® RCN-15 was tested in an unscheduled DNA synthesis assay in rat liver primary cells in an
unpublished study performed in compliance with GLP (McKeon, 1992). The test substance was
formulated in DMSO and applied at seven concentrations in the range 5–1,000 lg/mL in a ﬁrst trial
and at 10 concentrations in the range 101,000 lg/mL in a second trial. Precipitation was observed
from 5 lg/mL onwards in the ﬁrst trial and from 10 g/mL onwards in the second trail. No overt toxicity
(i.e. < 78 of survival) and no induction of unscheduled DNA synthesis was observed in both
experiments. The positive control 2-acetylaminoﬂuorene elicited the expected positive response. The
Panel noted that in this study a lower solubility of Avicel® RCN-15 was reported, compared to the
previous study by Cifone (1992).
In vivo
Avicel® RCN-15 was tested in a mouse bone marrow micronucleus assay in ICR mice (Murli, 1992).
The test material was mixed in a commercial diet at a concentration corresponding to an exposure
level of 5,000 mg/kg bw. The feed (1 g) was administered during an exposure time of 10 h, and
animals (groups of ﬁve males and ﬁve females) sacriﬁced 24, 48, and 72 h after the end of the
exposure period. No increase of micronucleated polychromatic erythrocytes and no evidence of toxicity
to bone marrow was observed in treated animals. A signiﬁcant positive response was induced by the
positive control cyclophosphamide, administered by gavage 24 h before sacriﬁce. This study was
performed in compliance with GLP.
Negative results were also reported with other microcrystalline cellulose preparations in other
unpublished studies (Documentation provided to EFSA n. 35–36).
4.2.3.2. Methyl cellulose (MC; E 461)
In a screening of cosmetic ingredients, MC was tested for mutagenicity in a spot test with
S. Typhimurium strains TA98, TA100, TA1535, TA1537 and TA1538, with and without metabolic
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activation. Negative results were reported by the study authors at the single dose level tested
(50 lg/plate) (Blevins and Taylor, 1982).
In another published study, MC was not mutagenic in bacterial reverse mutation assays in
S. Typhimurium strains TA92, TA1535, TA100, TA1537, TA94 and TA98, with and without metabolic
activation, up to the maximum dose of 70 mg/plate (Ishidate et al., 1984). In the same study, MC was
not clastogenic in an in vitro chromosomal aberration assay in Chinese hamster ﬁbroblasts (CHL), only
carried out without metabolic activation, up to the maximum tested concentration of 4 mg/mL. The
Panel noted that only a qualitative indication of the outcome of tests, with no presentation of
experimental results, was available from the above studies.
Further results of genotoxicity tests on MC are reported in an unpublished study (Litton Bionetics
Inc., 1974) on the test material Methocel (FDA 71-264). Negative results were obtained in the
following assays:
• two host-mediated assays in rats, dosed once or ﬁve times either with 4.75, 47.5 or 475 mg/kg
bw by gavage or with 5,000 mg/kg via feed, using S. Typhimurium strains TA1530 and G46
and yeast strain D3 as indicator organisms for reverse mutation and mitotic recombination
induction, respectively;
• a chromosome aberration assay with human embryonic lung cells (WI-38), only performed
without metabolic activation, at doses of 80, 800 and 8,000 lg/mL;
• an in vivo chromosome aberration assay in rat bone marrow, following single or repeated (ﬁve
times) oral administration of the test article, either at 4.75, 47.5 or 475 mg/kg bw by gavage,
or at 5,000 mg/kg bw per day via feed;
• a dominant lethal assay with male rats at identical dosage regimen as above.
The Panel noted that these studies, although acceptable at the time they were performed, are
based on limited and/or obsolete experimental protocol/system.
4.2.3.3. Ethyl cellulose (EC; E 462)
No data available.
4.2.3.4. Hydroxypropyl cellulose (HPC; E 463)
No data available.
4.2.3.5. Hydroxypropyl methyl cellulose (HPMC; E 464)
No data available.
4.2.3.6. Ethyl methyl cellulose (EMC; E 465)
No data available.
4.2.3.7. Sodium carboxy methyl cellulose (CMC; E 466)
Sodium CMC was not mutagenic in bacterial reverse mutation assays in the S. Typhimurium strains
TA92, TA1535, TA100, TA1537, TA94 and TA98, with and without metabolic activation up to the
maximum dose of 2.5 mg/plate (Ishidate et al., 1984). In the same study, sodium CMC was not
clastogenic in an in vitro chromosomal aberration assay in CHL, only carried out without metabolic
activation, up to the maximum tested concentration of 1 mg/mL. The Panel noted that no raw data
were presented for these tests, which were carried out in the framework of a large screening of food
additives.
Further results on sodium CMC were available from an unpublished study (Litton Bionetics Inc.,
1975, 1980). In this study, sodium CMC was not mutagenic in the following tests:
• bacterial reverse mutation tests with S. Typhimurium TA1535, TA1537 and TA1538, both in the
presence and the absence of metabolic activation, at concentrations of 2.5–10% (suspension
test) and 5 mg/plate (spot test);
• a mitotic recombination assay with Saccharomyces cerevisiae D4 at concentrations of 0.25%,
0.5% and 1%, only performed without metabolic activation;
The Panel noted that these studies, although acceptable at the time they were performed, are
based on limited and/or obsolete experimental protocol/system.
Negative results in an Ames test with S. Typhimurium TA98, TA100, TA1535, TA1537 and TA1538,
both in the presence and absence of metabolic activation at doses from 0.5 to 5,000 lg/plate, were
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also reported in another unpublished study (Litton Bionetics Inc., 1980), not available to the Panel for
evaluation.
4.2.3.8. Cross-linked sodium carboxy methyl cellulose (E 468)
The literature search and the EFSA call for data did not produce any genotoxicity data for cross-
linked sodium carboxy methyl cellulose (E 468). The previous evaluation by the SCF (1996) refers to
available genotoxicity data, but no further information is available. The most recent evaluation by
JECFA (2003) does not discuss the genotoxicity of cross-linked sodium carboxy methyl cellulose
(E 468).
4.2.3.9. Enzymatically hydrolysed carboxy methyl cellulose (E 469)
No data available.
4.2.3.10. Summary
Avicel® RCN-15 (a mixture of 85% microcrystalline cellulose with 15% guar gum) did not induce
mutagenic effects in the presence or absence of a metabolic activation system in bacterial reverse
mutation assays (Batt, 1992), in the mammalian cell gene mutation assays (Cifone, 1992) and in an
in vitro test for unscheduled DNA synthesis (McKeon, 1992). Avicel® RCN-15 was also tested negative
in mouse bone marrow micronucleus assays (Murli, 1992). Negative results were also reported in the
following unpublished studies: bacterial reversion assay with Avicel® AC-815 (85% microcrystalline
cellulose and 15% calcium alginate) (Documentation provided to EFSA no. 34), in vivo micronucleus
assays with Avicel® PH-101 (pharmaceutical microcrystalline cellulose, nominal mean particle size of 50
lm) (Documentation provided to EFSA no. 36) and Avicel® CL-611 (Documentation provided to EFSA
no. 35). The Panel noted that, even though the majority of these studies were carried out with
mixtures containing microcrystalline cellulose and guar gum rather than with microcrystalline cellulose
alone, the latter was present as main component (85% by weight) in such mixtures. Therefore, the
results of the studies can be considered directly relevant for the evaluation of the genotoxicity of E 460
(i). Based on the negative results reported, the Panel concluded that microcrystalline cellulose (E 460
(i) is not genotoxic. The Panel also considered that this conclusion can be extended to powdered
cellulose (E 460(ii)), which is structurally similar to E 460(i) but with a higher polymerisation degree.
Concerning modiﬁed celluloses, experimental data on genotoxicity were only available for methyl
cellulose (E 461) and sodium carboxy methyl cellulose (E 466).
Both substances were negative in Ames tests with different S. Typhimurium strains, both with and
without metabolic activation (Litton Bionetics Inc., 1975, 1980, Blevins and Taylor, 1982; Ishidate
et al., 1984). Negative results were also obtained in a chromosomal aberration assay in CHL (Ishidate
et al., 1984), only performed without metabolic activation, and in host-mediated assays with yeast and
bacteria (Litton Bionetics Inc., 1974, 1975).
MC was also tested with negative results in an in vitro chromosomal aberration assay in human
embryonic lung cells (WI-38), and in vivo in a chromosome aberration assay in rat bone marrow and in
the dominant lethal assay in male rats (Litton Bionetics Inc., 1974).
The Panel noted that most genotoxicity test results on MC and sodium CMC were from limited
and/or brieﬂy reported studies, not available for direct evaluation to the Panel. However, the Panel also
noted that there is a long history of use of MC and CMC as vehicles for non-water-soluble substances
in in vitro and in vivo genotoxicity assays (as recommended in OECD TG 478, 2015 and TG 483,
2015). Therefore, the Panel concluded that MC and CMC do not raise concern for genotoxicity.
The Panel also considered that read-across from MC (E 461) to the other modiﬁed celluloses
bearing similar simple substituents (E 462, E 463, E 464, E 465) was justiﬁed, as the SAR analysis of
E 462, E 463, E 464, E 465 using the OECD QSAR Toolbox did not highlight any structural alert for
genotoxicity in their structure. Thus, the Panel concluded that E 462, E 463, E 464, E 465 did not raise
genotoxic concern either.
Similarly, the Panel considered scientiﬁcally justiﬁed the read-across from sodium CMC (E 466) to its
products of enzymatic hydrolysis (E 469) or cross-linking (E 468), which in a similar in silico analysis
were shown not to bear additional structural determinants of genotoxicity.
Overall, the Panel concluded that microcrystalline cellulose (E 460(i)), powdered cellulose (E 460(ii))
and modiﬁed celluloses (E 461466 and E 468469) do not raise concern for genotoxicity.
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4.2.4. Chronic toxicity and carcinogenicity
4.2.4.1. Microcrystalline cellulose (E 460(i))
Rats
Groups of male and female rats (no further details) received the control diet or a diet containing
330 mg/kg microcrystalline cellulose (equivalent to 16.5 mg/kg bw per day), for a period of 6 months
(Yartsev et al., 1989; cited in JECFA, 1990). Six rats per group were then sacriﬁced, necropsy
performed, and tissues processed for histopathology (no further data available). No effects of the
treatment were reported.
An unpublished chronic feeding study is reported in the secondary literature (limited information;
no further details available). Three groups of 50 male and 50 female rats received in their diet either
30% ‘ordinary cellulose’ or microcrystalline cellulose or microcrystalline cellulose gel for 72 weeks
(equivalent to 15,000 mg/kg bw per day). The type of control was not speciﬁed. No clinical signs were
reported. The body weights of males treated with microcrystalline cellulose gel were higher than those
of the controls. No such effects were detected with the other cellulose formulations. Food efﬁciency,
survival and haematology were comparable in all groups. The liver and kidney weights of males
receiving microcrystalline cellulose gel were increased. Histopathology showed some dystrophic
calciﬁcation of renal tubules in females on microcrystalline cellulose. All other organs appeared
unremarkable. The tumour incidences did not differ between treated and control groups
(Documentation provided to EFSA no. 40).
A combined one-generation reproductive/chronic toxicity study was performed in rats (Lewerenz
et al., 1979; referred to by SCF, 1999) (Lewerenz et al., 1981a; referred to by SCF, 1999), in which
males and females of the F1 generation were fed microcrystalline cellulose (90% of particles < 20 lm)
at 0 (control), 30, 100 or 200 g/kg diet (equivalent to 0, 1,500, 5,000 or 10,000 mg/kg bw per day),
for up to 2 years (data from secondary sources, no further details available). The treatment induced
some growth depression of the F1 rats at the top dose during the early growth phase only. Food
consumption was increased in all treated groups. After 12 months, particles were detected in some
organs but no microemboli were identiﬁed. Some impairment of the renal function without any
associated histopathological changes and of some haematological changes in the highest dose group
could not be conﬁrmed in the surviving rats treated for 2 years. This study was also reported in the
JECFA evaluation (Lewerenz et al., 1981b; referred to by JECFA, 1999a,b). The Committee stated that
the available data are not sufﬁcient for evaluation due to the high mortality during the course of the
study, the evidence of confounding infection, the limited number of animals for histopathology and the
absence of details of the ﬁrst year of treatment. Limited information on this study was published in a
review (Steege et al., 1980) and did not permit a ﬁrm conclusion. The Panel agreed with this
conclusion.
Initiationpromotion studies
The Panel noted a series of studies which had investigated potential beneﬁcial effects of
microcrystalline cellulose administration on the development of cancer in laboratory animals treated
with an initiating agent (Freeman et al., 1978, 1980; Nigro et al., 1979; Yamamoto, 1994; Cohen
et al., 1996; Chang et al., 1997; Wijnands et al., 1999; Iwane et al., 2002) and a clinical study in
humans diagnosed with colon cancer (Hardman et al., 1997). The Panel did not consider these studies
relevant to the risk assessment of microcrystalline cellulose as a food additive (E 460(i)).
4.2.4.2. Powdered cellulose (E 460(ii))
Monkeys
Intestinal structure of male adult African Green monkeys (n = 4 per group) was studied after
feeding diets containing 10% psyllium husk (ﬁbre; highly branched arabino-xylan-polysaccharide) or
10% cellulose (Celluﬁl®; no further data) (equivalent to 7,500 mg/kg bw per day), for 3.5 years
(Paulini et al., 1987). The cellulose-treated animals did not show any abnormality in the GI tract.
4.2.4.3. Methyl cellulose (MC; E 461)
In a feeding study, groups of ﬁve female rats (strain not speciﬁed) were dosed via diet with 1.66 or
5% of MC (equivalent to 833 or 2,500 mg/kg bw per day) for 6 months (Bauer, 1945). Adverse effects
caused by the treatment were not reported.
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In another feeding study, 80 young male and female albino rats were dosed with 0.8% MC in the diet
(equivalent to 400 mg/kg bw per day) and with 1% MC via drinking water (equivalent to 900 mg/kg bw
per day) for about 9 months (Deichmann and Witherup, 1943). As controls, also 80 young male and
female albino rats were used. The combined average total daily intake was calculated to be 436 mg
of MC per animal. The dosing was well tolerated, there were no effects on growth rate and also
water and food intake were unchanged. At necropsy, no gross or microscopic pathological changes
were found.
Groups of ﬁve male and ﬁve female young Sprague–Dawley rats were dosed with diets containing
0%, 0.17% (changed after 6 weeks to 0.5%) or 5% of MC (average intake equal to 690775 mg/kg
bw per day) for 8 months (Bauer and Lehmann, 1951). Group body weights and food and water
consumption were recorded weekly. This treatment had no adverse effect on growth, but caused a
signiﬁcantly increased feed intake. Through 3 generations, reproduction was not impaired and the
second and third generation rats dosed with 5% MC showed no adverse effects. A macroscopic and
microscopic examination of representative animals revealed essentially normal tissues (not further
speciﬁed). There also was no deposition of abnormal material in the tissues, indicating that no methyl
cellulose was absorbed from the intestinal tract. After about 8 months on the experimental diet, the
rats were mated. The young of the F1 and F2 generations were kept in groups of ﬁve and placed on
5% MC diet, and later mated in the same manner as the F0 generation. Representative animals from
each group of the ﬁrst generation were sacriﬁced at 8 months of age for macroscopic and microscopic
examination. In the second experiment, nine young SpragueDawley rats (litter mates of the F1
generation, divided according to sex into three males and six females and weighing between 55 and
116 g), were placed on a modiﬁed paired-feeding regimen. This system was employed in order to
determine the effect of massive dosage and the ‘bulk’ producing effects of the questionably inert
substance, in contrast to one (cellulose ﬂour) shown to be inert and to possess only a ‘bulk’ effect
when included in the diet. The nine animals were divided into three groups. Rat 1 in each of the three
groups received a diet of equal parts of the nutrient and of MC (50% MC diet) ad libitum. Rat 2
received a diet of equal parts of the nutrient and cellulose ﬂour (forming the ‘bulk’ control) ad libitum,
while rat 3 was given the nutrient alone (nutritive control). Each animal was housed in an individual
metabolism cage, and daily records were kept of the urine volume, faeces weight and food and water
consumption. Pooled 7-day urine samples from each rat were subjected to quantitative formic acid
determinations. This study was terminated after 90 days of dosing. In dosed rats, growth depression
was seen, but a subsequent replacement of MC or cellulose diet by the basal diet resulted in marked
weight gain. There was no indication that signiﬁcant amounts of MC were hydrolysed to cellulose and
methanol in the intestinal tract.
In a long-term study, groups of 20 male and 20 female Wistar rats were dosed via diet containing 1
or 5% MC (15, 400 or 4,000 cP) (equivalent to 500 or 2,500 mg/kg bw per day) for 2 years
(McCollister et al., 1973). Duplicate control groups consisted of 20 males and 20 females each.
Additional groups of 10 rats of each sex for each treatment were set up for necropsy examination at
12 and 18 months. Haematological studies (PCV, Hb and total and differential WBC) were conducted at
12, 18 and 24 months on ﬁve male and ﬁve female rats from the groups fed the control ration and
each of the 5% diets. All rats appeared normal and exhibited no unusual behaviour during the test
period. Body weights were comparable between all groups and also feed consumption gave no
compound-related differences. Mortality was unaffected by treatment and was associated with a
variety of commonly observed spontaneous lesions. Haematological studies and determinations of BUN
and AP gave normal ﬁndings, with no differences between control and treated rats indicative of a
compound-related effect. Final mean body and organ weights of rats necropsied after 12, 18 and 24
months revealed a few random statistically signiﬁcant differences, none of which was associated with
treatment. Gross and histopathological examinations of the tissues showed no compound-related
changes, nor any evidence to indicate storage of the test material within the cells of the reticula-
endothelial system of treated rats. Also the observed tumours were similar in type and number in
treated and control groups.
For obtaining data on tumour incidence from larger numbers of rats, diets identical to those fed in
the above cited study as to sample and concentration were administered to groups of 30 male and 30
female Wistar rats for 2 years (McCollister et al., 1973). A control group of 30 rats of each sex
received untreated diets. The rats were examined frequently for evidence of tumour development.
Body weight records were maintained. Gross pathological examination was conducted on rats dying
during the study or sacriﬁced in extremis, and sections of grossly visible nodules or masses were
preserved for histopathological examination. Gross examination was conducted on all rats surviving at
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the end of the 2 years. Weights of liver and kidneys were recorded and grossly evident lesions
suggestive of tumour formation were preserved for histopathological examination. Also in this study,
no adverse effects were seen concerning mortality, body weights, terminal liver and kidney weights or
any increase in tumour incidences.
4.2.4.4. Ethyl cellulose (EC; E 462)
No data available.
4.2.4.5. Hydroxypropyl cellulose (HPC; E 463)
Rats
Groups of 10 young adult male and 10 female Wistar rats were administered daily doses of 0,
1,500, 3,000 or 6,000 mg/kg bw of HPC via gavage for 6 months (Kitagawa et al., 1976b). Rats were
weighed every day and food consumption was measured twice a week during the study. The dosing
caused a decrease in body weights of high-dosed male and female rats for 78 weeks (statistically
signiﬁcant for females). For the other investigated parameters (haematology, clinical chemistry and
histopathology), no signiﬁcant adverse ﬁndings were reported.
4.2.4.6. Hydroxypropyl methyl cellulose (HPMC; E 464)
Rats
In groups of 10 male and 10 female rats (strain not speciﬁed) dosed via diet with 0%, 20% or
25% of HPMC (equivalent to 0, 10,000 or 12,500 mg/kg bw per day) over 1 year, some retardation in
growth was seen at a level of 20% (more pronounced at 25%). The dosing caused no increase in
mortality and no adverse effects concerning urine analysis, haematology and histological examination
were reported (Hodge et al., 1950).
In a 2-year study, four groups of 50 male and 50 female rats (strain not speciﬁed) were dosed via
diet with 0%, 1%, 5% or 20% of HPMC (equivalent to 0, 500, 2,500 or 10,000 mg/kg bw per day)
(Hodge et al., 1950). In males dosed with 20%, a slight retardation of body weight gain (about 30 g
less compared to the other dose groups) was seen during the ﬁrst year (weights taken weekly).
During the second year (weights taken twice weekly), this trend was continued, although there were
considerable ﬂuctuations, especially near study termination. The mortality rates between all groups
were comparable (6084%). Pooled urine samples examined periodically for sugar and protein
concentrations gave no changes. Also, a haematological examination (total erythrocytes, haemoglobin
and total leucocytes) prior to beginning the study, eight times during the study, and at termination,
gave no adverse effects. However, there was small decrease in RBC counts and Hb values in both
sexes at a dose level of 20% (equivalent to 10,000 mg/kg bw per day), which was attributed to a
nutritional origin. Organ weights recorded at autopsy were comparable between all groups and also a
histological examination of stomach, small and large bowel, liver, kidneys, lungs, heart, brain, bladder,
spleen, testes and bone marrow gave no indications for an adverse or a carcinogenic effect.
4.2.4.7. Ethyl methyl cellulose (EMC; E 465)
Mice
In an unpublished study, groups of 50 male and 50 female mice (strain not speciﬁed) were dosed
via diet with 0%, 0.1% or 1% (equivalent to 0, 150 or 1,500 mg/kg bw per day) of EMC for 2 years.
Apart from slightly decreased body weights in the latter part of the study seen in both sexes dosed
with 1%, no adverse effects on survival rate, tumour incidence, blood picture and gross and
microscopic appearance of internal organs were reported (ICI, 1966; cited in JECFA, 1990).
Rats
In a parallel study, groups of 50 male and 50 female rats (strain not speciﬁed) were dosed via diet
with 0%, 0.1% or 1% (equivalent to 0, 50 or 500 mg/kg bw per day) of EMC for 2 years. Apart from
decreased body weights in the latter part of the study seen in male rats dosed with 1%, no adverse
effects on survival rate, tumour incidence, blood picture and gross and microscopic appearance of
internal organs were reported (ICI, 1966; cited in JECFA, 1990).
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4.2.4.8. Sodium carboxy methyl cellulose (NaCMC; E 466)
Mice
Groups of 50 male and 50 female young adult Alderley Park SPF mice were dosed via diet with 0,
10,000 or 100,000 mg/kg diet (equivalent to 0, 1,500 or 15,000 mg/kg bw per day) of sodium CMC for
100 weeks (McElligott and Hurst, 1968). In general, the dosing was well tolerated and caused no
increased mortality in dosed mice. During the ﬁrst 30 weeks, body weights and body weight gain were
not affected, while thereafter, a retarded growth was noted in dosed mice. The ﬁnal body weights at
0, 1,500 or 15,000 mg/kg bw per day were 45, 38 and 39 g for male mice and 39, 34 and 36 g for
female mice. At necropsy, there was no histological evidence of changes in the intestinal wall indicating
absorption of sodium CMC and also no evidence of storage in the regional lymph nodes or elsewhere.
Also the tumour incidences were comparable among all groups.
CMC has been used as vehicle in a bioassay of selenium sulﬁde for possible carcinogenicity. Groups
of 50 B6C3F1 mice of each sex were dosed via gavage with 10 mL/kg bw per day of 0.5% aqueous
CMC (50 mg/kg bw per day) on 7 days per week for 103 weeks (NCI, 1980). Similar groups of
untreated controls were also used. Observations made on the test animals were recorded twice daily.
Examinations of animals for clinical signs and the presence of palpable masses were performed and
recorded weekly. Mean body weights were recorded every 2 weeks for the ﬁrst 12 weeks and then
monthly for the remaining 93 weeks, with few exceptions. Animals that were moribund and those that
survived to the termination of the study were killed and necropsied. Gross and microscopic
examinations were performed on major tissues, major organs and all gross lesions from killed animals
and from animals found dead. Compared with untreated controls, for all investigated parameters, no
adverse effects were reported.
Rats
Ten male and 15 female young Wistar rats were fed a diet containing 5% CMC (equivalent to 2,500
mg/kg bw per day) for 201–250 days (Rowe et al., 1943). All animals were weighed twice weekly and
individual weight records were kept throughout the experimental period. All the animals that were
killed, as well as most of those that died during the study, were examined for gross pathology and
lesions. The dosing had no adverse effects on growth rate, mortality and organ weights. Also, the
results of histopathological examination of the liver, kidney, spleen, pancreas, adrenal gland, testis and
GI tract showed no signiﬁcant differences between the treated and the control groups.
Two groups of 50 male and 50 female white rats each were dosed with 500 or 1,000 mg/kg bw per
day of CMC via diet for 6 months (Shelanski and Clark, 1948). Forty rats were used as controls. The
animals were weight once monthly; other investigated parameters were fertility (not further speciﬁed),
urine analysis (sugar, albumin and phosphates as well as microscopic examination for casts and blood
cells), haematology at the beginning of the experiments, at the end of 3 months and at the end of 6
months (Hb percentage, leucocyte and erythrocyte counts as well as differential counts) and a
histopathological examination in ﬁve rats from each dose group, as well as in three rats from the
control group each month (liver, kidney, spleen, stomach, intestine and heart). For none of the
investigated parameters were adverse effects reported.
CMC has been used as vehicle in a bioassay of selenium sulﬁde for possible carcinogenicity (NCI,
1980). Groups of 50 F344 rats of each sex were dosed via gavage with 1 mL/kg bw per day 0.5%
aqueous CMC (5 mg/kg bw per day) on 7 days per week for 103 weeks. Similar groups of untreated
controls were also used. Observations made on the test animals were recorded twice daily.
Examinations of animals for clinical signs and the presence of palpable masses were performed and
recorded weekly. Mean body weights were recorded every 2 weeks for the ﬁrst 12 weeks and then
monthly for the remaining 93 weeks, with few exceptions. Animals that were moribund and those that
survived to the termination of the study were killed and necropsied. Gross and microscopic
examinations were performed on major tissues, major organs and all gross lesions from killed animals
and from animals found dead. Compared with untreated controls, for all investigated parameters, no
adverse effects were reported.
Groups of 50 male and 50 female young adult Alderley Park SPF rats were dosed via diet with 0,
10,000 or 100,000 mg/kg diet (equivalent to 0, 500 or 5,000 mg/kg bw per day) of sodium CMC for
104 weeks (McElligott and Hurst, 1968). In general, the dosing was well tolerated and caused no
increased mortality in dosed rats. During the ﬁrst 30 weeks, body weights and body weight gain was
not affected, while thereafter a retarded growth was noted in dosed rats. Although the feed intake
was increased in dosed rats, the ﬁnal body weights were dose dependently decreased (511, 498 and
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451 g for male rats and 344, 337 and 287 g for female rats at 0, 10,000 or 100,000 mg/kg diet,
respectively). Haematological examinations revealed no adverse effects. At necropsy, there was no
histological evidence of changes in the intestinal wall indicating an absorption of sodium CMC and also
no evidence of storage in the regional lymph nodes or elsewhere. Also the tumour incidences were
comparable between all groups.
Four groups of 25 male and female white rats each were dosed via diet for over 2 years with 0,
100, 500 or 1,000 mg/kg bw per day of sodium CMC (Shelanski and Clark, 1948). The weight curves
of the four groups were normal except that the groups receiving sodium CMC showed a slight increase
in weight compared with control rats. Monthly urine (albumin, casts and sugar) and haematology
examinations (Hb, RBC and WBC counts, differential counts) showed no deviations. Litters produced
within all groups were kept in their respective groups and placed on the same diet as the parents. This
was carried out into the third generation and these animals also showed no deviation from the animals
in the control group. At the end of 25 months, 12 of the animals in each group were autopsied; no
adverse ﬁndings were observed. Also a histological examination (heart, liver, kidney, stomach,
intestine, spleen and adrenals) revealed no adverse ﬁndings.
Guinea pigs
Two groups of 50 male and 50 female guinea pigs each were dosed with 500 or 1,000 mg/kg bw
per day of CMC via diet for 6 months (Shelanski and Clark, 1948). Forty guinea pigs were used as
controls. The animals were weighted once monthly. Other investigated parameters were fertility (not
further speciﬁed), urine analysis (sugar, albumin and phosphates, as well as microscopic examination
for casts and blood cells), haematology at the beginning of the experiments, at the end of 3 months
and at the end of 6 months (Hb percentage, leucocyte and erythrocyte counts, as well as differential
counts) and a histopathological examination in ﬁve guinea pigs from each dosage group, as well as in
three guinea pigs from the control group each month (liver, kidney, spleen, stomach, intestine and
heart). For none of the investigated parameters were adverse effects reported.
In a one-year study, groups of 20 guinea pigs each were dosed with 500 or 1,000 mg/kg bw per
day of CMC via diet (Shelanski and Clark, 1948). A control group consisted of 15 guinea pigs. Monthly
weight records were kept and showed a similar body weight gain in all groups. All animals were
autopsied at the end of the ﬁrst year and none of the animals showed gross pathological changes.
Also sections of liver, kidney, spleen, heart, stomach and intestines prepared from each animal and
examined histologically showed no changes.
4.2.4.9. Cross-linked sodium carboxy methyl cellulose (E 468)
No data available.
4.2.4.10. Enzymatically hydrolysed carboxy methyl cellulose (E 469)
No data available.
4.2.4.11. Summary
Overall, in a chronic feeding study, no consistent effects on the body weight were reported even at
very high doses of microcrystalline cellulose (30% in the diet) (Documentation provided to EFSA n.
40). Food efﬁciency, survival and haematology were comparable among all groups. The liver and
kidney weights of males receiving microcrystalline cellulose gel were increased. Histopathology showed
some dystrophic calciﬁcation of renal tubules in females of the high dose group. No further treatment-
related changes were observed. Other available studies were less suitable for evaluation of this
endpoint due to methodological shortcomings (Lewerenz et al., 1981a,b; Paulini et al., 1987) or limited
reported information (Bieri et al., 1977; Nigro et al., 1979; Yartsev et al., 1989; cited in JECFA, 1990;
Anastasia et al., 1990; Maurer et al., 1990). The Panel concluded that microcrystalline cellulose has no
carcinogenic properties.
Data are available for methyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose,
ethyl methyl cellulose and sodium carboxy methyl cellulose.
Groups of 20 male and 20 female Wistar rats were dosed via diet containing 1% or 5% (up to
5,000 mg/kg bw per day) methyl cellulose (15, 400 or 4,000 cP) for 2 years. For all examined
parameters, no adverse effects were reported and also the observed tumours were similar in type and
number in treated and control groups (McCollister et al., 1973). For obtaining data on tumour
incidence from a larger number of rats, diets identical to those fed in the above cited study as to
sample and concentration were administered to groups of 30 male and 30 female Wistar rats for 2
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years. Also in this study, no adverse effects were seen concerning mortality, body weights, terminal
liver and kidney weights or any increase in tumour incidences (McCollister et al., 1973).
In groups of 10 young adult male and female Wistar rats dosed daily via gavage with 0, 1,500, 3,000
or 6,000 mg/kg bw of hydroxypropyl cellulose for 6 months, apart from a decrease in body weights in
high-dosed male and female rats, no other adverse effects were noted (Kitagawa et al., 1976b).
In an older study, groups of 50 male and 50 female rats (strain not speciﬁed) were dosed via diet
with 0%, 1%, 5% or 20% of hydroxypropyl methyl cellulose (equivalent to 0, 500, 2,500 or 10,000
mg/kg bw per day). Also in this study, apart from a decrease in body weights of high-dosed males, no
other signiﬁcant adverse ﬁndings were reported and there was no indication of a carcinogenic effect
(Hodge et al., 1950).
For ethyl methyl cellulose, data are available from two unpublished studies with rats and mice. In
both trials, groups of 50 male and 50 female animals (strains not speciﬁed) were dosed via diet with
0%, 0.1% or 1% (equivalent to 0, 150 or 1,500 mg/kg bw per day for mice; equivalent to 0, 50 or
500 mg/kg bw per day for rats) over 2 years. Apart from decreased body weights in high-dosed
animals, no adverse effects on survival rate, tumour incidence, blood picture and gross and
microscopic appearance of internal organs were reported (ICI, 1966; cited in JECFA, 1990).
Sodium carboxy methyl cellulose was tested in two studies with groups of 50 male and 50 female
Alderley Park SPF mice and Alderley Park SPF rats, respectively (McElligott and Hurst, 1968). The
animals were dosed via diet with 0, 10,000 or 100,000 mg/kg diet (equivalent to 0, 1,500 or 15,000 mg/
kg bw per day for mice; equivalent to 0, 500 or 5,000 mg/kg bw per day for rats) for up to 104 weeks.
In the study with mice, during the ﬁrst 30 weeks, body weights and body weight gain were not affected,
while thereafter, a retarded growth was noted. The ﬁnal body weights at 0, 10,000 or 100,000 mg/kg
diet group were 45, 38 and 39 g for male mice and 39, 34 and 36 g for female mice. At necropsy, there
was no histological evidence of changes in the intestinal wall indicating an absorption of the substance
and there was also no evidence of storage in the regional lymph nodes or elsewhere. Also, the tumour
incidences were comparable between all groups. In rats, during the ﬁrst 30 weeks, body weights and
body weight gain also were not affected, while thereafter a retarded growth was noted. Although the
feed intake was increased in dosed rats, the ﬁnal body weights were dose dependently decreased (511,
498 and 451 g for male rats and 344, 337 and 287 g for female rats at 0, 10,000 or 100,000 mg/kg diet,
respectively). Also in this study, there was no evidence of histological changes in the intestinal wall
indicating absorption of sodium carboxy methyl cellulose and also no evidence of storage in the regional
lymph nodes or elsewhere. The tumour incidences were comparable among all groups.
4.2.5. Reproductive and developmental toxicity
4.2.5.1. Microcrystalline cellulose (E 460(i))
Reproductive toxicity studies
Rats
In a report available from secondary source (Documentation provided to EFSA n. 41), groups of
eight male and 16 female rats were used to produce P, F1a, F1b, F2 and F3 generations after having
been fed on diets containing 30% microcrystalline cellulose ﬂour or gel (equivalent to 15,000 mg/kg
bw per day). The control received 30% ‘ordinary cellulose’ (no further details). The authors stated that
no adverse effects on reproduction and no developmental effects were seen. The evaluation of this
study is hampered by limited and inconsistent documentation.
An unpublished, combined, one-generation reproduction/chronic toxicity study in rats with
microcrystalline cellulose (90% of particles < 20 lm) in the diet at levels of 0 (control), 30, 100 or 200
g/kg diet (equivalent to 0, 1,500, 5,000 or 10,000 mg/kg bw per day) (Lewerenz et al., 1979, 1981a;
referred to by SCF, 1999) revealed no effects on reproductive parameters (no details reported). Due to
the limited reporting and low number of animals involved, the Panel considered this study inadequate
for risk assessment.
Developmental toxicity studies
Rats
Groups of 25 pregnant SpragueDawley rats received Avicel® RCN-15 (a mixture of 85%
microcrystalline cellulose with 15% guar gum; median particle size of 21 lm, only 1% of particles < 5
lm) in the diet at dose levels of 0%, 2.5% or 5.0% (equal to 0, 2,091 or 4,490 mg/kg bw per day)
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ad libitum on gestation day (GD) 6–15 (Freeman, 1992b). Animals were fed basal diet at all other times.
The treatment in the high-dose group resulted in a signiﬁcant increase in food consumption from GD 6
to 15, presumably due to the increased ﬁbre content. On GD 20, a caesarean section was performed.
Number and distribution of corpora lutea, implantation sites, early and late resorptions, live and dead
fetuses and fetal sex were determined. External, visceral and skeletal examinations of the fetuses were
performed. There was no evidence for maternal toxicity or any developmental effects of microcrystalline
cellulose. The NOAEL for maternal and developmental toxicity was 4,500 mg/kg bw per day.
In a second study, the same experimental design was used, but pregnant rats were exposed to
Avicel® CL-611, a mixture of 85% microcrystalline cellulose and 15% sodium carboxy methyl cellulose
Documentation provided to EFSA n. 33). The mean particle size was 32 lm (1% of particles < 5 lm).
The doses were of 0%, 2.5% or 5.0% (equal to 0, 2,207 and 4,584 mg/kg bw per day), respectively.
In this study, the food consumption was signiﬁcantly increased at the 2.5% and 5% level. There was
no evidence for maternal toxicity or any developmental effects of microcrystalline cellulose. The NOAEL
for maternal and developmental toxicity was 4,600 mg/kg bw per day.
4.2.5.2. Powdered cellulose (E 460(ii))
Reproductive toxicity studies
Mice and rats
The effects of a synthetic diet (AIN-76TM) containing 5% cellulose (no further details) (equivalent to
2,500 mg/kg bw per day) for 6 weeks prior to mating and during pregnancy and lactation were
compared with a control group receiving a cereal-based diet containing 4.5% crude ﬁbre (no further
details) in rats and mice (strains not speciﬁed) (Bieri et al., 1977). In each group, 78 pregnant rats
were used (no further details). Litter size, birth weight, number of weaned F1 rats and body weight of
weaned rats were measured. In a ﬁrst trial, no differences were found between controls and treated
rats. In an independent second experiment, birth weight and body weight at weaning were
signiﬁcantly increased in treated rats. No effects on reproduction and lactation were detected in similar
experiments with mice. The reporting and the parameters measured were very limited.
Developmental toxicity studies
Rats
Four groups of 912 pregnant SpragueDawley rats were fed at GD 6–15 a mixture of four types
of a-cellulose (Elcema®; four types of a-cellulose in the ratio of 1/1/1/1: particle size 150 lm
(powder), 1100 lm (powder), 1150 lm (ﬁbrillar), 90250 lm (granulate)) at dose levels of 0%,
2.5%, 5% or 10% in the diet (equivalent to 0, 1,250, 2,500 or 5,000 mg/kg bw per day) (Ferch,
1973a,b, 1974). Maternal weight was measured every third day and dams were killed on day 21 of
pregnancy for caesarean section. Number, sex and weight of fetuses, corpora lutea, early and late
resorption, litter size and average backbone length were determined. Fetuses were examined for
external malformations, soft tissue or skeletal defects. Additionally, two groups of pregnant rats
received at GD 615 the basal diet (n = 12) or 10% cellulose in the diet (n = 10) and dams were
allowed to deliver the pups, which were maintained to weaning (day 21 postnatal). In these additional
groups, the following parameters were measured: duration of pregnancy, number of pups born and
surviving postnatal period, and weight of pups at days 7 and 21; pups were killed at day 21 postnatal
and histopathology was performed. Presumably basal diet was fed at all other times in both trials. No
statistical analysis was performed. The treatment did not induce effects on maternal weight gain.
There were no altered parameters after the caesarean section in comparison to the concurrent control,
except for a slight, but not dose dependent, increase in early resorptions (limited reporting prevents
the evaluation of this effect). However, the authors stated that no effects on early resorptions were
noted in comparison to historical controls. The treatment with 10% cellulose did not affect postnatal
development. The Panel noted that the test substance was not compliant with the speciﬁcations of the
food additive.
4.2.5.3. Methyl cellulose (MC; E 461)
Reproductive toxicity studies
No studies available.
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Developmental toxicity studies
Mice
Groups of 2022 pregnant albino CD-1 outbred mice were dosed once daily via gavage with 0, 16,
74, 345 or 1,600 mg/kg bw per day of a MC (FDA 71-51) suspension in corn oil (dose volume 10 mL/kg
bw) from GD 6 to 15. The control group received daily doses of corn oil. A caesarean section was
performed on GD 17. In dams dosed with 1,600 mg/kg bw per day, a signiﬁcant increase in mortality
was observed, with a reduced rate of pregnancy in survivors. At term, resorption sites were markedly
increased in number, live fetuses were signiﬁcantly reduced in number and fetal weight decreased. At
external and visceral examination of the fetuses, no dose-related abnormalities were observed. At fetal
skeletal examination, the ossiﬁcation of the fetuses was retarded in the 1,600 mg/kg bw group.
In fetuses, there was no evidence for developmental effects at any dose level (FDLI, 1973; cited in
JECFA, 1990).
Groups of 1217 pregnant mice (CD/1 strain) were dosed once daily via gavage with 0, 70, 153,
330 or 700 mg/kg bw per day of a MC (FDA 71-51) suspension in corn oil (dose volume 5.8, 12.7, 27.5
or 58.3 mL/kg bw) from GD 6 to 15. The control group received corn oil at the same dose as the
highest dose. A caesarean section was performed on GD 17. There were no dose-related effects on
growth, mortality or incidences of gross lesions in dams and in the number of implantations,
resorptions, live and dead fetuses and fetal weight. No increase in incidences of external, visceral and
skeletal abnormalities, reduced weight, or mortality was observed in fetuses from treated dams
(Cannon Labs, 1975; cited in JECFA, 1990).
Rats
Groups of 20–25 pregnant rats (not further speciﬁed) were dosed once daily via gavage with 0, 13,
51, 285 or 1,320 mg/kg bw per day of a MC suspension in corn oil (dose volume 6, 1, 1, 2 or 6 mL/kg
bw) from GD 6 to 15. The control group received daily doses of corn oil. A Caesarean section was
performed on GD 20. In dams dosed with 1,320 mg/kg bw per day, a reduced pregnancy rate was
observed. The dosing gave no adverse effects on growth, mortality or incidence of gross lesions in
dams. Also, the incidences of implantations, live or dead fetuses and resorptions were not affected.
Apart from an increased incidence of extra centres of ossiﬁcation in vertebrae of fetuses from high
dose dams, no increase in incidences of external, visceral and skeletal abnormalities was observed in
fetuses. Also, fetal weights were not affected (FDLI, 1973).
Groups of 1319 pregnant SpragueDawley rats were dosed once daily via gavage with 0, 120,
260, 550 or 1,200 mg/kg bw per day of a MC suspension in corn oil (dose volume 12, 1.2, 2.6, 5.6 or
12 mL/kg bw) from GD 6 to 15. The control group received daily doses of corn oil. A Caesarean
section was performed on GD 20. There were no dose-related effects on growth, mortality or
incidence of gross lesions in dams. The incidences of implantations, live fetuses, corpora lutea, dead
fetuses and resorptions in treated dams were within the normal range. Apart from a slight increased
incidence of extra centres of ossiﬁcation in vertebrae of fetuses from the high-dose group, no increase
in incidences of external, visceral and skeletal abnormalities was observed in fetuses. Also, fetal
weights were not affected (Cannon Labs, 1977).
Hamsters
Groups of 2224 Golden hamsters were dosed once daily via gavage with 0, 46, 216 or 1,000 mg/kg
bw per day of a MC suspension in corn oil (dose volume 4, 1, 1 or 4 mL/kg bw) from GD 6 to 10. The
control group received daily doses of corn oil (negative control). A caesarean section was performed on
GD 14. There were no dose-related effects on growth, mortality or incidences of gross lesions in dams.
Also, the incidences of implantations, live and dead fetuses and resorptions in dams were within the
normal range. In fetuses, there were no increased incidences of external, visceral and skeletal
abnormalities and also fetal weights were not affected (FDLI, 1973).
Rabbits
Groups of 10–17 Dutch belted rabbits were dosed once daily via gavage with 0, 7, 32, 148 or 685
mg/kg bw per day of a MC suspension in corn oil (dose volume 3, 1, 1, 1 or 3 mL/kg bw) from GD 6
to 18. The control group received daily doses of corn oil (negative control). A Caesarean section was
performed on GD 29. Dams of the highest dose group showed an increased mortality and a decrease
in pregnancy rate in survivors, but no dose-related effects on growth or incidence of gross lesions. The
incidences of corpora lutea, implantations, live and dead fetuses and resorptions in dams were within
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the normal range. In fetuses, there were no increased incidences of external, visceral and skeletal
abnormalities and also fetal weights were not affected (FDLI, 1973). Due to the high mortality in the
high-dose group, the Panel considered this study not relevant for risk assessment.
4.2.5.4. Ethyl cellulose (EC; E 462)
Reproductive and developmental toxicity studies
No studies available.
4.2.5.5. Hydroxypropyl cellulose (HPC; E 463)
Reproductive toxicity studies
No studies available.
Developmental toxicity studies
Rats
Pregnant Wistar rats (JCL) were dosed via gavage from GD 7 to 17 with 0, 200, 1,000 or 5,000
mg/kg bw hydroxypropyl cellulose of low substitution (L-HPC) (Kitagawa et al., 1978a). Since L-HPC is
insoluble in water, 8 g were suspended in 100 mL of 1% gum arabic solution. The amounts of
suspension administered were 2.5, 12.5 or 62.5 mL/kg bw in the low-, mid- and high-dose group. The
control group received 62.5 mL/kg bw of 1% gum arabic solution. The group sizes were 2124
animals for caesarean section and 1215 animals for spontaneous delivery. During the gestation
period, general symptoms, mortality and abortion rates of dams were examined. Body weight, and
food and water intake were recorded every 3 days. On GD 21, 2124 pregnant females in each group
were necropsied by caesarean section. The number of corpora lutea, implantations, viable and dead
fetuses, and resorbed embryos were counted, and positions of implantations were observed. Body
weight of all viable fetuses were weighed individually and examined for external abnormalities and
gender. Two to three of the viable fetuses per litter (random) were stained with alizarin Red S and
examined for skeletal anomalies and development. The other fetuses were examined for visceral
abnormalities. In the control, low-, mid- and high-dose groups, litter weight (36.6, 34.4, 33.8 and 28.4
g) and the percentage of pre-implantation loss (14.9%, 11.1%, 14.75 and 24.4%) and post-
implantation loss (6.2%, 6.5%, 10.2%, and 13.5%) were signiﬁcantly increased in the high-dose
group. The number of live fetuses in the control, low-, mid- and high-dose groups was 9.0, 9.0, 8.8
and 7.5. The authors considered the effect in the high-dose group not as treatment-related, as this
effect (pre-implantation loss) occurred before administration of the test substance. Furthermore, no
decrease in the number of liveborn pups was observed in the dams which were allowed to litter.
Furthermore, these effects were not observed in the litters of dams which were allowed to deliver. The
Panel agreed with the authors.
Twelve to 15 dams in each group of the study described above were allowed to deliver
spontaneously (Kitagawa et al., 1978a). Condition of each delivery was observed and the number of
viable and stillborn pups was counted. Body weight, sex and external anomalies were examined.
Litters were not adjusted. During the lactation period, general behaviour of the dam and newborn
were observed, and at the third day after birth and once a week thereafter, food consumption and
body weight gain of pups were recorded. The body weight of each newborn was weighed individually
at the time of birth and weaning. Otherwise, the body weight was recorded as ‘litter weight’ by
weighing a whole litter of each dam. Incisors eruption and eye opening were recorded. Pups were
weaned at the 28th day of birth and dams were dissected. On the 35th day, each weanling rat was
examined for the general behaviour and nervous functions, including anomalies in general behaviour,
righting reﬂex, corneal reﬂex, pinna reﬂex, body posture, traction and responsiveness to sounds. All of
the weanling rats from each litter were examined for skeletal anomalies taking soft X-ray pictures,
except for two males and two females randomly selected. Each was then dissected for the examination
of visceral malformations and positioning. One male and one female from each litter were sacriﬁced
and wet weights of brain, heart, lung, liver, spleen, kidney, thymus, adrenal, testis epididymis, prostate
gland, ovary, pituitary gland and thyroid gland were weighed. The weaning ratio was calculated
conventionally from the data obtained at 3 weeks. Offspring (F1) grown over 5 weeks were examined
for weight gains. After maturity, conditioned avoidance test and reproductive ability were examined.
For the reproductive ability, F1 offspring (42 from the 200 mg/kg bw group, 56 from the 1,000 mg/kg
bw group and 52 from the 5,000 mg/kg bw group) were used. Each male was examined for descent
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of testis at an age of 4 weeks, and each female was examined for opening of vagina at the age of 5
weeks. At weeks 1011 (about 1 week prior to mating), the oestrus cycle of each female was
examined, and in week 1112, each male and female among the same group were housed together
and observed for mating. The mating period was 15 days and during this period, oestrus cycle of each
female was examined every day until mating was conﬁrmed. Each male and female was separated
after the conﬁrmation of mating and the body weight of each female was recorded daily until GD 21.
On GD 21, a caesarean section was performed in each female, and implantations, corpora lutea, viable
or non-viable fetuses and the weight of each fetus were recorded, as well as external anomalies of
each fetus. In this part of the study, no effects on the number of pups, pup survival, growth and
physical development and reproduction (parameters) were observed. The authors considered in utero
exposure to the highest dose of 5,000 mg/kg bw per day as the NOAEL for this study and the
Panel agreed with this conclusion.
Developmental toxicity studies
Rabbits
In a study with Himalayan rabbits, groups of 11–12 pregnant animals were dosed daily via gavage
with 0, 200, 1,000 or 5,000 mg/kg bw of HPC during GD 618 (Kitagawa et al., 1978b). The test
substance was suspended in 1% arabic gum solution. The dose volume in the control, low-, mid- and
high-dose group was 50, 10, 10, or 50 mL/kg bw. Caesarean sections were performed on GD 29 and
all fetuses were examined for skeletal and organ malformations. In high-dose dams, a slight body
weight loss was seen up to GD 18. In the mid-dose group, the resorption rate was signiﬁcantly
increased (3.4%, 6.1%, 27.4% and 7.4%). The mean number of viable fetuses in the control, low-,
mid-, and high-dose group was 7.0, 5.5, 4.8 and 5.7 (historical control 6.37). Mean fetal viable weights
were comparable between the different groups. In high-dose dams, the pre-implantation loss was
signiﬁcantly increased (13.6%, 22.4%, 17.0% and 29.2%). The treatment gave no indications for an
increased incidence of malformations. The Panel noted that from this study no NOAEL can be derived,
as the number of fetuses was low in all dose groups.
4.2.5.6. Hydroxypropyl methyl cellulose (HPMC; E 464)
No studies available.
4.2.5.7. Ethyl methyl cellulose (EMC; E 465)
Reproductive and developmental toxicity studies
No studies available.
4.2.5.8. Sodium carboxy methyl cellulose (NaCMC; E 466)
Reproductive toxicity studies
Rats
In a study with male and female SpragueDawley-derived rats, 20 male and 40 female rats were
dosed via gavage with 0 or 200 mg/kg bw per day of CMC (aqueous solution, dose volume 10 mL/kg
bw) for at least 60 days (males) or for least 14 days (females) prior to mating, and also during the
6-day mating period (Fritz and Becker, 1981). One half of the females were dosed until sacriﬁce on GD
14, while the other half was dosed until weaning of the progeny (day 28 after birth). The treatment
caused no adverse reactions in the parents and also average body weights were comparable
throughout the study. In dams, no adverse effects concerning mating efﬁciency, pregnancy rate, mean
numbers of corpora lutea and implantation sites, ratios of corpora lutea to implantation sites or
resorption rates were noted. For the offspring, there were also no signiﬁcant changes in litter sizes, sex
ratios, body weight gains, nesting behaviour, eye opening and pinna detachment. In addition,
behavioural testing (e.g. righting and direct pupillary reﬂex) gave no adverse effects. Data were not
described very detailed in the publication. The only dose tested (200 mg/kg bw per day) did not induce
effects with regards to parental toxicity, reproduction and development and behaviour of the offspring.
Developmental toxicity studies
Mice
In a study with pregnant albino CD-1 outbred mice, groups of 19–24 animals were dosed via
gavage with 0, 16, 74, 345 or 1,600 mg/kg bw per day of sodium CMC in corn oil (dose volume 10
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mL/kg bw per day) from GD 15. The treatment caused no mortality, and no adverse effects were
observed on implantation or on fetal survival. There was also no increase in abnormalities of soft or
skeletal tissues compared with non-dosed controls (FDLI, 1975).
Rats
In another study with pregnant Wistar-derived rats, groups of 19–22 animals were dosed via
gavage with 0, 16, 74, 345 or 1,600 mg/kg bw per day of sodium CMC in corn oil (dose volume 5, 1,
1, 2 or 5 mL/kg bw) from GD 6 to 15. The treatment caused no mortality, and no adverse effects were
observed on implantation or on fetal survival. There was also no increase in abnormalities of soft or
skeletal tissues compared with non-dosed controls (FDLI, 1975).
4.2.5.9. Cross-linked sodium carboxy methyl cellulose (E 468)
Developmental studies
Rats
Cross-linked sodium carboxy methyl cellulose was administered to pregnant SpragueDawley CD
rats (25 females; age not stated) at 0, 10,000 or 50,000 mg/kg diet ad libitum from GD 6 to 15 (equal
to 0, 910 or 4,554 mg/kg bw per day) (Freeman et al., 2003). During GD 0–6 and GD 15–20, the
animals received an untreated basal diet, which was also given to the control animals for the duration
of the experiment. The animals were observed daily with detailed assessment of test material-related
effects. Body weight and food consumption were recorded. Clinical examinations included recording
the onset and duration of any toxicological effects. On GD 20, the animals were terminated, and all
dams examined for gross lesions, implantation sites, late resorptions and status of fetuses and corpora
lutea. The fetuses were examined for external alterations, after which they were euthanised, and
visceral and skeletal examinations carried out to detect abnormalities. No treatment-related clinical
signs or deaths were reported in the study. There were also no effects on body weight, uterine
weights or food consumption in dams compared to controls. No effects were noted in dams during
necropsy, and there were no external, skeletal or visceral malformations in the fetuses. The study
authors concluded that there were no treatment-related statistically signiﬁcant ﬁndings in the
developmental study. The Panel agreed with this conclusion and considered 4,554 mg/kg bw per day
as the NOAEL for this study.
4.2.5.10. Enzymatically hydrolysed carboxy methyl cellulose (E 469)
No data available.
4.2.5.11. Summary
Data from dietary reproductive studies were available for microcrystalline cellulose, powdered
cellulose and sodium carboxy methyl cellulose, (Documentation provided to EFSA n. 41, Lewerenz
et al., 1979; referred to by SCF, 1999; Bieri et al., 1977; Fritz and Becker, 1981).
Several prenatal developmental studies with oral dosing via diet of microcrystalline cellulose,
powdered cellulose and via oral gavage of methyl cellulose, hydroxypropyl cellulose, sodium carboxy
methyl cellulose and cross-linked sodium carboxy methyl cellulose have been performed in mice, rats,
hamsters and/or rabbits (FDLI, 1973, 1975; Cannon Labs, 1975, 1977; Kitagawa et al., 1978a,b; Fritz
and Becker, 1981; Freeman, 1992b).
From these studies, it can be concluded that adverse effects on reproduction and development
were unlikely.
• The reproductive toxicity studies with microcrystalline cellulose and powdered cellulose
did not report adverse effects up to 15,000 and 7,500 mg/kg bw per day, respectively.
However, the Panel noted that the studies were limited in design and reporting. In prenatal
developmental toxicity studies in rats, doses up to 10% powdered cellulose in the diet
(equivalent to 5,000 mg/kg bw per day) did not induce maternal or developmental toxicity and
did not affect postnatal development (FDLI, 1973; Ferch, 1973a,b, 1974; Cannon Labs, 1975;
Freeman, 1992b).
• From prenatal developmental toxicity studies by gavage in mice, rats and golden hamsters, the
Panel derived a NOAEL of 700, 550 and 1,000 mg methyl cellulose/kg bw per day,
respectively (vehicle: corn oil, daily dosing from GD 6 to 15) (FDLI, 1973; Cannon Labs, 1977).
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• In rats, no treatment-related developmental effects were observed at 5,000 mg hydroxy
propyl cellulose/kg bw per day, the highest dose tested (Kitagawa et al., 1978a). Himalayan
rabbits dosed daily by gavage with 0, 200, 1,000 or 5,000 mg hydroxypropyl cellulose/kg
bw per day (Kitagawa et al., 1978a) showed a decreased number of viable fetuses in all
treated groups. Therefore, the Panel could not derive a NOAEL from this study.
• Besides the reproductive study with a single dose, in which no reproductive effects were
observed, a prenatal developmental toxicity study in mice and in rats was performed with
sodium carboxy methyl cellulose. In mice and rats, no effects on maternal or
developmental toxicity were observed after daily dosing up to 1,600 mg sodium carboxy
methyl cellulose/kg bw per day by gavage (vehicle: corn oil, daily dosing from GD 6 to 15)
(FDLI, 1975).
• Cross-linked sodium carboxy methyl cellulose, when fed in the diet in a prenatal
developmental toxicity study at doses equal to 910 or 4,554 mg/kg bw per day from GD 6 to
15 to rats, gave no effects on maternal or developmental toxicity (Freeman et al., 2003). The
NOAEL of this study was 4,554 mg/kg bw per day.
4.2.6. Hypersensitivity, allergenicity and food intolerance
In the JECFA evaluation (1998), the Committee stated that microcrystalline cellulose had no skin
sensitising properties in guinea pigs (Freeman, 1991; referred to by JECFA, 1998a,b, 1999a,b)
(Freeman, 1996b; referred to by JECFA, 1998a,b, 1999a,b).
In human subjects suffering from seasonal allergic rhinitis, inhalation of inert cellulose powder or
oxidised cellulose has been reported to improve hay fever symptoms (Josling and Steadman, 2003;
Shani et al., 2011). However, this was not conﬁrmed in other studies where the authors concluded that
microcrystalline cellulose did not prove to be signiﬁcantly better than placebo in treating seasonal
allergic rhinitis symptoms (Paz Lanberg et al., 2016).
Anaphylactic reactions to carboxy methyl cellulose have been rarely reported (Dumond et al., 2009)
and this was usually when the cellulose was injected. Two patients who presented that reaction, did
not react to orally administered CMC (Rival-Tringali et al., 2008).
Overall, the Panel considered that there is no indication for an hypersensitivity potential for
celluloses (E 460466, E 468469) used as food additives.
4.2.7. Other studies
4.2.7.1. Human studies
Microcrystalline cellulose
In patients given 30 g microcrystalline cellulose per day as dry ﬂour (one male) or gel (one female)
for 5 weeks (added to the free-choice diet), no signiﬁcant effects in the GI tract were noted during the
administration period (Tusing, 1964).
Microcrystalline cellulose was used in the treatment of constipation in obese patients. After
recording control values for body weight, body mass index, total and fractionated cholesterol,
triglycerides, A and B lipoproteins, uric acid, glucose and glycosylated haemoglobin, a group of 30
subjects received for 4 weeks 2.4 g microcrystalline cellulose in tablet form in the morning and 3.6 g in
the evening (Adamii et al., 1998). In a further trial using the same experimental design, 10 obese
subjects were treated for 8 weeks and additionally blood counts and plasma iron levels were
determined. Each subject stated in a questionnaire data about evacuations and clinical symptoms. No
adverse effects were reported. Improved defecation was observed in 83% of the patients in the ﬁrst
trial and in 9 out of 10 subjects in the second trial. No changes were found in controlled parameters.
In an unpublished clinical study (data from secondary source), eight male and eight female
volunteers supplemented for 6 weeks their diet with 30 g microcrystalline cellulose per day as either
dry powder or gel (15% aqueous) (Documentation provided to EFSA n. 39. The treatment period
followed 2 weeks without supplementation. No adverse ﬁndings were reported on body weight. Most
subjects complained of fullness and mild constipation. Haematology was normal in all subjects and
clinical chemistry showed no differences between treatment and control periods. There was no
evidence for effects on liver or kidney function; urinalysis produced normal ﬁndings. Analysis of faeces
revealed no effects on faecal ﬂora but the amount of cellulose in faeces increased 5–8 eight times
during the test period. Microscopy revealed the presence of microcrystalline cellulose in faeces.
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The effects of microcrystalline cellulose were compared in a double-blind, cross-over trial in 20
poorly controlled Type 2 diabetic patients (initially 16 women and six men; ages ranged from 40 to 76
years, mean 63 years) (Niemi et al., 1988). There were 12-week control and treatment periods
separated by a 4-week wash-out period. Cellulose was given at 15 g/day for a 2-week period and then
at 5 g/day for the remaining 10-week period. Parameters in the control and treatment period were
measured after 6 and 12 weeks. Questionnaire survey was performed by physicians. Four patients
reported mild ﬂatulence or loose stools during the treatment. There was no signiﬁcant change in body
weight and blood pressure. Serum zinc, ferritin or urinary magnesium excretion were not altered
during the treatment period. There was no effect on fasting blood glucose level, glycosylated
haemoglobin, serum high density lipoprotein cholesterol and serum triglycerides.
No change was noted in blood chemistry parameters in eight healthy male volunteers after daily
ingestion of 30 g microcrystalline cellulose as supplement to their diet for 15 days (limited information,
data from secondary source) (Asahi Chemical Industry Co., 1966; referred to by JECFA, 1998a,b,
1999a,b). Furthermore, faecal ﬂora did not show any alterations. The absorption of I131-triolein was
unaffected, and examination of urine, blood and faecal levels of vitamin B1 during treatment showed
no difference from control periods. D-xylose absorption was lower during microcrystalline cellulose
ingestion.
In 11 healthy female volunteers (19–22 years old), the post-prandial serum vitamin A concentration
was measured 3, 5, 7 and 9 h after oral administration of 300,000 IU vitamin A-palmitate given with a
formula diet, to which 0 or 40 g microcrystalline cellulose (no further details) were added (Kasper
et al., 1979). The areas under the serum vitamin A concentration curves were signiﬁcantly increased,
suggesting an increased amount of vitamin A being absorbed.
A group of 12 female volunteers (non-pregnant, not lactating; no further data) received 5 g
microcrystalline cellulose in 200 mL water containing 15 g sucrose and 3 mg radiolabelled Fe as iron
sulfate. Controls (n = 12) received the same amount of Fe in a jelly containing 5 g pectin.
Microcrystalline cellulose did not appear to inhibit the uptake of iron (Gillooly et al., 1984).
Three men received 10 g of cellulose in addition to a low-ﬁbre diet for 20-day (Ismail-Beigi et al.,
1977). The faecal excretion of zinc and calcium was increased. The magnesium balance became
negative in two subjects and the phosphorus balance negative in one subject. When cellulose was
added to a ﬁbre-rich diet, faecal excretion of calcium and zinc increased in two subjects and
magnesium in one.
a-Cellulose and unspeciﬁed celluloses
Bradlow et al. (1994) tested a-cellulose in a clinical study. Using a randomised clinical trial, groups of
20 female volunteers received daily for 3 months 20 g packets of a-cellulose (women aged 2748 years,
mean body weight 59 kg) or a placebo (aged 18–53 years, mean body weight 57 kg). The packets were
mixed with fruit juice. Urine and blood samples were collected at the end of each month. Haemoglobin,
platelets, several clinical chemistry and endocrinological parameters were determined. The urinary 2-OH-
oestrone:oestriol oestrogen metabolite ratio was measured monthly at the same time of the menstrual
cycle. In most subjects, the cellulose was well tolerated; a few subjects dropped out of treatment group
because they found the cellulose suspension very unpleasant to consume (no details about ﬁnal group
number). No other unpleasant symptoms or problems were reported in the questionnaire. No
differences between control and treatment group were observed in any parameter examined.
A cross-over design study (two periods of 4 weeks) in a group of 10 healthy volunteers (six women
and four men; mean age 24 years) was undertaken to determine the effects of daily dietary
supplementation with 15 g/day a-cellulose ﬁbre (99.5% pure; derived from wood; Sigma Chemical
Comp.) (Hillman et al., 1985) on serum lipid levels. There was no signiﬁcant change in dietary intakes
except for the ﬁbre supplement. Each subject acted as his/her own control. At the end of both the
control and test periods, fasting blood sample were taken. Cellulose did not alter serum total
cholesterol, triglycerides, high-density lipoprotein cholesterol, or the ratio of high-density lipoprotein to
total cholesterol.
Seven healthy women consumed a low-ﬁbre diet of constant composition and the same
metabolically controlled diet, to which 16 g of reﬁned cellulose (Solca Floc, 85% wood a-cellulose and
15% non-glucose hemicelluose) was added for 30 days (Slavin and Marlett, 1980). After cellulose
consumption, the mean daily wet stool weight, main dry stool weight and the frequency of defecation
were increased. Cellulose shortened the transit time. Faecal excretion of calcium and magnesium were
increased after cellulose consumption.
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The effects of 21 g pure cellulose added to a low-ﬁbre diet were tested in nine non-anaemic
adolescent girls (age 16–18 years, average weight and height 48 kg and 155 cm) (Godara et al.,
1981). The girls consumed ﬁrst a low-ﬁbre diet for 21 days and thereafter the high-ﬁbre diet. The
cellulose intake increased the faecal excretion of calcium, phosphorus and the serum levels of calcium,
inorganic phosphorus and iron were decreased.
King et al. (1982) reported no effects on daily excretion of zinc, copper, calcium and magnesium
after feeding cellulose (0.5 g/kg bw per day) to 5 young men for 9 days in an egg white protein
formula. Faecal iron was increased in the cellulose group. Another group (n = 5) was fed for 15 days
egg white protein formula to which cellulose (0.5 g/kg bw per day) or phytate (3 g/day) was added.
The phytate diet did not increase the faecal dry solids but the faecal excretion of calcium, magnesium
and zinc in this group was increased. Serum calcium, magnesium and zinc did not change with the
phytate feeding. According to the authors, the alteration in absorption of calcium, magnesium and zinc
is due to phytate and not to the ﬁbre components.
After intake of 15 g cellulose/day for 4 weeks by 5 males and 5 females (age 2126 year), the
effects on stool pH, transit time and weight were measured (Hillman et al., 1983). In females, nausea,
retching (n = 1) and cramps and urgency (n = 1) were reported. The stool pH was decreased, the
stool transit time decreased and the stool weight increased.
The effects of 14 g/day of puriﬁed cellulose (99% cellulose on a dry basis) for 24 days was studied
in 13 healthy male and female adults (age 2360 years) (Spiller et al., 1980). The subjects were
chosen on the basis of slow intestinal transit time and low faecal output when consuming their normal
diets. Faecal weight increased and the transit time decreased. During the study, the faecal volatile fatty
acids concentration did not change.
Methyl cellulose (MC; E 461)
In three healthy adults, 5 g of methyl cellulose (4,000 cP) given twice daily over 8 days both
increased the number of stools per day and also the volume of the stools about twofold (Tainter, 1943).
In an older study, it was reported that the intake of 2.5–5.25 g of MC taken orally as gel was mildly
constipating (Bauer, 1945).
In 29 and in 8 patients suffering from acute and/or chronic constipation, the daily uptake of 1–3 g
of MC over 3–180 days or the daily uptake of 6 g over 4–240 days caused a signiﬁcant relief and was
well tolerated without toxicity (Schweig, 1948).
In six patients suffering from irritable bowel associated with diarrhoea or constipation, the oral
uptake of 2 g of MC every 4 h resulted in abdominal comfort and the reduction of number of stools
(Bargen, 1949).
In two female patients with an age of 31 and 35 years, after an oral uptake of 60–90 mL of a short-
chain MC preparation daily over 5 days, symptoms such as generalised oedema, mental cloudiness, and
poor coordination of some skeletal muscle actions were observed, which disappeared within 72 h of
cessation of intake. During administration, sodium and water retention, increase in serum osmolality
and an up to 75% decrease in urinary aldosterone excretion were seen (Crane et al., 1969).
In an unpublished study, ﬁve adult male volunteers were given daily doses of 250 mg/kg bw of MC,
divided into three equal portions, over a period of 23 consecutive days. The treatment was well
tolerated and gave no allergic responses or alteration in normal elimination patterns. MC administered
as a prehydrated gel caused increased faecal weights (wet and dry basis), but had variable effects on
intestinal transit time, causing increased transit time in three subjects and decreased transit time in the
other two. Haematology, serum biochemistry and urinalysis parameters were within normal limits.
Small, but signiﬁcant, reductions were observed in faecal volatile fatty acids and neutral sterols, but
breath hydrogen levels were not affected (Eastwood et al., 1988, 1990).
In a study with 50 healthy adults (44 women and six men with an age of 18–70 years), the
subjects were dosed with 19 g of a placebo during the ﬁrst week (Hamilton et al., 1988). Then each of
the subjects was randomised to 1 of 3 arms: a second week of a daily dose of 19 g of placebo, or 19
g of the bulk laxative containing 2 g MC, or 38 g of the laxative containing 4 g of MC. Nine subjects
completed the protocol on placebo, 20 subjects on 2 g MC and 21 on 4 g MC. At the end of the study,
stools were analysed for faecal weight, faecal solids, water content and percentage of water. In a
second phase of the study, during the ﬁrst week of the protocol, all subjects (135 women and 14 men
with an age of 18–70 years) took the 19 g of placebo. The second part of this protocol was a 10-day
treatment period during which the subjects were randomised into one of four daily dosage groups: the
study bulk laxative containing 1, 2 or 4 g MC in a total weight of 9.5, 19 or 38 g, respectively, or a
similar-appearing preparation, 11 g in weight, containing 3.4 g of psyllium as positive control. Only 59
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subjects (56 women, three men) entered into the second part of phase 2 (15 on 3.4 g psyllium, 15 on
1 g MC, 15 on 2 g MC and 14 on 4 g MC). The age range of this group was 19–59 years. As in phase
1, stools were analysed for total weight, faecal solids, total water content and percentage water. MC in
daily doses of 4 g caused a statistically signiﬁcant increase in faecal frequency, faecal water and faecal
solids. The results of the second phase showed that the dosing with MC statistically signiﬁcantly
increased stool frequency, water content and faecal solids.
Ethyl cellulose (EC; E 462)
No data available.
Hydroxypropyl cellulose (HPC; E 463)
In a clinical trial, patients (aged 18 years or more) with chronic watery diarrhoea, presumably
secondary to idiopathic bile acid malabsorption, were randomly assigned to two groups given either
colestyramine (n = 13, 7 females/6 males) or HPC (n = 13, 11 females/2 males) (Fernandez-Ba~nares
et al., 2015). Both substances were given in the form of 4 g sachets twice daily for 8 weeks. The
Panel noted that the two adverse effects (muscle pain, nasopharyngitis) observed in the HPC group
seem not to be associated with the intake of HPC, thus HPC is considered to be well tolerated in doses
of two or three 4 g sachets per day.
Hydroxypropyl methyl cellulose (HPMC; E 464)
In a study with 25 young and healthy adults (23 males and two females), each person was given
three graduated doses of HPMC ranging from 0.6 to 8.9 g. The time interval between the doses was at
least 1 week. Following each dose, stool specimens were collected at approximately 24-h intervals for
72 or 96 h. A mild laxative effect was noted in 11 cases and a mild constipating effect in 16 cases
(Knight et al., 1952).
Ethyl methyl cellulose (EMC; E 465)
No data available.
Sodium carboxy methyl cellulose (CMC; E 466)
The daily dosing of ﬁve male volunteers (age: 24–58 years; body weights: 73–84 kg) with 3 9 5 g
of sodium CMC over 23 days was well tolerated. Also routinely examined parameters such as clinical
chemistry, haematology, urine analysis, glucose tolerance, serum cholesterol, triglyceride and
phospholipids, and breath hydrogen and methane concentrations were not adversely affected. Other
effects such as shortening of intestinal transit times, increased faecal weights or changes in faecal bile
acids or faecal fat were attributed to an increased cellulose intake without any toxicological signiﬁcance
(Anderson et al., 1986).
In 11 male and female patients with an age of 27–82 years, daily doses of 10 g of sodium carboxy
methyl cellulose over 6 months were well tolerated. A haematological examination (RBC and WBC counts,
differential smears of WBCs and haematocrit) showed no signiﬁcant variations. No patients experienced
anaemia or a leukopenia and bone marrow studies of three patients during the early part of the test
period, as compared to similar studies at the end of 6 months, revealed no changes (Brick, 1952).
In a study with 12 men with an age of 26–62 years and body weights ranging from 77.5 to 111.5
kg, one basal diet containing relatively low-ﬁbre foods was given to the subjects throughout the 20
weeks of the study (Behall et al., 1984). Four ﬁbre sources, locust bean gum, karaya gum, CMC and
cellulose were used as the ﬁbre supplements. The four ﬁbre sources were added singly to the basal
diet for 4 weeks at the level of 0.75 g ﬁbre/100 cal. The basal di et al one and with the four ﬁbre
sources was given in a randomised rotation pattern during the ﬁve 4-week dietary periods so that each
diet was followed by each of the other diets an equal number of times. The basal diet provided
approximately 50.4% of the calories from carbohydrates, 35% from fat and 14.6% from protein. The
diet had a P/S ratio of 0.39, and contained 640 mg cholesterol, 27 g crude ﬁbre, and 6.33 g neutral
detergent ﬁbre per 2,550 kcal. Caloric intake of the men ranged from 2,550 to 3,600 kcal/day and
19.1 to 27.0 g/day added ﬁbre source, respectively, when given. At the end of each 4-week dietary
period, two fasting blood samples were drawn, one for serum analysis and one in
ethylenediaminetetraacetic acid (EDTA) to be used for analysis of plasma lipoprotein cholesterol for
high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL).
Fasting serum samples were analysed for cholesterol, triglycerides and free fatty acids (FFA). At the
end of the 4 weeks, total serum cholesterol had dropped signiﬁcantly (from 196 to 164 mg/dL) and
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plasma LDL decreased signiﬁcantly (from 131 to 107 mg/dL). No statistically signiﬁcant changes were
noted for triglycerides, FFA, VLDL, or HDL levels. The ratio of HDL/VLDL+LDL cholesterol was
signiﬁcantly higher than the ratios after consumption of the basal di et al one (0.33 versus 0.28).
Cross-linked sodium carboxy methyl cellulose (E 468)
No data available.
Enzymatically hydrolysed carboxy methyl cellulose (E 469)
No data available.
Summary
Overall, there is no evidence that microcrystalline cellulose or other unmodiﬁed celluloses in
repeated doses up to 35 g/person adversely affect clinical chemistry and haematological parameters,
as well as the absorption and/or the metabolism of dietary constituents.
Several celluloses have been used in patients suffering from diarrhoea or constipation. In general, it
can be concluded that an oral uptake of up to 5,000 mg/person per day is well tolerated. Even a daily
uptake of 6,000 mg over 4–240 days was well tolerated.
4.2.7.2. Case reports
Cases of oesophageal and GI obstruction have been reported in the literature following intake of
methyl cellulose (Belmont, 1952; Hedayaty and Shuman, 1953; Friedman and Alessi, 1954; FDA,
2015), carboxy methyl cellulose (Leger et al., 1952; Monod-Broca, 1952; Soullard et al., 1952;
Derobert and Heully, 1956; FDA, 2015) and cellulose ﬁbre diet pills (Jones and Pillsbury, 1990).
5. Discussion
The present opinion deals with the re-evaluation of the safety of microcrystalline cellulose (E 460(i)),
powdered cellulose (E 460(ii)), methyl cellulose (E 461), ethyl cellulose (E 462), hydroxypropyl cellulose
(E 463), hydroxypropyl methyl cellulose (E 464), ethyl methyl cellulose (E 465), sodium carboxy methyl
cellulose (E 466), cross-linked sodium carboxy methyl cellulose (E 468) and enzymatically hydrolysed
carboxy methyl cellulose (E 469) as food additives. These celluloses are authorised as food additives in
accordance with Annex II and Annex III of Regulation (EC) No 1333/2008.
Cellulose is a linear glucose homopolymer consisting of glucopyranose units linked by b-1,4-
glycosidic bonds; its molecular formula is (C6H10O5)m, with the DP dependent on the origin of the
cellulolytic material. Cellulose molecular weight has been calculated to fall approximately in the range
50,000–2,500,000. In modiﬁed celluloses, the chemical and physical characteristics of the native
substances are modiﬁed in order to confer different technological properties for particular food
applications. They are obtained from ﬁbrous plant material and the modiﬁcations consist mainly in
depolymerisation, etheriﬁcation (with methyl, ethyl or hydroxypropyl groups), or the formation of salt
of the carboxymethyl ether of native cellulose. The preparation of modiﬁed celluloses can also involve
physical (E 460(ii)) or enzymatic treatments (E 469).
Animal and human data clearly demonstrated that microcrystalline cellulose (E 460(i)) and powdered
cellulose (E 460(ii)) are not absorbed intact in the GI tract but could be fermented during their passage
through the large intestine by strains of bacteria found in the human colon, although to a lesser degree
than other polysaccharides such as gums, starches or pectins. Data for methyl cellulose (E 461),
hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), ethyl methyl cellulose (E 465),
sodium carboxy methyl cellulose (E 466), cross-linked sodium carboxy methyl cellulose (E 468) and
enzymatically hydrolysed carboxy methyl cellulose (E 469) demonstrated that these modiﬁed celluloses
are not absorbed intact, not fermented and are excreted intact via the faeces.
Data on acute oral toxicity are available for microcrystalline cellulose (E 460(i)), powdered cellulose
(E 460(ii)), ethyl cellulose (E 462), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose
(E 464) and sodium carboxy methyl cellulose (E 466). These data indicate low oral acute toxicity,
which would also apply to the other celluloses for which speciﬁc data were not available.
Short-term and subchronic toxicity studies have been performed with microcrystalline cellulose
(E 460(i)), powdered cellulose (E 460(ii)), methyl cellulose (E 461), ethyl cellulose (E 462),
hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), sodium carboxy methyl
cellulose (E 466), cross-linked sodium carboxy methyl cellulose (E 468) and enzymatically hydrolysed
carboxy methyl cellulose (E 469). In the majority of studies, animals were dosed via diet at levels up
to 10%. Effects on body weight at the highest dose tested (10%) were reported in some, but not all
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studies, which may reﬂect nutritional constraints rather than toxicity. No adverse effects were reported
with most of the tested celluloses, except for local effects on caecal size due to the presence of
undigested ﬁbre. Groups of 20 Wistar rats per sex were dosed with sodium carboxy methyl cellulose
(E 466) or enzymatically hydrolysed carboxy methyl cellulose (E 469) via diet with 0%, 2.5%, 5% and
10% (up to 6,800 mg/kg bw per day) for up to 102 days (Til, 1992; B€ar et al., 1995a). Effects on
caecal weight, urothelial hyperplasia, pelvic nephrocalcinosis, corticomedullary nephrocalcinosis and
increased incidence of diffuse epithelial hyperplasia in the urinary bladder were observed. The ﬁndings
in kidneys and urinary bladder were attributed to the concentration of sodium, which was up to
fourfold higher in the test diet compared with the basal diet. The Panel noted that this was a plausible
explanation for the reported ﬁndings.
Data concerning genotoxicity are available for microcrystalline cellulose (E 460(i)), methyl cellulose
(E 461) and sodium carboxy methyl cellulose (E 466) (Litton Bionetics Inc., 1974, 1975, 1980; Blevins
and Taylor, 1982; Ishidate et al., 1984; Batt, 1992; Cifone, 1992; McKeon, 1992; FMC, 1991, 1994,
1995; Murli, 1992). Overall, despite the limitations of some of the studies, the Panel concluded that
the available data and the in silico analysis conducted by the Panel, did not identify structural
determinants indicating a genotoxic concern for microcrystalline cellulose, methyl cellulose and carboxy
methyl cellulose. The Panel considered that these results could be read-across to the other modiﬁed
and unmodiﬁed celluloses covered by this opinion, for which the same conclusion can be reached.
Chronic toxicity studies have been performed with microcrystalline cellulose (E 460(i)), methyl
cellulose (E 461), hydroxypropyl cellulose (E 463), hydroxypropyl methyl cellulose (E 464), ethyl
methyl cellulose (E 465) and sodium carboxy methyl cellulose (E 466). Although there were some
inconsistencies in the data, the main effects seen were decreases in body weight gain at the highest
dose, which are likely to be due to the amount/bulk of celluloses in the diet leading to nutritional
imbalance. Furthermore, in a chronic feeding study with microcrystalline cellulose (E 460(i)), some
dystrophic calciﬁcation of renal tubules was observed in the high dose group (15,000 mg/kg bw per
day). The NOAEL values ranged up to 9,000 mg/kg bw per day. The Panel concluded that
microcrystalline cellulose and modiﬁed celluloses have no carcinogenic properties and that there was
no reason to expect carcinogenic properties with powdered cellulose (E 460(ii)).
Concerning reproductive and developmental toxicity, data are available for microcrystalline cellulose
(E 460(i)), methyl cellulose (E 461), hydroxypropyl cellulose (E 463) and sodium carboxy methyl
cellulose (E 466). The substances were tested in mice, rats, hamsters and/or rabbits with oral dosing
via gavage (FDLI, 1973, 1975; Ferch, 1973a,b; Cannon Labs, 1975, 1977; Kitagawa et al., 1978a,b;
Fritz and Becker, 1981; Freeman, 1992b). Adverse effects on reproductive performance or
developmental effects were not observed with modiﬁed and unmodiﬁed celluloses at doses greater
than 1,000 mg/kg bw by gavage (often the highest dose tested).
Speciﬁc toxicity data were not always available for all the celluloses for all endpoints. In general,
the most complete data sets were available for microcrystalline cellulose (E 460(i)) and sodium
carboxy methyl cellulose (E 466). Given the similarities in their structure, relevant physicochemical,
metabolic and toxicological properties, the Panel considered it possible to read-across between all the
celluloses.
In addition, the Panel noted that methyl cellulose (E 461) and sodium carboxy methyl cellulose
(E 466) were frequently used in the formulations for administration of xenobiotics by gavage in
chronic, reproductive and developmental toxicity and carcinogenicity studies. In these studies, there
should be a control group receiving the formulation alone. Although modiﬁed cellulose levels were
usually only up to 2%, given the number of studies and group sizes in these studies, the overall
number of animals tested would be very large. The Panel considered that the absence of reported
adverse effects from such vehicle control groups provided additional evidence of the lack of safety
concern for modiﬁed celluloses at levels up to 2% in the vehicle.
There was evidence that repeated doses up to 35 g/person of microcrystalline cellulose or
powdered cellulose did not adversely affect clinical chemistry and haematological parameters and had
no effect on the absorption and/or the metabolism of dietary constituents.
Some modiﬁed celluloses have been used in patients suffering from diarrhoea or constipation. In
general, it can be concluded that an oral ingestion of up to 6,000 mg/person per day for 8 months
was well tolerated.
Carboxy methyl cellulose was one of the food additives reported to alter the gut microbiota,
promote gut inﬂammation, promote obesity and to impair glycaemic control in mice (Chassaing et al.,
2015). Other emulsiﬁers have been reported to alter the gut microbiota, promote gut inﬂammation,
promote obesity and to impair glycaemic control in experimental studies with animals (Swidsinski
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et al., 2009a,b; Renz et al., 2012; Merga et al., 2014; Cani and Everard, 2015; Chassaing et al., 2015;
Romano-Keeler and Weitkamp, 2015; Lecomte et al., 2016; Shah et al., 2017).
The Panel noted that some of the effects associated with emulsiﬁers are not systematically studied
as speciﬁc endpoints in toxicity studies performed according to current toxicity testing guidelines,
therefore, they would have be investigated on a case-by-case basis if indicated by the results of the
general toxicity testing, as recommended in the Guidance for submission of food additives (EFSA ANS
Panel, 2012). However, the Panel noted that the histopathological ﬁndings reported in some of the
studies are not seen in long-term studies at high doses of celluloses.
The Panel considered that based on the animal data, the toxicity of microcrystalline, powdered and
modiﬁed celluloses was low and that NOAELs were generally the highest dose tested (up to at least
9,000 mg/kg bw per day). The available data in humans indicate that daily doses of up to 6,000 mg
for around 8 months were not associated with adverse effects; however in line with many other
dietary ﬁbres, large bolus intakes of celluloses were occasionally associated with laxation, but there
was a lack of dose–response data available. Overall, there were no indications that humans would be
more sensitive than laboratory animals.
The Panel considered that in line with the conceptual framework, it would be useful if risk managers
had an indicative total exposure (daily consumption value) for microcrystalline, powdered and modiﬁed
celluloses used as food additives, which would not pose a safety concern and uses up to this value would
not require a further risk assessment. The Panel considered this could be based on all the reported
NOAELs from subchronic and chronic toxicity studies (ranging from 2100 to more than 9000 mg/kg
bw/day either the highest doses tested or the highest doses tested not inducing nutritional
imbalance)taking into account human data and allowing for interindividual uncertainty. The
Panel considered that an indicative total exposure (daily consumption value) of around 660 to 900 mg/kg
bw per day for microcrystalline, powdered and modiﬁed celluloses could be identiﬁed.
To assess the dietary exposure to celluloses (E 460–466, E 468 and E 469) from their use as food
additives, the combined exposure was calculated based on (1) maximum levels of data provided to
EFSA (deﬁned as the maximum level exposure assessment scenario) and (2) reported use levels
(deﬁned as the reﬁned exposure assessment scenario brand-loyal and non-brand-loyal consumer
scenario).
Celluloses (E 460–466, E 468 and E 469) are authorised in a wide range of foods. The Panel did
identify brand loyalty to speciﬁc food categories in infants and toddlers (e.g. ﬂavoured drinks). Further,
the Panel considered that the non-brand-loyal scenario covering other population groups was
appropriate and a realistic scenario for risk characterisation because it was assumed that the
population would probably be exposed long-term to the food additive present at the mean reported
use level in processed food.
A reﬁned estimated exposure assessment scenario taking into account the FSMP for infants and
young children (FC 13.1.5.1 dietary foods for infants for special medical purposes and special formulae
for infants and 13.1.5.2 dietary foods for babies and young children for special medical purposes as
deﬁned by Commission Directive 1999/22/EC in which E 466 is authorised) was also performed to
estimate exposure for infants and toddlers who may be on a speciﬁc diet. However, no reported use
levels were made available by industry for these food categories. Thus, MPLs of E 466 for FSMP were
used. The Panel noted that according to Mintel, very few baby foods were on the European market
containing E 466. This was in line with the fact that no data were submitted for the food categories
13.1.5.1 and 13.1.5.2.
A reﬁned estimated exposure assessment scenario taking into account the consumption of food
supplements for consumers only was also performed to estimate exposure for children, adolescents,
adults and the elderly, as exposure via food supplements may deviate largely from that via food, and
the number of food supplements consumers may be low depending on populations and surveys.
The reﬁned estimates were based on 26 out of 84 food categories in which celluloses (E 460–466,
E 468 and E 469) are authorised. The Panel considered that the uncertainties identiﬁed would, in
general, result in an overestimation of the exposure to celluloses (E 460–466, E 468 and E 469) as
food additives in European countries considered in the EFSA European database for the reﬁned
scenario if it is considered that the food additives may not be used in food categories for which no
usage data have been provided.
The Panel noted that given the information from the Mintel’s GNPD, it may be assumed that
celluloses (E 460–466, E 468 and E 469) are used in food categories for which no data have been
provided by food industry. The main food categories, in terms of amount consumed, not taken into
account were processed fermented milk products, cheeses (unripened, processed), ﬁsh and ﬁshery
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products and breakfast cereals. However, according to the Mintel GNPD (Appendix B), in the EU
market, a small percentage (< 1%) of food products belonging to these food categories are labelled
with celluloses (E 460–466, E 468 and E 469). Therefore, the Panel considered that if these
uncertainties were conﬁrmed, it would result in a slight underestimation of the exposure.
The Panel further noted that the exposure to celluloses (E 460466, E 468469) from their use
according the Annex III to Regulation (EC) No 1333/2008 was not considered in the exposure
assessment.
The Panel also noted that the reﬁned exposure estimates were based on information provided on
the reported levels of use of celluloses (E 460466, E 468469). If actual practice changes, this
reﬁned estimates may no longer be representative and should be updated.
6. Conclusions
General population
Following the conceptual framework for the risk assessment of certain food additives re-evaluated
under Commission Regulation (EU) No 257/2010 (EFSA ANS Panel, 2014) and given that:
• their structural, physicochemical and biological similarities, allows for read-across between all
the celluloses
• animal and human data demonstrate that microcrystalline cellulose (E 460(i)) and powdered
cellulose (E 460(ii)) are not absorbed intact in the GI tract but could be fermented by intestinal
microbiota. Chemically modiﬁed celluloses are not absorbed intact, nor fermented, but are
excreted intact via the faeces
• using the read-across approach, adequate data on short- and long-term toxicity and
carcinogenicity and reproductive toxicity are available,
• despite the limitations of some of the studies, the available data do not indicate a genotoxic
concern for microcrystalline cellulose, methyl cellulose and carboxy methyl cellulose, and by
read-across, of the other modiﬁed and unmodiﬁed celluloses
• no adverse effects were reported after repeated doses up to 35 g/person of microcrystalline
cellulose or powdered cellulose; oral ingestion of some modiﬁed celluloses up to 6,000 mg/person
per day for 8 months in patients suffering from diarrhoea or constipation was well tolerated;
• adequate combined exposure data were available; in the general population, the highest 95th
percentile reﬁned exposure assessment estimates calculated based on the reported data from
food industry was 506 mg/kg bw per day in toddlers (brand-loyal scenario)
• an indicative high reﬁned exposure assessment of up to 448 mg/kg bw per day for the elderly
has been calculated at the 95th percentile among the population classes consuming food
supplements
The Panel concluded that there was no need for a numerical ADI and that there would be no safety
concern at the reported uses and use levels for the unmodiﬁed and modiﬁed celluloses (E 460(i);
E 460(ii); E 461–466; E 468 and E 469). The Panel further suggested an indicative total exposure
(daily consumption value from food additive use) of 660900 mg/kg bw per day where these
conclusions would remain valid.
Infants and young children consuming foods for special medical purposes and special
formulae
Concerning the use of sodium carboxy methyl cellulose (E 466) in ‘dietary foods for special medical
purposes and special formulae for infants’ (FC 13.1.5.1) and in ‘dietary foods for babies and young
children for special medical purposes as deﬁned in Directive 1999/21/EC’ (FC 13.1.5.2), and given that:
• for infants and toddlers consumers only of FSMP, the highest 95th percentile reﬁned exposure
estimate was 1,557 mg/kg bw per day in infants
• no adequate speciﬁc studies addressing the safety of use of sodium carboxy methyl cellulose
(E 466) in this population under certain medical conditions were available;
the Panel concluded, that the available data did not allow for an adequate assessment of the safety of
use of sodium carboxy methyl cellulose (E 466) in infants and young children consuming foods
belonging to the categories 13.1.5.1 and 13.1.5.2. The Panel noted that E 466 seemed not to be used
in these food categories as no use or use levels were submitted by industry and only very few food
belonging to these categories appeared to be labelled with E 466.
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7. Recommendations
The Panel recommended that:
• The European Commission considers lowering the maximum limits for the toxic elements
arsenic, lead, mercury and cadmium present as impurities in the EU speciﬁcations for
unmodiﬁed and modiﬁed celluloses re-evaluated in the present opinion (E 460(i), E 460(ii),
E 461, E 462, E 463, E 464, E 465, E 466, E 468, E 469) should be revised to ensure that
these food additives will not be a signiﬁcant source of exposure to these toxic elements in food.
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Abbreviations
AAS atomic absorption spectroscopy
ADI acceptable daily intake
AESGP Association of the European Self-Medication Industry
AGU anhydroglucose unit
AHP-WS wheat straw pretreated with alkaline hydrogen peroxide
ANS Panel EFSA Panel on Food Additives and Nutrient Sources added to Food
AOAC Association of Ofﬁcial Analytical Chemists
AP alkaline phosphatase
BUN blood urea nitrogen
bw body weight
CAS Chemical Abstract Service
CHL Chinese hamster ﬁbroblast cell line
CHO Chinese hamster ovary cells
CMC carboxy methyl cellulose
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DMSO dimethylsulfoxide
DP degree of polymerisation
DS degree of substitution (the average number of substituted hydroxyl groups per glucose)
EDA European Dairy Association
EDTA ethylenediaminetetraacetic acid
EHPM European Federation of Associations of Health Products Manufacturers
EINECS European Inventory of Existing Commercial Chemical Substances
EMA European Medicines Agency
EMC ethyl methyl cellulose
FAO Food and Agriculture Organization
FC freezing–cooking
FCS Food Classiﬁcation System
FDA Food and Drug Administration
FDE FoodDrinkEurope
FFA free fatty acids
FSE Food Supplements Europe
FSMP food for special medical purpose
GALT gut-associated lymphoid tissue
GC gas chromatography
GD gestation day
GI gastrointestinal
GLP good laboratory practice
GNPD Global New Products Database
GPC gel permeation chromatography
GRAS Generally Recognized as Safe
Hb haemoglobin
HDL high-density lipoprotein
HMWSDF high-molecular weight soluble dietary ﬁbres
HPC hydroxypropyl cellulose
HPLC high-performance liquid chromatography
HPMC hydroxypropyl methyl cellulose
ICGA International Chewing Gum Association
ICP-AES inductively coupled plasma atomic emission spectroscopy
IR infrared
JECFA Joint FAO/WHO Expert Committee on Food Additives
L-HPC hydroxypropyl cellulose of low substitution
LD50 lethal Dose, 50% i.e. dose that causes death among 50% of treated animals
LDL low-density lipoprotein
MA metabolic activation
MALDI MS matrix-assisted laser desorption/ionisation mass spectrometry
MC methyl cellulose
MCC microcrystalline cellulose
MHEC methyl hydroxyethyl cellulose
MPL maximum permitted level
MS mass spectrometry
NaCMC sodium carboxy methyl cellulose
NDA Panel EFSA Panel on Dietetic Products, Nutrition and Allergies
NDO non-digestible oligosaccharides
NMR nuclear magnetic resonance
NOAEL no observed adverse effect level
OECD Organisation for Economic Co-operation and Development
OFCA Organisation des Fabricants de produits Cellulosiques Alimentaires
OM organic matter
OPEFB oil palm empty fruit pulp
PCV packed cell volume
PCH propylene chlorohydrin
PMC propyl methyl cellulose
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QS quantum satis
RBC red blood cell
SCF Scientiﬁc Committee on Food
SCFA short-chain fatty acids
S-GOT serum glutamic-oxaloacetic transaminase
S-GPT serum glutamate pyruvate transaminase
TAMC total anaerobic microbial count
TYMC total combined yeast and mould count
UV/VIS ultraviolet/visual (spectrometry)
VFA volatile fatty acids
VLDL very low-density lipoprotein
WBC white blood cell
WG Working Group
WHO World Health Organization
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Appendix A – Summary of the reported use levels (mg/kg or mg/L as
appropriate) of celluloses (E 460–466, E 468 and E 469) provided by
industry
Appendix B – Number and percentage of food products labelled with
celluloses (E 460–466, E 468 and E 469) out of the total number of food
products present in the Mintel GNPD per food subcategory between 2012
and 2017
Appendix C – Concentration levels of celluloses (E 460–466, E 468 and E
469) used in the reﬁned exposure scenarios (mg/kg or mL/kg as
appropriate)
Appendix D – Total estimated exposure of celluloses (E 460–466, E 468
and E 469) from its use as a food additive for the maximum level exposure
scenario and the reﬁned exposure assessment scenarios per population
group and survey: mean and 95th percentile (mg/kg bw per day)
Appendix E – Main food categories contributing to exposure to celluloses
(E 460–466, E 468 and E469) for the maximum and reﬁned (brand-loyal
and non-brand-loyal) scenarios
Appendix A–E can be found in the online version of this output (‘Supporting information’ section):
https://doi.org/10.2903/j.efsa.2018.5047
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